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Human being are members of a whole, 
In creation of one essence and soul. 
If one member is afflicted with pain, 
Other members’ unease will remain. 
If you have no sympathy for human pain, 
The name of human you cannot retain. 
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Abstract  
The development of computer-assisted approaches capable of accurate 
prediction of the retention behaviour of analytes, leading to optimisation of 
chromatographic performance, is a major goal for method development in 
chromatography. Statistically-derived quantitative structure-retention 
relationships (QSRRs) represent a quite popular approach to retention 
prediction. Hydrophilic interaction chromatography (HILIC) is nowadays 
well known as a powerful technique for the separation of polar compounds. 
However, the detailed retention mechanism applicable in HILIC is still under 
some discussion and for this reason, method development in HILIC is 
difficult. 
The first part of this thesis concerns the application of QSRR methodology to 
predict the retention times of pharmaceutical test analytes on five HILIC 
stationary phases (bare silica, amine, amide, diol and zwitterionic), with a 
view to selecting the most suitable stationary phase(s) for the separation of 
these analytes. QSRR methodology seeks mathematical equations that 
correlate molecular features to chromatographic parameters. Genetic 
algorithm (GA) feature selection and partial least squares (PLS) regression 
were used to correlate experimental retention data to various density-
functional-theory-computed molecular descriptors. The predictive power of 
the QSRR models was successfully evaluated performing an external 
validation to predict retention times of test compounds. The QSRR models 
developed were also utilised to provide some insight into the separation 
mechanisms operating in the HILIC mode.  
The second part of this thesis describes a Quality-by-Design workflow, which 
combines QSRR methodology with design of experiments (DoE) principles 
 	 xi	
to successfully integrate predictive modelling into HILIC method 
development. DoE principles were first used to explore the chromatographic 
variables (percentage of acetonitrile, as well as pH and salt concentration) 
known to be effective in HILIC, followed by regression analysis to generate 
models capable of predicting retention parameters over a wide range of 
chromatographic conditions. The mathematical DoE model was shown to be 
highly predictive when applied to test conditions inside the design space. A 
QSRR model was then generated to predict retention times of test probes. A 
compound classification based on the concept of similarity was applied prior 
to QSRR modelling in order to enhance the predictive capability of QSRRs. 
Finally, the QSRR-DoE computed retention times of pharmaceutical test 
analytes and subsequently calculated separation selectivity factors were used 
to optimise the chromatographic conditions for efficient separation of targets. 
Quality assurance was achieved through the application of Monte Carlo 
simulation to propagate the prediction error. The desired separation for the 
target analytes was established experimentally, which confirmed the 
theoretical predictions.  
In the third and main part of the thesis, an in depth study on the strategies 
which enhance QSRRs prediction accuracy able to support HILIC method 
development was carried out. A similarity searching approach was applied in 
order to generate localised QSRR models, in which the retention of any given 
compound is predicted using only the most similar compounds in the 
available dataset. Two similarity measures were performed; retention factor 
ratio as a chromatographic similarity measure and Tanimoto index as the most 
popular similarity measure based on chemical structure. Prediction error was 
reduced when QSRR was based on similar compounds rather than using the 
entire dataset, with an excellent result for retention time (tR) similarity-based 
local models. However tR filtering is unable to be applied to a real-life 
 	 xii	
situation, as the retention time of a new analyte is unknown. To tackle this 
challenge, a novel QSRR methodology was presented based on a dual-
filtering strategy which combines Tanimoto similarity (TS) searching as the 
primary filter and tR similarity clustering as the secondary filter. To employ 
tR similarity filtering, correlation to a molecular descriptor was used as a 
measure of retention time. A comparison of diverse, global, TS-based and 
dual-filtering-based QSRR models over five different HILIC stationary 
phases showed that the proposed dual-filtering-based QSRR model was the 
most successful approach. 
 
		 	 xiii	
Table of content  
Declaration	........................................................................................................	iii	
Acknowledgements ..................................................................................... iv 
Statement of co-authorship ......................................................................... v 
List of publications and presentations ..................................................... vii 
Abstract ......................................................................................................... x 
Table of content ......................................................................................... xiii 
List of abbreviations ................................................................................ xvii 
1. Introduction ..................................................................................... 1 
1.1 Motivations and thesis overview ............................................................ 1 
1.2 Hydrophilic-Interaction Chromatography (HILIC) .............................. 2 
1.2.1 Retention mechanism in HILIC .......................................................... 3 
1.2.2 Stationary phases for HILIC ............................................................. 4 
1.2.3 Mobile phases in HILIC .................................................................... 8 
1.2.4 Application of HILIC in pharmaceutical analysis ............................. 11 
1.3 Retention prediction in HILIC ............................................................ 11 
1.3.1 Mechanism-based models ............................................................... 11 
1.3.2 Quantitative structure-retention relationships (QSRR) ...................... 15 
1.3.3 Linear solvation energy relationships (LSER) .................................. 16 
1.3.4 Hydrophilic-subtraction model ........................................................ 17 
1.4 HILIC method development ................................................................ 18 
1.4.1 Chromatography method development ............................................. 18 
1.4.2 Column scoping ............................................................................. 20 
       1.4.2.1 Determination of physico-chemical properties of the stationary 
phase  .................................................................................................... 20 
 	 xiv	
       1.4.2.2 Model-based column characterization .................................... 21 
       1.4.2.3 Chemometric methods ........................................................... 21 
1.4.3 Method optimisation ....................................................................... 22 
1.5 Quantitative structure-retention relationships (QSRRs) ..................... 25 
1.5.1 QSRR components .......................................................................... 26 
       1.5.1.1 Molecular descriptors ........................................................... 26 
       1.5.1.2 Feature selection ................................................................... 28 
       1.5.1.3 Regression analysis ............................................................... 29 
       1.5.1.4 Model validation ................................................................... 30 
1.5.2 QSRR accuracy .............................................................................. 31 
1.6 The concept of molecular similarity .................................................... 32 
1.6.1 Chemical representations ............................................................... 33 
1.6.2 Weighting scheme .......................................................................... 36 
1.6.3 Similarity coefficients ..................................................................... 36 
1.7 Summary of project aims .................................................................... 37 
1.8 References ........................................................................................... 39 
2. Experimental section and data collection ................................... 59 
2.1 Data collection ..................................................................................... 59 
2.1.1 Sample preparation ........................................................................ 59 
2.1.2 Standard solutions .......................................................................... 60 
2.1.3 Instrumentation .............................................................................. 61 
2.1.4 Design of experiments .................................................................... 62 
2.2 Model generation ................................................................................ 62 
2.2.1 Software ........................................................................................ 62 
2.2.2 Calculation of molecular descriptors ............................................... 91 
2.2.3 Genetic algorithm (GA) .................................................................. 92 
2.2.4 Partial least square regression (PLS) .............................................. 93 
2.2.5 Model validation ............................................................................ 93 
 	 xv	
2.3 References ........................................................................................... 95 
3. Prediction of retention in hydrophilic interaction liquid 
chromatography using solute molecular descriptors based on 
chemical structures ......................................................................... 100 
3.1 Introduction ...................................................................................... 100 
3.2 Method .............................................................................................. 103 
3.3 Results and discussion ....................................................................... 104 
3.3.1 Analytes and retention behaviour .................................................. 104 
3.3.2 QSRR modelling ........................................................................... 109 
3.3.3 Potential insights into the HILIC retention mechanism ................... 118 
3.3.4. Conclusions ................................................................................ 130 
3.4 References ......................................................................................... 130 
4. Rapid method development in hydrophilic interaction liquid 
chromatography for pharmaceutical analysis using a combination 
of quantitative structure-retention relationships and design of 
experiments ...................................................................................... 137 
4.1 Introduction ...................................................................................... 137 
4.2 Method .............................................................................................. 139 
4.2.1 Data set ....................................................................................... 139 
4.2.2 Compound classification ............................................................... 140 
4.2.3 QbD methodology ........................................................................ 142 
4.3 Results and discussion ....................................................................... 146 
4.3.1 Generation of DoE models ............................................................ 146 
4.3.2 Combined QSRR and DoE modelling ............................................. 154 
4.3.3 Prediction of the optimal separation conditions by applying    QSRR-
DoE-QbD methodology ......................................................................... 163 
4.3.4. Conclusions ................................................................................ 167 
4.4 References ......................................................................................... 169 
 	 xvi	
5. Use of dual-filtering to create training sets leading to improved 
accuracy in quantitative structure-retention relationship 
modelling for hydrophilic interaction liquid chromatographic 
systems ............................................................................................. 173 
5.1 Introduction ...................................................................................... 173 
5.2 Method .............................................................................................. 176 
5.2.1 Data set ....................................................................................... 176 
5.2.2 Model generation ......................................................................... 176 
       5.2.2.1 Similarity searching ............................................................ 176 
       5.2.2.2 Dual-filtering based QSRRs ................................................. 177 
5.3 Results and discussion ....................................................................... 177 
5.3.1 Tanimoto similarity (TS) searching into QSRR modelling ................ 182 
5.3.2 Incorporation of retention time (tR) similarity searching into QSRR 
modelling ............................................................................................. 193 
5.3.3 Dual-filtering based QSRR modelling ............................................ 194 
5.3.4 Relationship between molecular descriptors and the HILIC mechanism 
............................................................................................................ 205 
5.3.5 Conclusions ................................................................................. 206 
5.4 References ......................................................................................... 206 
6. General conclusion ...................................................................... 213 
 
		 	 xvii	
List of abbreviations 
Acronym  Representation  
3DMoRSE 3D-molecule representation of structure based on 
electron diffraction 
AC-Carn  O-acetyl-1-carnitine 
ACN  Acetonitrile  
AMW Average molecular weight 
AROM Aromaticity index 
ATSC1e Centred Broto-Moreau autocorrelation of lag 1 weighted 
by Sanderson electronegativity 
ATSC1s Centred Broto-Moreau autocorrelation of lag 1 weighted 
by I-state 
ATSC4s Centred Broto-Moreau autocorrelation of lag 4 weighted 
by I-state 
B3LYP Becke 3-parameter (exchange) with correlation by  Lee 
Yang and Parr 
BTMA Benzyltrimethylammonium 
CA Cluster analysis  
CAD Charged aerosol detector 
CATS Chemically Advanced Template Search  
CATS2D_08_DL CATS2D Donor-Lipophilic at lag 08 
Carn 1-carnitine 
CQA Critical quality attribute 
DAD  Diode array detector 
DFT Density functional theory 
DLS_02 Modified drug-like score from Oprea et al. (6 rules) 
DOE  Design of experiments 
ESI-MS Electrospray ionization mass spectrometry 
FA  Formic acid 
FD  Fluorescence detection 
 	xviii	
Acronym  Representation  
G3i 3rd component symmetry directional WHIM index / 
weighted by ionization potential 
G3u 3rd component symmetry directional WHIM index / 
unweighted 
G3v 3rd component symmetry directional WHIM index / 
weighted by van der Waals volume 
GA Genetic algorithm 
GATS3e Geary autocorrelation of lag 3 weighted by Sanderson 
electronegativity 
GATS3p Geary autocorrelation of lag 3 weighted by polarisability 
GETAWAY Geometry, topology, and atom-weights assembly 
HATS2p everage-weighted autocorrelation of lag 2 / weighted by 
polarisability 
HATS3s leverage-weighted autocorrelation of lag 3 / weighted by 
I-state 
HATS7u leverage-weighted autocorrelation of lag 7 / 
unweighted 
HCA Hierarchical cluster analysis  
HILIC  Hydrophilic interaction chromatography 
HOMT HOMA (Harmonic Oscillator Model of Aromaticity 
index) total 
HPLC  High performance liquid chromatography 
Hy Hydrophilic factor 
ICH International conference on harmonisation 
IEFPCM Integral equation formalism variant of the polarizable  
continuum model 
J_D Balaban-like index from topological distance matrix 
(Balaban distance connectivity index) 
JGI2 mean topological charge index of order 2 
JGI5 mean topological charge index of order 5 
K Retention factor 
K-ratio Retention factor ratio 
LOO Leave-one-out 
LMO Leave-many-out 
 	 xix	
Acronym  Representation  
LSER   Linear solvation energy relationship 
LVs Latent variables 
MAE Mean absolute error 
MAEP Mean absolute error prediction 
MATS1e Moran autocorrelation of lag 1 weighted by Sanderson 
electronegativity 
MATS2i Moran autocorrelation of lag 2 weighted by ionization 
potential 
MATS3i Moran autocorrelation of lag 3 weighted by ionization 
potential 
MATS1m Moran autocorrelation of lag 1 weighted by mass 
MATS2p Moran autocorrelation of lag 2 weighted by 
polarisability 
MATS6p Moran autocorrelation of lag 6 weighted by 
polarisability 
MATS1s Moran autocorrelation of lag 1 weighted by I-state 
MATS1v Moran autocorrelation of lag 1 weighted by van der 
Waals volume 
MeOH  Methanol 
MLOGP Moriguchi octanol-water partition coeff. (logP) 
MLR Multiple-linear regression 
MMff94 Merck molecular force field 
MOPAC Molecular orbital package 
Mor22s Signal 22 / weighted by I-state 
Mor23s Signal 23 / weighted by I-state 
Mor31s Signal 31 / weighted by I-state 
Mor28u Signal 28 / unweighted 
MP Mobile phase 
MS  Mass spectrometry 
NH4Ac Ammonium acetate 
NH4FA  Ammonium formate 
 	 xx	
Acronym  Representation  
NPLC Normal phase liquid chromatography 
nVar Number of selected variables 
OVAT   One-variable-at-a-time 
PCR ratio of multiple path count over path coun 
PLS Partial least squares 
PM7 Semi-empirical Parametric Method number 7 
PTMA Phenyltrimethylammonium 
PW3 path/walk 3 - Randic shape index 
Q2ext Correlation coefficient of external validation 
Q2LOO Correlation coefficient of leave-one-out 
Q2LMO Correlation coefficient of leave-many-out 
QbD Quality-by-design 
qnmax maximum negative charge 
QSAR Quantitative structure-activity relationship 
QSPR Quantitative structure-property relationship 
QSRR  Quantitative structure-retention relationship 
PCA Principal component analysis 
R5e+ R maximal autocorrelation of lag 5 / weighted by 
Sanderson electronegativity 
R6m+ R maximal autocorrelation of lag 6 / weighted by mass 
R6u+ R maximal autocorrelation of lag 6 / unweighted 
RF Random forest 
RMSECV Root mean square error of cross validation 
RMSEP Root mean square error of prediction 
RP-HPLC  Reversed-phase high performance liquid chromatography 
Si–H   Silicon hydride 
Si–OH   Silanols   
 	 xxi	
 
 
 
Acronym  Representation  
SaasC Sum of aasC E-states 
SP  Stationary phase 
SpMax_B(v) leading eigenvalue from Burden matrix weighted by van 
der Waals volume 
SpMax_B(m) leading eigenvalue from Burden matrix weighted by 
mass 
SpMax3_Bh(s) largest eigenvalue n. 3 of Burden matrix weighted by I-
state 
SpPosA_B(m) normalised spectral positive sum from Burden matrix 
weighted by mass 
TDB08s 3D Topological distance based descriptors - lag 8 
weighted by I-state 
TFA  Trifuoroacetic acid 
TMAO Trimethylamine-N-oxide 
tR Retention time 
TS Tanimoto similarity 
VIP Variable importance to projection 
WHIM weighted holistic invariant molecular  
Chapter	1	 	 	 	 	 Introduction	
 
 
1 
1 Introduction 
 1.1 Motivations and Thesis Overview 
Hydrophilic interaction chromatography (HILIC) has recently become 
popular in the separation science community [1]. The availability of a broad 
range of HILIC stationary phases provides opportunities for meaningfully 
different retention and separation selectivity. With ever more diverse 
stationary phases available, it becomes more challenging for analysts to 
select a suitable chromatographic system or even a starting point for method 
development. This is especially the case in high performance liquid 
chromatography (HPLC) method development for the pharmaceutical 
industry, where the analyst has to deal with ever more complex samples 
containing an increasing number of individual compounds that need to be 
separated. One attractive solution is the development of computer-based 
systems which would be able to predict the retention behaviuor of the 
analytes with good accuracy in a particular chromatographic system. This 
has inspired many chromatographers to devote a great deal of effort to 
propose possible strategies to accelerate HILIC method development with 
the aid of quantitative structure-retention relationship (QSRR) methodology 
[2]. This thesis aims to add to this work, exploring strategies for the 
acceleration of HILIC method development and the computational 
prediction of analyte retention times. 
This thesis comprises the development of retention prediction models for a 
variety of pharmaceutical compounds and commercially available stationary 
phases used in the HILIC mode. Strategies are proposed to enhance the 
predictive power of QSRR models using the concept of molecular similarity 
[3]. The proposed QSRR methodology is used in column scoping and 
optimising steps of HILIC method development. Furthermore, the 
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mechanism within HILIC columns is studied by analysis of the molecular 
descriptors obtained in the final QSRRs.  
1.2 Hydrophilic-Interaction Chromatography (HILIC) 
Reversed-phase HPLC (RP-HPLC), by far the most popular LC 
technique for pharmaceutical analysis, features an apolar stationary phase 
and a polar mobile phase. Consequently, retention increases when the 
polarity of the mobile phase increases and/or when the polarity of the 
analysed compounds and/or the stationary phase decreases [4]. The elution 
sequence goes from the most to the least hydrophilic (polar) compound. The 
main drawback of RP-HPLC is that it offers poor retention for hydrophilic 
compounds. 
In normal phase LC (NPLC), contrary to RP-HPLC, a polar stationary 
phase and an apolar mobile phase are used, leading to increased retention 
with decreasing mobile phase polarity, and/or increasing polarity of the 
analysed compounds and/or stationary phase [4]. The most apolar 
compounds are eluted first, and the most polar last. The main drawbacks of 
NPLC are that the nonpolar mobile phase solvents can be quite expensive, 
toxic or environmentally unfriendly, and polar compounds often show poor 
solubility in these solvents. 
The expression hydrophilic-interaction chromatography (HILIC) - 
coined by Alpert in 1990 [5] - defines an alternative chromatographic mode 
to RP-HPLC and NPLC. HILIC using a polar sorbent in combination with a 
hydro-organic mobile phase, provides an approach for the effective 
separation and quantitative determination of small polar compounds. Similar 
to NPLC, retention increases with decreased mobile phase polarity and/or 
with increased polarity of the analysed compounds and/or the stationary 
phase.  
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After experiencing a slow start [6, 7], in the past few years HILIC has 
become one of the preferred analytical techniques for the separation of polar 
compounds [8-11]. Recently, HILIC has been successfully applied to the 
analyses of a wide range of small polar compounds, including drugs, toxins, 
plant extracts, and other compounds important to the food and 
pharmaceutical industries. The reason for the increase in popularity is that 
HILIC offers an alternative to NP chromatography for the separation of 
polar compounds. HILIC mobile phases are of hydro-organic character, 
which permits, on the one hand, an excellent suitability for coupling to mass 
spectrometry (MS) detectors and especially for use with electrospray 
ionization mass spectrometry (ESI-MS), as acetonitrile-rich eluents assist 
spray formation and improve ionization efficiency, leading to enhanced 
detection sensitivity [12]. On the other hand, the NPLC drawback of 
insolubility of hydrophilic compounds is also largely solved in HILIC, 
because of its mobile phase properties. Moreover, HILIC has the well-
known advantage of alternative selectivity to RP liquid chromatography, 
that is, good retention for very polar compounds (compared with low 
retention in RP) [13], and simultaneously, it is characterised by low 
operational back pressures guaranteed by the low viscosity of the organic-
rich mobile phases used. 
1.2.1 Retention mechanism in HILIC 
Although HILIC has been widely applied, retention mechanisms of this 
chromatographic mode are still debated. The most accepted model is based 
on hydrophilic partitioning, i.e., partitioning of analytes between the mobile 
phase and the hydrophilic environment of the stationary phase [6, 14]. The 
polar surface of the HILIC stationary phases attracts water molecules, which 
are subsequently adsorbed to form a stagnant water-enriched liquid layer [5, 
15]. The acetonitrile-rich bulk and the water-enriched layer are two liquid 
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phases of different polarity and can be regarded as a liquid–liquid separation 
system. The HILIC separation mechanism is based primarily on the 
differential distribution of the analyte between these two phases. The more 
hydrophilic the analyte, the more the partitioning equilibrium is shifted 
towards the immobilized water layer on the stationary phase, and thus, the 
more the analyte is retained [6, 16]. A schematic view of the partitioning 
mechanism of a hydrophilic analyte in HILIC system is provided in Figure 
1.1.  
It is nowadays generally accepted that retention of analytes within a 
HILIC system is caused by not only partition-driven phenomena but also by 
surface adsorption (hydrogen bonding, dipole-dipole), electrostatic 
interactions (attractive or repulsive) with charges on the stationary phase 
and also to some extent hydrophobic interactions [6, 8, 13, 14, 17-23]. 
1.2.2 Stationary phases for HILIC 
Any polar stationary phase that can retain water may be used in the 
HILIC mode. With the growing interest in polar compound analysis, a large 
number of HILIC stationary phases have been developed on different 
supports (silica, polymers and hybrid materials) modified with many polar 
functional groups, such as amide, cyano, amino, diol, polyethylene glycol, 
poly(succinimide) and its derivatives, sulfoalkylbetaine, cyclodextrin, 
polyvinylalcohol, pentafluorophenyl-propyl, polypeptidyl and other polar 
functional groups [6, 24-26], which are suitable for a wide range of 
applications [25]. Most of the HILIC stationary phases are silica-based 
materials and can be arranged into roughly five groups, namely bare silica, 
amine, amide, diol and zwitterionic.  
Unmodified silica phases remain among the most popular of HILIC 
stationary phases, especially in pharmaceutical analysis [6, 26-29]. A  
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Figure 1.1. Scheme of the partitioning mechanism in a HILIC system. (Buszewski 
and Noga, Anal. Bioanal. Chem. 2012, © Elsevier; Reprinted with permission).  
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list of the applications of HILIC on unmodified silica columns in 
pharmaceutical analysis can be found in a recently published review [9]. 
Unlike chemically bonded silica phases, these phases are not subject to 
bleeding of the bonded phase from the column [30]. There are three types of 
bare silica materials, silica type A, silica type B and silica type C. Type A 
silica is prepared by precipitation of silicate solutions and type B silica can 
be prepared by the aggregation of silica sols in air [25, 31]. Unmodified bare 
silica gels type A and B are hydrophilic phases with silanol groups and 
siloxane bridges, which can display hydrogen donor and acceptor activities. 
At higher pH values, silanol groups are deprotonated and separation may be 
achieved through ion-exchange interactions for charged compounds. In this 
case, a cation-exchange mechanism takes place, to retain strongly 
positively-charged basic analytes, whereas negative analytes are poorly 
retained due to electrostatic repulsions. Type A and B silica materials can be 
contaminated with metal impurities during the preparation process. Type B 
silicas contain a lower amount of impurity and are more stable at 
intermediate and high pH compared with type A silicas. Type C silica gels 
are a class of less hydrophilic silica phases, consisting of a hydrosilation 
silica surface populated mostly with silicon hydride (Si–H) groups instead 
of silanols (Si–OH) groups [25]. This type of HILIC phase shows less 
attraction of water and consequently improved reproducibility of retention 
[32].  
Aminopropyl-bonded silica was the first bonded stationary phase of 
HILIC mode separations [33] and is still widely used in the HILIC mode for 
separations of sugars, amino acids, peptides, carboxylic acids, nucleosides 
and some pharmaceuticals [25]. The primary amino group is positively 
charged and therefore is thought to display an ion-exchange mechanism. 
Uncharged and polar analytes are retained primarily through hydrophilic 
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interactions, whereas anion-exchange interactions prevail in the retention of 
charged compounds with irreversible binding for acids [34]. Amino phases 
with ligands containing secondary or tertiary amino groups have the 
advantage over aminopropyl phases in that they provide symmetrical peak 
shapes, shorter retention times for acids [24, 25], and longer lifetimes of the 
columns [25].  
Chemically bonded diol phases, among the first chemically bonded 
silicas to be developed [35], usually have neutral hydrophilic 2,3-
dihydroxypropyl ligands. The diol phase is prepared by bonding 
glycidoxypropyltrimethoxysilane to the silica gel surface, followed by 
hydrolysis of epoxy groups. Diol phases demonstrate high polarity, 
hydrogen bonding properties and a relative absence of ionizable groups, 
meaning that they are nearly ideal for the HILIC mode [36]. Hydrogen bond 
interactions, in addition to the hydrophilic partitioning, may play an 
important role in the retention of polar analytes with hydrogen donor or 
acceptor functionalities. Related to the diol phase is the cross-linked diol, 
which contains hydroxyl groups present on the surface of the polymer 
coating and is prepared by cross linking the diol group through an ether 
linkage, thus forming a polymer layer on the silica surface [37]. HILIC on a 
diol column is suitable for the quantitative analysis of polar active 
pharmaceutical ingredients in drug formulations [25]. 
Amide phases are produced by functionalization of the silica gel surface 
with carbamoyl or amide groups, linked through an alkyl spacer. Amide 
phases do not possess basic properties, so the retention of ionizable 
compounds is not affected by ion-exchange interactions. They thus show 
good recovery [38], repeatability and reproducibility [39]. After Yoshida 
[40] (producer of TSKgel Amide-80 as one of the most popular phases) 
applied these phases to the separation of peptides, the amide-silica phase 
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soon found common usage in HILIC. This type of HILIC phase is also 
suitable for separations of oligosaccharides, glycoproteins, or various 
glycosides [39]. 
In addition, newer stationary phases, such as zwitterionic phases, have 
been developed. Zwitterionic stationary phases contain equal amounts of 
oppositely charged groups, which impart a net surface charge equal to zero. 
A common zwitterionic stationary phase is the sulfoalkylbetaine phase, 
constituted of positively charged quaternary ammonium and negatively 
charged sulfonate groups separated by a short alkyl spacer. Zwitterionic 
ligands strongly adsorb water to the surface, and partitioning of hydrophilic 
analytes into the water layer largely controls the retention mechanism [41]. 
In addition, hydrogen bonding and electrostatic interactions may contribute 
to the retention of charged compounds with hydrogen donor and acceptor 
activities. Electrostatic interactions with the zwitterionic phases are weaker 
than those with the charged materials, and both anionic and cationic species 
can be retained by zwitterionic phases. Application examples of zwitterionic 
HILIC columns are the separations of small polar compounds [42], 
metabolomes [43], glucosinolates [44], aminoglycosides [45], glycopeptides 
[46] and other compounds. 
Different selectivities can be obtained with amino, diol, amide and 
zwitterionic stationary phases, which are now becoming more popular as 
well as silica, and the option of different selectivities is considered to be the 
gold standard. The available stationary phases for HILIC have recently been 
reviewed by Guo and Gaiki [26] and Jandera [25]. 
1.2.3 Mobile phases in HILIC 
As discussed above, HILIC uses mobile phases with hydro-organic 
character in which a high percentage of organic solvent, typically between 
60-95%, is mixed with 5-40% water or aqueous buffer. HILIC retention is 
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strictly dependent on the composition and thickness of the water layer. 
Typically, a minimum of 2% of water is needed to enable the formation of 
the water layer on the surface of the polar stationary phase, and to create a 
layer which is thick enough to establish liquid-liquid partition with the bulk 
organic mobile phase [25]. The selection of the organic solvent has a strong 
effect on retention, elution order and peak shape in the HILIC mode. The 
ideal organic solvent should be miscible with water, but without hydrogen 
donor or acceptor functionalities. The elution strength of organic solvents in 
the HILIC mode increases by increasing solvent polarity and its ability to 
participate in proton-donor/proton-acceptor interactions. Relative solvent 
strengths in HILIC can be approximately summarised as follows: methanol 
> ethanol > isopropanol > tetrahydrofuran > acetonitrile (ACN) [47]. ACN 
is therefore the strongly preferred organic solvent in HILIC mode, while 
protic solvents (alcohols) that allow for hydrogen bonding interactions 
competing with water in the solvation of the stationary phases surface are 
not recommended [25, 48, 49]. Several attempts to replace acetonitrile with 
a less toxic solvent were reported with no success, as mobile phases 
containing other solvents (e.g. acetone, tetrahydrofuran) often provide 
insufficient sample retention, insufficient separation efficiency, lower 
intensity MS signals and significant band broadening [19, 23, 50-52]. The 
percentage of organic solvent in the mobile phase has a crucial influence on 
the retention observed in HILIC. In general, increasing concentration of the 
organic solvent (ACN) in the mobile phase enhances the retention of polar 
compounds on various types of stationary phases. The reason is that in a 
higher ACN concentration, a stronger interaction between the water 
molecules and the polar stationary phase takes place, allowing a stronger 
partitioning mechanism [25]. 
As mentioned above, the ion-exchange interaction on the charged 
stationary phases contributes significantly to the retention and selectivity in 
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HILIC. Early research indicated that the presence of buffer salts in the 
mobile phase allowed control of electrostatic interactions [53]. Salts 
commonly used in HILIC are ammonium acetate and ammonium formate 
due to their good solubility in mobile phases with high organic content and 
compatibility with mass spectrometric detection. The effect of the type and 
concentration of buffer salts on the retention of polar compounds on various 
polar phases has been investigated in several HILIC studies [8, 19, 20, 27]. 
In general, the presence of buffer salts in the mobile phase can effectively 
reduce the electrostatic interactions (both attractive and repulsive) of 
charged solutes with charged or zwitterionic HILIC stationary phases. In the 
case of electrostatic attractions, an increase in the salt concentration leads to 
decreased retention of charged solutes on stationary phases of opposite 
charge, whereas in the case of electrostatic repulsions, it leads to increased 
retention of charged solutes on stationary phases with the same charge [8]. 
Mobile phase pH is an important chromatographic factor since it can 
affect the charge state of both the stationary phase and the polar solutes. 
HILIC separations are usually performed with mobile phases in the pH 
range of 3–8, and formic and acetic acids are the common acid additives due 
to their volatility and MS compatibility. The residual silanols on the surface 
of silica-based stationary phases are significantly deprotonated at pH above 
5, leading to an increase in electrostatic interactions between the negatively 
charged stationary phases and positively charged solutes [54]. 
HILIC separations are performed either in the isocratic mode with a high 
percentage of acetonitrile or with gradients starting from 95% acetonitrile 
containing 5% aqueous ammonium acetate or ammonium formate buffer 
and ending with a high water concentration (up to 90%) to remove strongly 
retained sample compounds [16, 25]. 
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1.2.4 Application of HILIC in pharmaceutical analysis 
A wide variety of pharmaceutical compounds, including therapeutic, 
diagnostic, and preclinical drugs, as well as toxic compounds, have been 
analysed under the HILIC mode [9]. Pharmaceutical compounds and their 
metabolites often have ionizable functional groups, resulting in insufficient 
resolution, long equilibration requirements, poor retention and co-elution 
when applying the RPLC mode for separation [55]. HILIC is considered 
suitable to analyse the polar drugs and their metabolites, with higher signal-
to-noise ratios and thus better sensitivity, better retention and better peak 
shapes [55]. The application of HILIC analysis for some pharmaceutical 
compounds from publications in 2016 is summarised in Table 1.1. 
1.3 Retention prediction in HILIC 
Retention prediction modelling plays an important role in 
chromatographic method development. Several approaches are generally 
employed in retention modelling in HILIC, such as retention-mechanism-
based, quantitative structure–retention relationship (QSRR)-based, linear 
solvation energy relationship (LSER)-based and hydrophilic-subtraction-
based modelling approaches. 
1.3.1 Mechanism-based models 
In HILIC, the mechanism-based approach has mostly been used to 
discuss how retention behaviour is affected by the mobile phase 
composition, however the quantitative description of retention has received 
little attention [6, 41]. Many studies on the retention mechanism have 
centred around two common models, namely, partitioning and adsorption as 
described by eq (1.1) and eq (1.2) [74, 75]: log $ = &'($) − +,																												(1.1) 
	 
 
12 
 
T
able 1.1. C
onditions for analyses of pharm
aceutical analytes under H
ILIC
 m
ode 
A
nalytes 
C
olum
n 
M
obile phase 
D
etection 
R
ef. 
C
olum
n nam
e 
Functional 
group 
phenolic acids 
U
nitary X
A
m
ide 
am
ide 
A
C
N
/w
ater/FA
1 
Photo D
A
D
2 
[56] 
cotinine 
LunaH
ILIC
 
diol 
A
C
N
/N
H
4 A
c
3 
buffer 
(pH
 5.8) 
D
A
D
 
[57] 
neuro-
transm
itters 
X
B
ridge A
m
ide
TM
 B
EH
 
am
ide 
A
C
N
/N
H
4 FA
4 
buffer 
(pH
 3.0) 
M
S 
[58] 
lipids 
C
ogent D
iam
ond H
ydride 
silica 
A
C
N
/FA
/N
H
4 FA
 
buffer (pH
 4.0) 
M
S 
[59] 
am
ino acids 
A
ccucore A
m
ide H
ILIC
 
am
ide 
A
C
N
/N
H
4 FA
 
buffer 
(pH
 3.2) 
C
A
D
5 
[60] 
insulins 
A
C
Q
U
ITY
 U
PLC
 G
lyco-
protein B
EH
 A
m
ide 
am
ide 
A
C
N
/TFA
6/w
ater 
U
V-D
A
D
 
[61] 
veterinary 
drugs 
A
C
Q
U
ITY
 
U
PLC
 
B
EH
 
H
ILIC
 
hybrid silica 
A
C
N
/M
eO
H
7/N
H
4 FA
  
 
M
S/M
S 
[62] 
trisulfide 
A
cclaim
 
Trinity 
P1 
colum
n 
hybrid silica 
A
C
N
/N
H
4 FA
 
buffer 
(pH
 4.0) 
C
A
D
 
[63] 
β-blockers 
ZO
R
B
A
X
 
R
R
H
D
 
Poroshell 120-H
ILIC
 
silica 
A
C
N
/N
H
4 A
c 
buffer 
(pH
 7.5) 
U
V
 
[64] 
biothiols 
ZIC
-H
ILIC
 
Inertsil A
m
ide 
sulfoalkyl-
betaine 
am
ide 
A
C
N
/N
H
4 FA
 buffer 
(pH
 3.0) 
FD
8 
[65] 
choline, 
betaine, A
C
-
Phenom
e-nex 
Luna 
H
ILIC
 
diol 
A
C
N
/w
ater/N
H
4 A
c 
buffer (pH
 4.0) and 
M
S/M
S 
[66] 
	 
 
13 
C
arn
9, C
arn
10 
and TM
A
O
11 
A
C
N
/ N
H
4 FA
 buffer 
(pH
 3.0)  
 
cetirizine 
Poroshell 120 H
ILIC
 
silica 
A
C
N
/FA
 
M
S 
[67] 
m
iltefosine 
Phenom
enex Luna H
ILIC
 
diol 
M
eO
H
/FA
 
M
S/M
S 
[68] 
nicotine 
Phenom
enex Luna H
ILIC
 
diol 
A
C
N
/N
H
4 FA
 buffer 
(pH
 3.2) 
M
S/M
S 
[69] 
granisetron 
ZIC
-H
ILIC
 
sulfoalkyl-
betaine 
 
A
C
N
/N
H
4 A
c buffer 
(pH
 3.0) 
U
V
 
[70] 
glycans 
X
B
ridge B
EH
 A
m
ide 
am
ide 
A
C
N
/N
H
4 FA
 
M
S 
[71] 
genotoxic 
im
purities 
K
inetex H
ILIC
, 
Phenom
enex X
B
ridge 
H
ILIC
, and Prim
esep B
 
silica, silica, and 
am
ine 
A
C
N
/N
H
4 FA
/FA
 
Photo D
A
D
 
[72] 
am
ino acids 
A
C
Q
U
ITY
 
U
PLC
 
B
EH
 
am
ide 
am
ide 
A
C
N
/N
H
4 FA
/FA
 
M
S 
[73] 
1form
ic acid, 2diode array detector, 3am
m
onium
 acetate, 4am
m
onium
 form
ate, 5charged aerosol detector, 6trifluoroacetic acid, 7m
ethanol, 
8fluorescence detection, 9O
-acetyl-l-carnitine, 10l-carnitine, 11trim
ethylam
ine-N
-oxide. 
Chapter	1	 	 	 	 	 Introduction	
 
 
14 
!"#$ = !"#$& −	)*+& !"#,&																		 1.2  
where φ is the volume fraction and CB the mole fraction of solvent B 
(stronger solvent) in the mobile phase, kw is the extrapolated value of 
retention factor when φ = 0, and kB is the retention factor when CB = 1. S is 
the slope of log k versus φ when fitted to a linear regression model. AS and 
nB are the cross-sectional areas occupied by the solute molecule on the 
surface and the B molecules, respectively.  
The mechanism-based approach has also been used in modelling the 
retention of polar solutes in HILIC. Eq (1.1) represents the simplest 
partitioning model based on linear solvent strength theory, but it is only 
valid for narrow φ ranges. It relies on the assumption that there is a linear 
relationship between !"#$  and the mobile phase composition. Two 
modified partitioning models, a quadratic model (eq (1.3)) [76] and an 
empirical model (eq (1.4)) [77], have been proposed to describe retention 
behaviour more accurately than the linear model (eq (1.1)): ln $ = !+$2 + *14 + *245																											(1.3) 
ln $ = !+$2 + 2 ln 1 + *24 − *141 + *24																											(1.4) 
In addition, Liang and coworkers proposed a mixed model (eq (1.5)) to 
describe the retention behaviour of polar compounds in HILIC [78]: ln $ = !+$2 + *14 + *2!+4																									(1.5) 
where 4  is the fraction of water. They have applied the proposed 
quantitative descriptive retention equation to predict retention time of 
studied compounds under different mobile phase conditions. They 
investigated the retention of 8 nucleosides on 6 polar stationary phases with 
different functional groups and compared four retention models (eq (1.1), eq 
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(1.2), eq (1.3) and eq (1.5)). The mixed model seemed to fit the retention 
data better than the partitioning and adsorption models. Guillarme and co-
workers [79] investigated the possibility of retention modelling in the 
HILIC mode, testing equations (1.3), (1.4) and (1.5) using data generated 
with 9 compounds on 4 different HILIC stationary phases (a bare silica, a 
hybrid silica, an amide and a zwitterionic column). Among the considered 
mathematical models, the mixed model (eq (1.5)) was found to best fit the 
retention data and the quadratic model (eq (1.3)) gave the poorest fit in the 
isocratic mode, while the empirical model (eq (1.4)) seemed to be the best 
compromise for HILIC gradient mode prediction. 
1.3.2 Quantitative structure-retention relationships (QSRR) 
The fundamental assumption in QSRRs is that a relationship exists 
between molecular descriptors and retention parameters [80]. QSRR studies 
start from the selection and calculation of descriptors characterising the 
molecular structure of a series of analytes, followed by the use of 
computerized statistical chemometric techniques to derive mathematical 
models of retention parameters as a function of the molecular descriptors. 
Details of QSRR methodology are discussed in Section 1-5. QSRRs have 
been utilised to good effect: Jinno et al. [81] reviewed the application of 
QSRR methods in predicting the retention factors of adrenoreceptor agonists 
and antagonists in HILIC using predefined solute and mobile phase 
descriptors. Kaliszan et al. [82] developed an accurate QSRR model to 
predict the retention times of compounds (metabolites and drugs) analysed 
in the HILIC mode using multiple-linear regression (MLR). The obtained 
model allowed false positive identification to be removed during the 
interpretation of metabolomics data. Creek et al. [83] established a QSRR 
model incorporating six predefined physicochemical variables in a MLR 
model based on 120 authentic standard metabolites with good predictive 
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ability. Application of the model led to an improvement in metabolite 
identification. More recently, Cao et al. modelled the retention time in 
HILIC using a random forest (RF) algorithm for the purpose of peak 
annotation of plant metabolites [84].  
1.3.3 Linear solvation energy relationships (LSER) 
The LSER is known as a QSRR model that correlates the retention 
parameter of solutes to their characteristics as described by the Abraham 
parameters [85]. The conventional representation of the LSER model 
presented by Abraham et al. [85] is given in eq (1.6).  !"#$ = ; + <= + >* + ?) + @& + AB					(1.6) 
in this equation, capital letters represent the solute descriptors, related to 
particular interaction properties, while lower case letters represent the 
coefficients of the model or system constants, related to the complementary 
effect of the stationary phases. The model intercept term is c, which when 
the retention factor is used as the dependent variable is dominated by the 
phase ratio. The terms E, S, A, B, and V are solute-dependent molecular 
descriptors. E is the excess molar refraction and expresses polarisability 
contributions from n and π electrons; S is the solute dipolarity and 
polarisability; A and B are the solute overall hydrogen-bonding acidity and 
basicity; and V is the McGowan characteristic volume. To be able to apply 
the LSER model in the HILIC mode with a mixed mode mechanism, Chirita 
et al. [20] modified the conventional LSER model with two additional 
parameters which account for the electrostatic interactions of the charged 
solutes, as shown in eq (1.7) !"#$ = ; + <= + >* + ?) + @& + AB +	DEFE + DGFG				(1.7) 
where D− represents the negative charge carried by anionic solutes and D+ 
represents the positive charge carried by cationic solutes. The LSER model 
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has been successfully used for RPLC [86], however the statistical analysis 
of the regression equations showed that LSER is not accurate enough to 
support the retention prediction purpose in HILIC and its application is 
limited to column classification [20, 87].  
1.3.4 Hydrophilic-subtraction model 
The research group of Snyder and Dolan has published a series of articles 
dealing with the characterisation of a variety of RP stationary phases using a 
hydrophobic-subtraction model [88]. The column parameters have been 
determined for a wide range of columns, and are available from the U.S. 
pharmacopeia [89]. This group classified and compared stationary phases, 
providing a means to select stationary phases of different characteristics for 
method development. Other research groups [90] have also classified 
columns using the hydrophobic subtraction method in RP mode. 
More recently, Liang and co-workers developed a hydrophilic- 
subtraction model to describe the retention in HILIC, which is constructed 
using the same strategies applied to produce the hydrophobic-subtraction 
model [91]. The hydrophilic-subtraction model was designed based on the 
major interactions governing HILIC retention, including hydrophilic 
partitioning, hydrogen-bonding and electrostatic interactions as shown in eq 
(1.8): !"#$ = !"#$I<J + ℎL + ?) + @& + ;, + DF										(1.8) 
where k is the retention factor of a given solute, and kref the value of k for a 
reference compound on the same column under the same conditions. In eq 
(1.8), all the capital letters are solute descriptors: H, hydrophilicity; A, 
solute hydrogen-bond acidity; B, solute hydrogen-bond basicity; C, solute 
cation-exchange activity; and D, solute anion-exchange activity. The lower-
case letters (h, a, b, c, d) are the system constants reflecting the magnitude 
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of difference in the particular interactions between the stationary phase and 
the mobile phase. A multiple linear regression was performed to calculate 
all the solute descriptors and system constants. This approach was 
successfully applied for HILIC column classification purposes. The high 
correlation coefficients (R2 ≥ 0.990) of the hydrophilic-subtraction model 
may indicate the reliability of this model for retention prediction of analytes. 
1.4 HILIC method development 
1.4.1 Chromatography method development 
In the development of a chromatographic method three stages can be 
considered. The first stage is to select the appropriate chromatographic 
technique, which provides the desired separation selectivity for the 
particular analytes to be separated (method selection). The next stage (stage 
2) is to choose the particular combination of SP (i.e. which chromatographic 
column), MP (i.e. which liquid or mixture of liquids), and type of flow-
through detector, which is most likely to lead to a successful separation. In 
this step, the retention of the substances is often optimised by selecting a 
mobile phase with an acceptable solvent strength (retention optimisation). 
Retention has to be sufficiently low to obtain an acceptable analysis time, 
but also sufficiently high to achieve separation of the compounds of interest. 
Conditions leading to an acceptable retention do not necessarily lead to the 
separation of all peaks.  
The final stage (stage 3) of method development is to identify the precise 
details of the separation, such as the exact MP composition, the flow-rate, 
the column length, the temperature, etc. In this stage, first, organic modifier 
composition is adapted (by e.g. replacement of one organic modifier by 
another one, or a change in the pH and/or the ionic strength of the buffer in 
the mobile phase) in order to achieve selectivity (selectivity optimisation) 
followed by the optimisation of the system (system optimisation). In the 
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latter step, system parameters such as the column length, the particle size 
and the flow-rate can be changed in order to further improve the resolution 
or the sensitivity of the method, or to reduce the analysis time while a 
similar separation is maintained. In the system optimisation phase the best 
experimental conditions for a sufficient resolution of the relevant peaks that 
gives acceptable and preferably robust results in a short analysis time are 
defined. For clarity, throughout this thesis we will refer collectively to 
stages 1 and 2 as “scoping” the LC method, and stage 3 as “optimising” the 
LC method.  
The traditional approach (one-variable-at-a-time (OVAT) approach) to 
LC method development is to systematically vary one parameter at a time 
while keeping the others constant. The best performing level of the varied 
parameter is identified normally by visual inspection of the trial 
chromatograms; the parameter is then fixed at this level, and a new 
parameter is selected for the next iteration. In the OVAT process, factors are 
examined sequentially until an adequately performing instrumental method 
is obtained. At present, most of the method development undertaken in the 
pharmaceutical and other industries is carried out by the OVAT process, 
which is not only time-consuming and costly but can lead to 
chromatographic methods that are not inherently robust and are poorly 
understood. That is, a small change in an experimental parameter can lead to 
a major loss in performance of the method. This OVAT process requires 
screening of multiple types of LC techniques and numerous 
chromatographic columns using a large number of experimental conditions, 
which generates significant waste of resources (both human and 
instrumentation) as well as excessive consumption of organic solvents. New 
advances in combinatorial chemistry have enabled pharmaceutical industries 
to synthesize a much greater number of potential new drugs than at any time 
Chapter	1	 	 	 	 	 Introduction	
 
 
20 
in the past. As a result, analytical method development is also required to be 
fast enough to keep up with the high-throughput drug discovery processes.  
1.4.2 Column scoping 
Hundreds of HILIC stationary phases have been tested and characterised 
in the literature. Several approaches for the analysis of the stationary-phase 
chemistry have been established, and can be divided into chromatographic 
test methods and chemometric methods. The chromatographic tests can be 
further divided into the determination of physico-chemical properties and 
model-based tests. The information obtained from column classification 
helps prospective users to select columns needed for their specific purposes. 
1.4.2.1 Determination of physico-chemical properties of the stationary phase  
This method of column characterisation is helpful to classify HILIC 
stationary phases on the basis of their chromatographic properties. Such 
properties can be determined using retention/separation information of 
given solutes that are known to reflect given stationary phase properties. 
Kawachi et al. [17] have analysed 14 commercially available HILIC 
columns in terms of their degree of hydrophilicity, selectivity for 
hydrophilic/hydrophobic substituents, regio-selectivity and configurational 
differences in hydrophilic substituents, selectivity of molecular shapes, 
evaluation of electrostatic interactions and evaluation of the acidic/basic 
nature of the stationary phase using model nucleoside, phenyl glucoside and 
xanthine derivatives as probe analytes. They used radar plots to classify the 
stationary phases and to illustrate the characteristics of each phase visually. 
Ibrahim et al. [92] have characterised 30 HILIC stationary phases by 
constructing simple selectivity plots capable of classifying different HILIC 
phases based on their hydrophilicity and ion-exchange properties.  
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1.4.2.2 Model-based column characterisation 
This characterisation is based on building a specific model, such as the 
linear solvation energy relationships or the hydrophobic subtraction model. 
The model coefficients provide information on the properties of the column, 
such as e.g. its hydrophilicity, hydrogen-bonding acidity and basicity, 
electrostatic interactions and steric resistance to the insertion of bulky 
molecules into the stationary phase. Schuster et al. [87] employed the LSER 
[20] approach to characterise 22 commercially available and home-made 
HILIC columns. Hierarchical cluster analysis (HCA) according to the 
obtained normalised LSER coefficients revealed that the stationary phases 
could be arranged into three main groups: acidic, basic and neutral. More 
recently, Wang et al. [91] have established a hydrophilic-subtraction model 
using a set of 41 solutes and 8 HILIC columns. A hydrophilic-subtraction 
model correlates the retention with solute descriptors and column 
parameters. The model was successfully validated by characterising 15 test 
HILIC columns. The model regression coefficients were used to 
characterise HILIC stationary phases by an angle graph and a spider 
diagram, which could be used as guidance for researchers to select 
appropriate columns for their specific purposes.   
1.4.2.3 Chemometric methods 
Chemometric methods can be used to handle and interpret data sets from 
chromatographic tests and do not directly analyse stationary phase 
chemistry or properties. Such methods include principal component analysis 
(PCA) and cluster analysis (CA), which help to classify columns in groups 
based on similar (or dissimilar) properties. This can then simplify column 
selection procedures. Chirita et al. [54] have considered several 
neurotransmitters as model compounds and they have evaluated the 
retention data of 12 HILIC columns by performing PCA calculations. They 
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have then proposed a method development scheme useful to help in the 
initial choice of a HILIC stationary phase for the separation of polar targets. 
Lammerhofer et al. [93] have evaluated 19 mixed-mode columns based on 
their hydrophobic selectivity and ion-exchange capacity under HILIC and 
RPLC modes using PCA calculations. They have employed xanthines, 
nucleosides and vitamins as model analytes. Dinh et al. [18] conducted an 
extensive study on 22 hydrophilic and polar HILIC stationary phases using 
PCA calculations, taking into account their hydrophilic, hydrophobic, 
electrostatic, hydrogen bonding, dipole–dipole, π-π interaction and shape-
selectivity interactions, using a set of 21 hydrophilic probe compounds. 
They have classified the columns into four functional groups based on their 
selectivity: (1) cation-exchange – unmodified silicas; (2) anion-exchange – 
columns with amino functionality; (3) dipole-dipole and multi-point 
hydrogen bonding – polymeric sulfobetaine and polysulfoethyl phases; (4) 
low specific interaction group – hydroxyl, diol, amide, and monomeric 
zwitterionic phases. More recently, Periat et al. [23] have provided some 
guidelines for HILIC method development in pharmaceutical analysis. For 
this purpose, they have analysed five HILIC stationary phases (bare silica, 
hybrid silica, amide, diol and zwitterionic) under various mobile phase 
conditions based on PCA, HCA and correlation maps, employing a diverse 
set of 82 pharmaceutical compounds. The chemometric analysis revealed 
that the diol and hybrid silica phases were similar in both retention and 
selectivity, and the bare silica and amide phases appeared to be in separate 
groups in terms of selectivity, while the zwitterionic phase was found to 
behave differently from the other phases.  
1.4.3 Method optimisation 
Method optimisation can, generally, be conducted in two ways, 
univariate or multivariate. As mentioned above, usually the OVAT approach 
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is used, which is univariate in nature. Various publications on univariate 
HILIC method development reported in the literature have been reviewed 
by Dejaegher et al. [94]. A drawback of these methods is that they are time-
consuming due to the large number of experiments that must be conducted 
in order to determine the effect of each parameter on the retention of the 
analytes. Thus, the need to maximise the efficiency of scientific discovery in 
order to minimize waste and cost, has caused researchers to do smarter 
experiments that give the most information possible with the fewest 
experiments.  
An alternative to the single variable approach is the use of a Quality-by-
Design (QbD) methodology for LC method development [95, 96]. A QbD 
methodology for LC method development uses a statistical experiment 
design plan (Design of Experiments, or DOE) [97] to systematically vary 
multiple study factors in combination through a series of experiment trials 
that, taken together, can comprehensively explore a multi-factor design 
space. Such a design can provide a data set which can be used to identify 
and quantify interaction effects of the factors. This quantitation translates 
the design space into a knowledge space. This increased depth of knowledge 
leads to the possibility that the process can be designed to operate robustly 
and to be capable of tolerating small changes in experimental variables 
without loss of performance. In turn, this allows the developed process to be 
transferred successfully between locations where both personnel and 
instrumentation differ. When applied to chromatographic methods, QbD 
principles dictate that the specific experimental conditions used for a 
particular separation should be able to provide and maintain optimal 
performance, even when there are slight changes in these conditions [98]. A 
general QbD guide for separation method development is shown in Figure 
1.2.
Chapter	1	 	 	 	 	 Introduction	
 
 
24 
While the classic theories of experimental design have been around since 
the middle of the twentieth century, adoption of DOE methods in 
chromatography research has seen increased activity only in the past decade. 
Although experimental design-based procedures have already been applied 
successfully to optimise other analytical methods, e.g. RP-HPLC and NPLC 
methods, unfortunately, only a few HILIC methods found in the literature 
have been optimised using an experimental design approach [23, 26, 99-
102]. The DOE method is a planned series of experiments with changing 
variables describing the experiment in the most efficient way [103]. The aim 
of DOE is to get the best description of the response surface, which is a 2D 
or 3D plot showing the influence of one or more variables on an output 
response.  
In an experimental design approach, different steps can be distinguished. 
First, the factors to be examined should be defined as well as the level 
intervals in which these factors will be evaluated. Factors to be optimised in 
the HILIC mode using the DOE method can include the acetonitrile content 
in the mobile phase, buffer concentration and pH of the mobile phase, and 
column temperature [99, 100]. After choosing factors, a screening design is 
usually applied that allows the examination of a relatively high number of 
factors in a feasible number of experiments [104]. The factors most 
influencing the assay can then be determined by analysing the results of the 
screening design. Subsequently, these factors then can be further evaluated 
using a response surface design methodology [104], in which a relationship 
between responses to values of one or more factors is established. In the 
response surface design step, an optimisation design is selected which is 
determined by the definition of the responses. For separations, responses 
related to the quality of the separation/method, such as resolution and 
retention factor, are usually selected. In a further optimisation phase, the 
experimental protocol is defined and the required experiments are 
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performed. For each experiment, the responses are measured or calculated. 
Consequently, data analysis is performed on the design results. For a 
response surface design, the response is usually modelled by a second order 
polynomial model and then a 2-D contour plot or a 3-D response surface can 
be drawn to visualize and to determine the best and most robust conditions.  
Before an optimised method can be used in routine analysis, method 
validation is performed to show that the method is capable of doing what is 
claimed. Before starting with method validation often a robustness or 
ruggedness test is performed. In a robustness/ruggedness test one evaluates 
the influence of small variations in the procedure on the performance of the 
method. These small variations are deliberately introduced and represent 
variations that could occur when a method is transferred, e.g. from one 
laboratory to another.  
1.5 Quantitative structure-retention relationships (QSRRs) 
QSRR methods represent a powerful tool in chromatography and are 
intensively studied for chromatographic retention predictions [80, 105, 106]. 
QSRRs, as the name suggests, are techniques for relating the variations in 
one response variable (Y-variable) to the variations of several descriptors 
(X-variables), with predictive purposes. Y-variables are often called 
dependent and X-variables independent variables. One of the Y- or X-
variables should be related to chromatographic retention, the other should 
encode the molecular structure. QSRR methodology assumes that 
chromatographic behaviour of analytes is correlated with the chemical 
structure and that as a consequence chromatographic characteristics can be 
modelled as a function of calculable molecular descriptors. QSRR 
methodology is used for the solution of the following problems in analytical 
chemistry: (i) the identification of the most informative structural 
descriptors, (ii) understanding of molecular mechanisms of separation under 
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chromatographic conditions, (iii) the quantitative comparison of separation 
properties of chromatographic columns, (iv) the prediction of retention of 
new compounds or identification of unknown compounds.  
A scheme of the QSRR methodology is shown in Figure 1.3. A typical 
QSRR study comprises the following steps: compilation of a database of 
retention of analytes of known structures, structure entry in order to estimate 
descriptors, descriptor selection, model building, and model validation. 
1.5.1 QSRR components 
1.5.1.1 Molecular descriptors 
There are three common ways of structure representations, whole 
molecule 1D descriptors (sometimes known as 0D), 2D descriptors, and 3D 
descriptors. 1D descriptors attempt to express chemical information in a 
simple 1D molecular code and are designed for compact storage of 
information. These pre-defined codes allow the measurement of whole 
molecule descriptors, which represent the bulk molecular properties. 2D 
descriptors are computed from a chemical structure that is represented as a 
connection table or a molecular graph. In the graphical representation of 
molecular structures, atoms in the molecular structure are represented as 
vertices while bonds are represented as edges. 3D molecular descriptors 
provide molecular information about the 3D arrangement of structural 
features and general molecular surfaces and volumes. There are many 
thousands of descriptors defined in a comprehensive handbook [107]. 
Dragon software [108] is widely used to calculate molecular descriptors 
for QSRR modelling. Generally, the Dragon calculated descriptors encoding 
the molecular structure are classified in 22 different types: constitutional 
(1D), functional group counts (1D), atom-centred fragments (1D), charge
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Figure 1.2. Quality-by-design guide for analytical method development. 
 
 
Figure 1.3. scheme of the QSRR methodology. 
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descriptors (1D), molecular properties (1D), topological (2D), walk and path 
counts (2D), connectivity indices (2D), information indices (2D), 2D 
autocorrelation (2D), edge adjacency indices (2D), Burden eigenvalues 
(2D), topological charge indices (2D), eigenvalue-based indices (2D), 2D 
binary fingerprints (2D), 2D frequency fingerprints (2D), Randic molecular 
profiles (3D), geometrical descriptors (3D), Radial Distribution Function 
(RDF) descriptors (3D), 3D-MoRSE (3D Molecular Representation of 
Structure based on Electron diffraction) descriptors (3D), WHIM (Weighted 
Holistic Invariant Molecular) descriptors (3D), and GETAWAY (Geometry, 
Topology and Atoms-Weighted AssemblY) descriptors (3D). 
Chemometric methods are utilised to identify the subset of descriptors 
that shows the strongest ability to predict retention times (feature selection) 
and to derive a mathematical relationship between analyte descriptors and 
retention time (regression technique). The goal is to use the smallest number 
of analyte descriptors commensurate with a valid prediction of retention 
time (see below).  
1.5.1.2 Feature selection 
One of the most important processes in QSRRs is feature selection, 
which is applied to select the most relevant variables (descriptors) from a 
large pool. Feature selection is important because some variables in a given 
data set may be redundant, be irrelevant or represent noise [109, 110]. 
Feature selection can provide faster and more cost-effective models by 
helping to avoid overfitting when modelling, improving the model 
performance, and reducing the model dimensions [109, 110]. In addition, 
feature selection can help in interpretation of the retention mechanism by 
gaining knowledge about the most important features [72]. Many feature-
selection techniques have been applied in QSRR studies, such as genetic 
algorithms on MLR (GA-MLR) [111], partial least squares regression [112, 
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113], artificial neural networks [114, 115], support vector machines [116], 
classification and regression trees [117, 118], and random forests [118]. 
1.5.1.3 Regression analysis 
Multiple linear regression (MLR) was the first statistical tool used widely 
for QSRR models [105, 106]. With the introduction of additional molecular 
descriptors, many new chemometric modelling tools have been applied to 
QSRR modelling in order to handle the greater number of variables [119].  
Partial least squares (PLS) regression is a linear, multiple regression 
method used frequently in chemometrics and multivariate calibration 
studies. Unlike MLR, PLS is particularly useful in reducing the 
dimensionality of the large set of independent molecular variables even in 
the presence of co-linearity, redundancy, and noise in both independent and 
dependent variables [120, 121]. In mathematical terminology, PLS 
summarises the variation in the independent variables into a small set of 
orthogonal, linear, latent variables (LVs) by maximising the covariance 
between molecular descriptors and the dependent variable [122, 123]. The 
complexity of the model is controlled by optimising the number of LVs, 
thus over-fitting can be minimized. The PLS method can be expressed as  y = a1LV1 + a2LV2 + ⋯+ amLVm																									 1.9  
where y  is the dependent variable, a1, a2, … , am  are the regression 
coefficients, and LVi is the ith latent variable, that is, a linear combination 
of the independent variables xi LVi = b1x1 + b2x2 + ⋯+ bnxn																																	 1.10  
where xi  is the i th independent variable and 	bi  is the i th variable 
coefficient.
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1.5.1.4 Model validation 
The statistical reliability of QSRR models should be validated, and this 
can be performed by several approaches including leave-one-out cross 
validation, leave-many-out cross validation, y-randomization, and external 
validation. 
Leave-one-out (LOO) cross validation [119] is one of the simplest 
procedures for model validation. It consists of excluding each analyte once, 
constructing a new model without this compound, and then predicting the 
value of its retention parameter. Therefore, for a training set of M samples, 
LOO is carried out M times, resulting in M predicted values. The residuals - 
the differences between the experimental and predicted values from the 
model - are used to calculate the root mean square error of cross validation 
(RMSECV) and the correlation coefficient of leave-one-out cross validation 
(Q2LOO), as presented in eq (1.11) and eq (1.12), respectively. The minimum 
acceptable statistics for regression models in QSRR include conditions Q2 > 
0.5 [124]. 
[\*=,B = (]^ "@>D − ]^(_I<D))5a`bc + 																			(1.11)	
d5 = 1 −	 ]^ "@>D − ]^ _I<D 5a`bc ]^ "@>D − ] e<?+ 5a`bc 																									(1.12)	
where yi(obsd) and yi(pred) are the observed and predicted retention 
times of the left out analyte from the training set during cross validation. 
The y(mean) is the average value of the observed retention times and n is 
the number of analytes.  
Leave-many-out (LMO) cross validation [125, 126] is performed by 
partitioning the data set randomly into a validation data set consisting of d 
analytes and the construction data subset, which contains the remaining (M 
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– d) compounds. The data splitting process is repeated many times and the 
cross-validated error estimates are averaged over all data splits. LMO cross-
validated correlation coefficients (Q2LMO) are calculated in the same way as 
for LOO (eq (1.10)). It is recommended that d represents 20-30% of the 
dataset [127], and it has been shown [128] that repeating the LMO cross 
validation for randomly ordered data and using average of Q2LMO is 
statistically more reliable than LMO being performed only once.  
The purpose of the y-randomization test [129] is to detect and quantify 
chance correlations between the dependent variable and the descriptors. The 
y-randomization test consists of several runs for which dependent variable 
values are scrambled and new QSRR models are developed using the 
original descriptors values (unrandomized or real values). For an acceptable 
QSRR model, the predictive ability of the real model should be stronger 
than that of the randomized models. 
External validation testing requires the split of the complete data set into 
training and external validation sets. The purpose of this validation is to test 
the predictability of the QSRR model. Basic statistical parameters that are 
used to judge the external validation performance are the root mean square 
error of prediction (RMSEP), and the correlation coefficient of external 
validation (Q2ext), which are calculated in the same way as for internal 
validation, eq (1.11) and eq (1.12) respectively. Here yi obsd  and yi pred  are the observed and predicted retention times of the test 
compounds. 
1.5.2 QSRR accuracy 
The predictive accuracy of a QSRR model is influenced by the following 
basic operations: (i) the feature-selection method applied to select the most 
relevant descriptors, (ii) the modelling approach used for the building of the 
QSRR, (iii) the model validation approach (e.g. splitting the dataset into 
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training and test set), (iv) the number of predictor variables (descriptors) 
that are incorporated into the model, (v) the geometry optimisation method, 
(vi) the size of whole dataset, and (vii) the range of diversity or similarity of 
the molecular structures or characteristics. 
One concern occurs when a diverse data set, covering a wide range of 
chemicals, is utilised to find a global QSRR model. The retention time 
prediction accuracy may not be sufficient to provide a reliable method 
because such a diverse dataset with different molecular characteristics and 
structures is forced into a general model. QSRR models based on 
compound-classification may provide greater predictive power compared 
with the QSRR models derived from the diverse dataset. This compound-
classification based QSRR modelling strategy has been validated in a few 
papers. For example, Wang et al. [130] presented subset-specific models by 
using a compound classification method based on log D profile similarity. 
The result showed that while the predictive accuracy for QSRR models 
derived from subsets consisting of molecules with similar log D profiles 
might not have improved compared to traditional QSRR models, there was 
improved elution order prediction in acidic and basic chromatographic 
conditions. Muteki et al. [131] have also assessed the reliability of the 
QSRR prediction and found that the compound-classification based QSRR 
methodology significantly improved the retention time predictability of 
compounds by comparing with the global models.  
The present thesis presents a novel scheme of compound-clustering based 
QSRR modelling based on the concept of molecular similarity. 
  1.6 The concept of molecular similarity 
The essence of the molecular similarity concept, which originates from 
the comprehensive book “In concepts and applications of molecular 
similarity” written by Johnson and Maggiora [132], is that structurally 
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similar compounds are more likely to exhibit similar properties. From this, 
an area of interest has been the prediction of properties of chemical 
compounds on the basis of molecular similarity [133-137]. The term 
similarity is used widely for determination of quantitative relationships 
between the structure and properties of compounds (QSPR analysis) through 
cluster analysis [134, 137], similarity searching [136] and diversity analysis 
[138]. Cluster analysis and similarity searching allow the use of a similar 
subset as a training set as an alternative to the diverse training set 
traditionally used in QSRR studies. While comparing diverse and similar 
datasets for the modelling of structure-retention relationships, one may 
notice that in a diverse dataset method, the model reflects the properties of 
diverse compounds; therefore, a novel compound may be dissimilar to the 
compounds in the training set and the target may have properties that are not 
found in the training set. On the other hand, in the case of a similar dataset, 
the model takes into account the properties of similar compounds to the 
novel compound. 
The degree of resemblance between two compounds is calculated using a 
similarity measure, which has three components: (i) a structural 
representation, used to represent the two compounds that are to be 
compared, (ii) a weighting (standardisation) scheme, used to normalise the 
different parts of the chosen representation, and (iii) a similarity coefficient, 
used to calculate the degree of resemblance between the molecules’ 
representations. There is a comprehensive review on the three components 
of similarity by Willett [3] and this thesis hence briefly discusses these three 
components. 
1.6.1 Chemical representations 
In similarity calculations, a combination of 1D molecular descriptors 
may be used to represent a relevant property, normally after some sort of 
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standardisation procedure. An overview of 1D similarity measures is given 
by Dixon [139]. 
2D molecular descriptors are a straightforward chemical representation 
used to easily calculate the structural similarity between molecules. Most 
approaches using 2D structural description to quantify chemical similarity 
can be grouped into two broad classes. First, there are topological indices, 
which are single numbers that typically characterise a structure based on its 
size and shape [140]. The most well-known topological indices and their 
applications in chemistry are described in the reviews by Balaban and 
Estrada [141, 142]. Second, there are some approaches in which a molecule 
is described based on some count of shared substructure features, either by 
the molecule’s connection table [143-146] or the fragment substructure 
encoded by setting-bits in a bit-string (or fingerprint) [147, 148].  
Different types of fragment coding systems are available, which fall into 
two major classes: dictionary based fingerprints and open-ended list based 
fingerprints. The dictionary-based fingerprints represent dictionaries of 
predefined structural fragments. Structural ‘keys’ [149] is the simplest form 
of substructure fingerprints; each bit position in the string is associated with 
a specific molecular feature and is, therefore, dependent on a predefined list 
of structural fragments. In the dictionary-based fingerprint, the presence of 
individual fragments in a structure can be described as a sequence of 0s and 
1s, where 0 means that the fragment is not present in the structure and 1 
means that it is present. 
The open-ended list based fingerprints involve the hashing of unique 
structural paths. In this approach, individual bit positions are characterised 
by the nature of the chemical structures in a database rather than specific 
features in some database. Daylight Chemical Information [150] and 
ChemAxon hashed fingerprint [151] are typical examples of a hashed 
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fingerprint encoding method, which encode molecular features into a bit 
string of fixed format by applying a hash function to map possible paths 
through the molecular graph. Other fingerprint designs use a combination of 
the keyed and hashed fingerprinting approaches [152].  
One of the attractive advantages of molecular fingerprints is that they are 
particularly efficient and robust 2D descriptors. In addition, binary 
representations can be compared extremely quickly due to the fact that they 
are suited to computer processing. At the same time, there is a significant 
criticism of all 2D binary representations that concerns the lack of ability to 
encode the conformer information about a molecule. These representations 
are obtained only from the connectivity matrix of a compound and thus 
cannot differentiate between molecular configurations and do not take into 
account conformational features. More recently some researchers have 
attempted to involve 3D information into molecular graphs or fingerprints in 
order to overcome the insufficiency of the 2D descriptors information [153]. 
3D similarity measures have been reviewed in the literature [3, 153-155]. 
Examples include field-based approaches, quantum chemical calculations, 
shape-based approaches and surface-based approaches. Field-based 
techniques are probably the most popular source of 3D molecular 
descriptors, and express the 3D molecular field by a collection of sampled 
data points. At the heart of this approach is the application of a 3D grid, 
which covers the structures of all the compounds in the database. Quantum 
chemical calculations characterise molecular features by representations of 
all the electronic and geometric properties of compounds and their 
interactions. Shape-based approaches find and calculate the maximal 
overlap of the volume of two compounds by Gaussian functions [156], 
spheres [157] or other representations of densities. Surface-based 
approaches analyse 3D molecular similarity by some representations of the 
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3D molecular surface. The calculation of similarity based on 3D descriptors 
is less well established than 2D descriptors because some 3D molecular 
descriptor based methods require a time-consuming optimisation process 
and also there is no guarantee they will describe the molecules precisely 
[158]. 
1.6.2 Weighting scheme 
A weighting scheme is a standardisation method that is applied to 
normalise different parts of the chosen representation. Thus far, there have 
been a few studies of the effect of weighting schemes on molecular 
similarity measures. Willett, et al. [159] reported a systematic comparison of 
six weighting schemes using six similarity coefficients for the determination 
of molecular structural similarity. The results suggested that the weighting 
of fragments by the frequency of occurrence in molecules is more effective 
than merely noting the presence or absence of a fragment. However, most 
interest in the chemistry literature has focused on the roles of the 
representations and of the similarity coefficients in similarity measures 
rather than the role of weighting schemes [3, 160]. 
1.6.3 Similarity coefficients 
The similarity measures’ coefficients or indices are functions that convert 
pairs of compatible structure representations into numbers. There are many 
measures to quantify the degree of dissimilarity/similarity between pairs of 
objects but many of them can be clustered into three broad groups: distance 
coefficients, correlation coefficients and association coefficients [148, 161, 
162]. Association coefficients were originally developed to use with binary 
data and they are thus very well suited to the measures of fingerprint-based 
similarities. In most cases the values taken by association coefficients are 
normalised to lie in the range from 0 to 1. This means that the similarity and 
dissimilarity coefficients can be converted to each other by subtraction from 
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1. Todeschini et al. [163] have provided a table that summarises the form 
and the different properties of 51 similarity coefficients from the literature.  
The Tanimoto coefficient is one of the most common similarity measures 
among the association coefficients. If two molecules B and C have b and c 
bits set in their fragment bit-strings, with a of these bits being set in both of 
the fingerprints, then the Tanimoto coefficient is defined to be: SA, B =opGqEo. The Tanimoto coefficient takes values between zero to unity, with 0 
corresponding to no bits in common and 1 to identical fingerprints.  
There have been several studies to compare the different association 
coefficients for fingerprint similarity [164-167].  Holliday et al. [166] 
carried out a comparison of 22 association coefficients including the 
Tanimoto index for similarity searching in datasets of chemical compounds 
represented by 2D fingerprints. This study and an early study from Willett 
[159] have suggested the use of the Tanimoto coefficient as a superior 
coefficient for molecular similarity studies. Todeschini et al. [163] reported 
a comparison of the use of a total of 51 binary similarity coefficients when 
used for similarity-based searching of some datasets. This study also 
presented the considerable merits of the well-established Tanimoto 
coefficient.  
1.7 Summary of Project Aims 
The overall plan of this project is based on the development of strategies 
that employ QbD principles to develop chromatographic analytical methods. 
The research will comprise a series of highly integrated research topics 
(shown schematically in Figure 1.4) which cover the areas of structure-
retention relationships for the HILIC mode, selection of the stationary 
phases based on predicted retention, and detailed mobile phase optimisation 
and selection of robust method conditions using QbD principles. 
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Figure 1.4. Project overview
.
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Aim 1: To establish a QSRR model based on molecular descriptors 
computed from chemical structures utilising GA-PLS tools. The prediction 
of retention allows scoping of HILIC methods for target analytes. 
Aim 2: To develop strategies to enhance the accuracy of QSRR 
methodology in HILIC using a combination of the concepts of structural 
molecular similarity and chromatographic molecular similarity. 
Aim 3: To develop a QbD workflow, which combines DoE principles 
with QSRR methodology for rapid optimisation of the chromatographic 
conditions in terms of separation of a mixture of pharmaceutical targets.  
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2 Experimental section and data collection 
2.1 Data collection 
2.1.1 Sample preparation 
Standards of adrenaline, noradrenaline, isoproterenol, salbutamol, 
dopamine, tyramine, synephrine, 3-methoxytyramine, norfenefrine, 
normetanephrine, N-methylephedrine, octopamine, salicylic acid, 4-
hydroxybenzoic acid, 2,3-dihydroxybenzoic acid, 2,4-dihydroxybenzoic 
acid, 3,5-dihydroxybenzoic acid, benzoic acid, 3-amino-4-hydroxybenzoic 
acid, 3-aminobenzoic acid, vanillic acid, syringic acid, 2-methoxybenzoic 
acid, p-toluic acid, 3-hydroxybenzoic acid, 2,5-dihydroxybenzoic acid, 3,4-
dihydroxybenzoic acid, 4-aminobenzoic acid, 4-aminosalicylic acid, 2’-
deoxyadenosine, 2’-deoxycytidine, 2’-deoxyguanosine, adenosine, cytidine, 
guanosine, inosine, thymidine, uridine, 2’-deoxyuridine, acyclovir, guanine, 
xanthine, caffeine, theophylline, theobromine, hypoxanthine, 1,3-
dimethyluric acid, 5-sulfosalicylic acid, mandelic acid, nicotinic acid, p-
toluenesulfonic acid, 4-hydroxybenzenesulfonic acid, tropic acid, 4-
aminophenylacetic acid, tryptophan, 2-phenylethylamine, phenylalanine, 
benzyltrimethylammonium (BTMA) chloride, phenyltrimethylammonium 
(PTMA) chloride, labetalol, nadolol, propranolol, adenine, uracil, thymine, 
cytosine, pindolol, alprenolol, satolol, atenolol, 4-nitrophenyl-β-D-
glycopyranoside, uric acid, vidarabine, gallic acid, phthalic acid, isophthalic 
acid, terephthalic acid, caffeic acid, 3,5-dinitrosalicylic acid, acetylsalicylic 
acid, phenylacetic acid, 1,2-benzenedisulfonic acid, malic acid, 2-
sulfobenzoic acid, ceftiofur and tyrosine were purchased from Sigma–
Aldrich (St. Louis, MO, USA) and the standards of fenotrole, ritudrine, 
metaproterenol, isoxuprine, terbutaline, phenylephrine, methoxamine, 5-
methylsalicylic acid, 2’,3’-dideoxyadenosine, 3’-deoxyguanosine, 5-
methyluridine, 3’-deoxythymidine, 2’-deoxyinosine, 7-methylguanosine, 
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pentoxyphylline, diphylline, 7-hydroxyethyl-theophylline, 1-methyluric 
acid, 1-methyl-guanine, 9-methyl-guanine, 3,7-dimethyluric acid, 7-methyl-
xanthine, 1,7-dimethyluric acid, proxyphylline and 1,3,7-trimethyl uric acid 
were purchased from Santa Cruz Biotechnology Inc. (CA, USA). 
Acetonitrile and methanol of HPLC grade were supplied by VWR 
International (Melbourne, VIC, Australia) and Sigma–Aldrich (St. Louis, 
MO, USA), respectively. Formic acid (FA), ammonium formate (NH4FA), 
and ammonium hydroxide (NH4OH), all of analytical grade, were obtained 
from Sigma–Aldrich (St. Louis, MO, USA). 18.2 MΩ Milli-Q water 
produced using a Millipore Gradient water purification (Millipore, Bedford, 
MA, USA) system, was used to prepare mobile phase and sample solutions.   
2.1.2 Standard solutions 
Standard stock solutions (1000 µg mL–1) of each analyte were obtained 
by dissolving an appropriate amount of each standard with the appropriate 
solvent. For β-adrenergic agonists and β-blockers methanol was used, with 
the exception of adrenaline and 3-methoxytyramine, which were prepared in 
acidified methanol (0.5% 1M formic acid in methanol); for benzoic acids 
and nucleosides the standard solutions were prepared in acetonitrile-water 
(90:10) solution. 0.01M NaOH solution was used to dissolve the uric acids, 
and the standard solutions of the xanthines were prepared in water, with the 
exception of 1-methyl-guanine and guanine which were prepared in aqueous 
formic acid (1% v/v). The aqueous solutions of guanine, xanthine, 7-methyl-
xanthine, theobromine, hypoxanthine, 1-methyluric acid, uric acid and 
vidarabine were centrifuged and the supernatant used as the stock solution. 
The standard solutions for the rest of the compounds were prepared in 
acetonitrile-water (50:50) solution. The individual stock solutions were 
stored at –20 °C and were stable for at least 3 months. A working standard 
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(100 µg mL–1) of each compound was prepared by diluting the stock 
solution in acetonitrile: Milli-Q water (90:10). 
2.1.3 Instrumentation 
All experiments were performed using a Thermo Fisher Scientific 
Ultimate 3000 instrument (Lane Cove, Australia) equipped with a DGP-
3600RS pump, a DAD-3000RS diode array detector, a WPS-3000TRS 
autosampler with temperature control, and a TCC-3000RS column 
compartment. Chromeleon software (ver. 7.1.2) was used for system control 
and data processing. The HPLC columns employed in this study were all 
obtained from Thermo Fisher Scientific and consisted of a bare silica ( 
Accucore, 4.6 mm id × 150 mm, 2.6 µm); an amino (Syncronis, 4.6 mm id × 
150 mm, 3.0 µm); an amide (Acclaim HILIC-10, 3.0 mm id × 150 mm, 3.0 
µm), a diol (Acclaim Mixed-Mode HILIC-1, 3.0 mm id × 150 mm, 3.0 µm, 
dual reversed phase/HILIC mechanism), and a zwitterionic column 
(Syncronis HILIC, 4.6 mm id × 150 mm, 3.0 µm). In this thesis, these five 
different columns are referred to as bare silica, amine, amide, diol and 
zwitterionic, respectively. The isocratic eluents used contained 
acetonitrile−formate buffer solution. Formate buffer was prepared with an 
adapted volume of ammonium formate and the pH adjusted to the desired 
value with formic acid or ammonium hydroxide. The pH measurements 
were performed at 25°C with a TPS pH meter (QLD, Australia), before the 
addition of the organic solvent. 
All data were collected at a column temperature of 25°C at an eluent 
flow-rate of 1.0 mL/min for the zwitterionic and amine columns, 0.4 
mL/min for the diol and amide columns, and 1.5 mL/min for the bare silica 
column. Columns were equilibrated with 15–20 column volumes of eluent 
to guarantee stable equilibrium situations. The void time of each column 
was measured by the injection of acetone [1]. The typical injection volume 
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was 5 µL. UV detection was carried out at 254 nm and 280 nm to obtain 
maximal absorbance for all analytes. 
2.1.4 Design of experiments 
The stationary phase type, pH, buffer concentration, and acetonitrile 
content have been proven to be the critically influential parameters for 
tuning selectivity in the HILIC mode [2-4]. Consequently, a central 
composite design for three selected chromatographic factors (acetonitrile 
concentration, pH and salt concentration) on the amide column and a full 
factorial design on the bare silica, amine, diol, and zwitterionic stationary 
phases were carried out. Table 2.1 shows the levels studied for selected 
critical chromatographic parameters. Design matrices with 17 independent 
trials for the central composite design, and 11 for the full factorial design, 
were constructed as seen in Tables 2.1-2.3 and Figure 2.1. 
The retention times on the amide, amine, zwitterionic, bare silica, and 
diol stationary phases are provided in Tables 4-8, respectively. 
2.2 Model generation 
2.2.1 Software 
MarvinSketch version 16.2.15 from ChemAxon [5] (Budapest, Hungary) 
was used for drawing the molecular structures. Initial conformational 
searches to find the 50 lowest energy structures were performed using a 
Merck Molecular Force Field (MMff94) [6-9] implemented in Balloon [10]. 
Geometry optimisation using the semi-empirical Parametric Method number 
7 (PM7) [11] was performed in Molecular Orbital PACkage (MOPAC) [12], 
followed by further geometry optimisation of the lowest energy structure 
using density functional theory [13, 14] implemented in Gaussian 09 [15]. 
Finally, Dragon 6.0 software [16] (Talete, Milano, Italy) was employed for 
calculation of molecular descriptors. A genetic algorithm in Matlab [17] 
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Table 2.1. Experimental design to optimise the HILIC method development assay 
factor low 
(-1) 
central 
(0) 
high 
(1) 
Acetonitrile content (%) in MP 70 80 90 
pH in water phase 3 5 7 
Salt concentration (mM) in MP 10 15 20 
MP is the mobile phase 
 
 
 
 
 
 
 
 
 
 
Table 2.2. Plan of experiments defined by the central composite design.  
nr. Acentonitrile content  
in mobile phase 
pH Salt concentration  
in mobile phase 
1 70 3 10 
2 90 3 10 
3 70 7 10 
4 90 7 10 
5 70 3 20 
6 90 3 20 
7 70 7 20 
8 90 7 20 
9 70 5 15 
10 90 5 15 
11 80 3 15 
12 80 7 15 
13 80 5 10 
14 80 5 20 
15 80 5 15 
16 80 5 15 
17 80 5 15 	
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Table 2.3. Plan of experiments defined by the full factorial design.  
nr. Acentonitrile content  
in mobile phase 
pH Salt concentration  
in mobile phase 
1 70 3 10 
2 90 3 10 
3 70 7 10 
4 90 7 10 
5 70 3 20 
6 90 3 20 
7 70 7 20 
8 90 7 20 
9 80 5 15 
10 80 5 15 
11 80 5 15 
																													
	
Figure 2.1. Diagram of the design space. 
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T
able 2.4. Experim
entally obtained retention tim
es for each operating condition of the central com
posite design using am
ide colum
n. 
A
nalyte 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
A
cetone 
2.00 
2.04 
2.01 
2.04 
2.01 
2.03 
2.01 
2.03 
2.01 
2.04 
2.02 
2.02 
2.02 
2.01 
2.06 
2.01 
2.02 
Toluene 
1.83 
1.89 
1.84 
1.88 
1.85 
1.87 
1.83 
1.87 
1.84 
1.87 
1.84 
1.84 
1.85 
1.82 
1.83 
1.83 
1.84 
2'-D
eoxyadenosine 
2.60 
4.73 
2.60 
4.71 
2.60 
4.93 
2.63 
4.99 
2.61 
4.75 
3.16 
3.15 
3.14 
3.19 
3.16 
3.15 
3.14 
2'-D
eoxycytidine 
2.87 
10.49 
3.06 
10.47 
2.92 
10.75 
3.11 
11.58 
3.07 
10.46 
4.24 
4.35 
4.35 
4.42 
4.36 
4.34 
4.33 
2',3'-D
ideoxyadenosine 
2.54 
3.98 
2.55 
3.96 
2.55 
4.03 
2.57 
4.07 
2.56 
3.95 
2.96 
2.95 
2.95 
2.98 
2.95 
2.94 
2.94 
2'-D
eoxyguanosine 
2.89 
8.93 
2.88 
8.75 
2.89 
9.88 
2.92 
10.10 
2.89 
9.08 
3.95 
3.95 
3.93 
4.01 
3.95 
3.93 
3.93 
3'-D
eoxyguanosine 
2.87 
8.70 
2.87 
8.51 
2.87 
9.74 
2.90 
9.79 
2.87 
8.81 
3.87 
3.86 
3.86 
3.93 
3.88 
3.86 
3.86 
5'-M
ethyluridine 
2.46 
4.16 
2.45 
4.13 
2.46 
4.58 
2.48 
4.52 
2.46 
4.27 
2.89 
2.88 
2.88 
2.93 
2.90 
2.89 
2.88 
8-H
ydroxy-2'-deoxyguanosine 
2.92 
9.50 
2.93 
9.30 
2.92 
10.79 
2.97 
10.80 
2.93 
9.63 
4.02 
4.03 
4.02 
4.10 
4.05 
4.01 
4.01 
A
denosine 
2.68 
5.46 
2.67 
5.42 
2.68 
5.99 
2.71 
5.93 
2.68 
5.55 
3.35 
3.33 
3.33 
3.40 
3.35 
3.34 
3.33 
C
ytidine 
2.98 
12.00 
3.12 
11.90 
3.02 
13.45 
3.17 
13.71 
3.12 
12.17 
4.51 
4.56 
4.57 
4.66 
4.59 
4.56 
4.56 
G
uanosine 
2.99 
10.91 
2.99 
10.70 
2.99 
12.84 
3.03 
12.67 
2.99 
11.22 
4.26 
4.26 
4.24 
4.34 
4.28 
4.25 
4.25 
Inosine 
2.72 
6.91 
2.73 
6.91 
2.73 
8.12 
2.76 
8.09 
2.73 
7.29 
3.57 
3.59 
3.56 
3.65 
3.59 
3.58 
3.58 
Thym
idine 
2.38 
3.53 
2.37 
3.51 
2.38 
3.77 
2.39 
3.73 
2.38 
3.58 
2.71 
2.70 
2.69 
2.73 
2.70 
2.70 
2.69 
U
ridine 
2.48 
4.30 
2.47 
4.27 
2.48 
4.85 
2.50 
4.76 
2.48 
4.46 
2.95 
2.95 
2.93 
3.00 
2.96 
2.95 
2.94 
A
drenaline 
2.00 
7.75 
2.56 
9.38 
2.28 
8.33 
2.65 
10.39 
2.47 
9.12 
3.09 
3.69 
3.45 
3.58 
3.48 
3.45 
3.50 
N
oradrenaline 
2.05 
9.81 
2.63 
12.26 
2.35 
10.86 
2.73 
13.45 
2.54 
11.32 
3.32 
3.96 
3.70 
3.85 
3.75 
3.71 
3.77 
3'-M
ethoxytyram
ine 
1.92 
5.98 
2.39 
6.55 
2.17 
6.16 
2.47 
7.19 
2.33 
6.64 
2.78 
3.21 
2.63 
3.15 
3.07 
3.04 
3.07 
Isoproterenol 
1.93 
6.40 
2.44 
- 
2.21 
6.66 
2.54 
8.45 
2.36 
7.20 
2.86 
3.33 
3.13 
3.24 
3.15 
3.15 
3.19 
Fenotrole 
1.91 
6.75 
2.33 
6.83 
2.15 
6.83 
2.41 
7.42 
2.30 
6.85 
2.79 
3.13 
3.00 
3.07 
3.01 
2.98 
3.01 
Terbutaline 
1.91 
5.88 
2.32 
6.25 
2.15 
5.98 
2.40 
6.70 
2.28 
6.22 
2.74 
3.10 
2.96 
3.04 
2.97 
2.95 
2.98 
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Salbutam
ol 
1.93 
6.49 
2.39 
6.99 
2.20 
6.68 
2.48 
7.62 
2.35 
6.99 
2.86 
3.29 
3.12 
3.22 
3.13 
3.11 
3.14 
R
itudrine 
1.84 
5.43 
2.25 
5.66 
2.08 
5.37 
2.33 
6.01 
2.22 
5.63 
2.57 
2.90 
2.78 
2.84 
2.79 
2.76 
2.79 
M
etaproterenol 
1.94 
6.41 
2.37 
6.86 
2.18 
6.62 
2.46 
7.46 
2.33 
6.88 
2.84 
3.24 
3.08 
3.18 
3.09 
3.07 
3.10 
Synephrine 
1.94 
6.32 
2.43 
7.10 
2.19 
6.53 
2.52 
7.74 
2.36 
7.15 
2.85 
3.36 
3.16 
3.27 
3.17 
3.15 
3.19 
D
opam
ine 
2.02 
7.64 
2.57 
8.38 
2.28 
8.16 
2.61 
9.54 
2.48 
8.60 
3.09 
3.52 
3.43 
3.49 
3.41 
3.39 
3.43 
N
-m
ethylephrine 
1.81 
3.98 
2.25 
4.34 
2.04 
3.89 
2.31 
4.40 
2.19 
4.26 
2.43 
2.79 
2.66 
2.71 
2.65 
2.64 
2.67 
N
orphenylephrine 
1.99 
7.58 
2.48 
8.12 
2.25 
7.99 
2.57 
9.06 
2.41 
8.23 
3.02 
3.51 
3.31 
3.43 
3.34 
3.31 
3.35 
Phenylephrine 
1.94 
6.06 
2.41 
6.75 
2.18 
6.24 
2.50 
7.28 
2.35 
6.73 
2.82 
3.30 
3.11 
3.21 
3.12 
3.10 
3.14 
Tyram
ine 
1.92 
6.26 
2.39 
6.90 
2.17 
6.46 
2.47 
7.60 
2.33 
6.98 
2.79 
3.25 
3.07 
3.17 
3.09 
3.07 
3.10 
N
orm
etanephrine 
1.98 
7.55 
2.49 
8.24 
2.26 
7.97 
2.58 
9.18 
2.43 
8.31 
3.04 
3.55 
3.35 
3.47 
3.37 
3.35 
3.39 
O
ctopam
ine 
1.99 
7.93 
2.50 
8.63 
2.26 
8.40 
2.59 
9.75 
2.44 
8.78 
3.06 
3.58 
3.38 
3.50 
3.40 
3.38 
3.42 
M
ethoxam
ine 
1.86 
5.04 
2.27 
5.39 
2.09 
5.01 
2.34 
5.67 
2.23 
5.33 
2.58 
2.92 
2.79 
2.86 
2.80 
2.79 
2.81 
Isoxuprine 
1.76 
3.98 
2.10 
3.46 
1.97 
3.84 
2.15 
3.51 
2.08 
3.48 
2.32 
2.45 
2.42 
2.45 
2.42 
2.42 
2.42 
C
eftiofur 
4.86 
9.11 
3.80 
9.14 
3.62 
8.08 
3.36 
9.15 
3.67 
8.37 
4.14 
4.10 
4.53 
4.04 
4.32 
4.32 
4.25 
Tyrosine 
3.22 
24.42 
3.32 
24.33 
3.24 
25.85 
3.33 
29.55 
3.28 
24.50 
5.26 
5.46 
5.44 
5.41 
5.41 
5.40 
5.44 
Pentoxyfylline 
2.12 
2.37 
2.12 
2.36 
2.12 
2.36 
2.12 
2.36 
2.13 
2.35 
2.21 
2.21 
2.21 
2.20 
2.20 
2.22 
2.20 
G
uanine 
3.04 
9.73 
3.07 
9.35 
3.06 
10.58 
3.10 
10.94 
3.07 
9.63 
4.15 
4.21 
4.17 
4.21 
4.18 
4.18 
4.18 
X
anthine 
2.65 
5.39 
2.78 
5.60 
2.67 
5.85 
2.77 
6.41 
2.71 
5.73 
3.23 
3.40 
3.33 
3.35 
3.34 
3.34 
3.34 
C
affeine 
2.24 
2.50 
2.24 
2.46 
2.25 
2.52 
2.25 
2.53 
2.25 
2.49 
2.35 
2.35 
2.35 
2.35 
2.34 
2.36 
2.35 
Theophylline 
2.34 
3.02 
2.36 
2.98 
2.35 
3.05 
2.37 
3.07 
2.36 
3.00 
2.54 
2.56 
2.55 
2.56 
2.55 
2.57 
2.55 
Theobrom
ine 
2.39 
3.11 
2.40 
3.05 
2.40 
3.15 
2.41 
3.16 
2.40 
3.07 
2.63 
2.63 
2.62 
2.63 
2.62 
2.64 
2.62 
D
iphylline 
2.39 
3.50 
2.40 
3.41 
2.41 
3.64 
2.41 
3.66 
2.41 
3.47 
2.72 
2.73 
2.71 
2.74 
2.72 
2.74 
2.72 
7-H
ydroxyethyltheophylline 
2.31 
2.92 
2.31 
2.87 
2.32 
2.91 
2.32 
2.93 
2.32 
2.88 
2.51 
2.52 
2.51 
2.52 
2.51 
2.53 
2.51 
	 
 
67 
1-M
ethyluric acid 
2.86 
7.36 
4.70 
17.37 
2.82 
7.37 
4.21 
19.68 
4.11 
15.80 
3.57 
6.16 
6.40 
5.73 
6.17 
6.02 
6.07 
1-M
ethylguanine 
2.77 
6.18 
2.80 
5.90 
2.80 
6.43 
2.82 
6.63 
2.81 
6.07 
3.48 
3.51 
3.49 
3.52 
3.49 
3.51 
3.50 
9-M
ethylguanine 
2.83 
6.57 
2.85 
6.25 
2.86 
6.89 
2.88 
7.09 
2.86 
6.44 
3.59 
3.61 
3.58 
3.61 
3.59 
3.61 
3.60 
U
ric acid 
3.27 
13.83 
5.56 
34.38 
3.17 
13.56 
4.86 
41.13 
4.98 
31.95 
4.51 
8.20 
8.87 
7.73 
8.60 
8.46 
- 
3,7-D
im
ethyluric acid 
2.66 
5.21 
3.86 
9.64 
2.65 
5.33 
3.54 
11.67 
3.43 
9.62 
3.16 
4.70 
4.69 
4.38 
4.64 
4.56 
4.57 
7-M
ethylxanthine 
2.50 
4.03 
2.53 
3.92 
2.53 
4.17 
2.55 
4.28 
2.53 
4.01 
2.90 
2.92 
2.90 
2.92 
2.91 
2.93 
2.91 
H
ypoxanthine 
2.65 
5.52 
2.70 
5.36 
2.68 
5.89 
2.71 
6.20 
2.69 
5.59 
3.28 
3.34 
3.29 
3.33 
3.31 
3.33 
3.32 
Proxyphylline 
2.26 
2.75 
2.26 
2.71 
2.27 
2.69 
2.27 
2.74 
2.27 
2.64 
2.42 
2.43 
2.42 
2.43 
2.43 
2.45 
2.43 
1,7-D
im
ethyluric acid 
2.70 
5.27 
4.36 
11.69 
2.66 
5.11 
3.92 
12.98 
3.80 
10.47 
3.17 
5.36 
5.41 
4.88 
5.32 
5.20 
5.21 
1,3-D
im
ethyluric acid 
2.57 
4.72 
3.47 
7.53 
2.57 
4.85 
3.23 
8.70 
3.07 
7.20 
3.01 
4.13 
4.06 
3.78 
4.00 
3.91 
3.92 
1,3,7-Trim
ethyluric acid 
2.30 
2.81 
2.32 
2.75 
2.32 
2.71 
2.32 
2.76 
2.40 
3.08 
2.61 
2.62 
2.61 
2.62 
2.47 
2.51 
2.48 
4-N
itrophenyl-B
-D
-
glycopyranoside 
2.25 
3.48 
2.25 
3.38 
2.25 
3.67 
2.25 
3.76 
2.25 
3.49 
2.52 
2.52 
2.52 
2.53 
2.52 
2.55 
2.52 
A
cyclovir 
2.78 
7.60 
2.79 
7.18 
2.80 
8.18 
2.82 
8.77 
2.80 
7.58 
3.66 
3.70 
3.65 
3.71 
3.70 
3.73 
3.69 
2'-D
eoxyuridine 
2.39 
3.73 
2.40 
3.62 
2.41 
3.91 
2.41 
4.06 
2.40 
3.76 
2.77 
2.77 
2.75 
2.79 
2.78 
2.82 
2.77 
3'-D
eoxythym
idine 
2.28 
2.95 
2.29 
2.90 
2.29 
2.97 
2.30 
3.01 
2.29 
2.92 
2.48 
2.48 
2.48 
2.49 
2.49 
2.52 
2.48 
2'-D
eoxyinosine 
2.63 
5.95 
2.65 
5.75 
2.66 
6.45 
2.67 
6.96 
2.65 
6.09 
3.35 
3.39 
3.34 
3.40 
3.39 
3.43 
3.38 
Satolol 
1.85 
4.76 
2.25 
5.09 
2.06 
4.70 
2.31 
5.32 
2.22 
5.03 
2.55 
2.86 
2.74 
2.80 
2.75 
2.78 
2.76 
7-M
ethylguanosine 
2.20 
15.24 
3.16 
19.93 
2.55 
16.29 
3.23 
24.69 
2.92 
19.77 
4.04 
5.51 
5.01 
5.15 
5.05 
5.01 
5.07 
A
tenolol 
1.97 
7.45 
2.47 
8.11 
2.25 
7.45 
2.56 
9.05 
2.41 
8.12 
3.02 
3.53 
3.32 
3.44 
3.36 
3.39 
3.37 
Vadarabine 
2.70 
6.34 
2.72 
6.13 
2.73 
6.76 
2.74 
7.28 
2.73 
6.37 
3.49 
3.50 
3.47 
3.52 
3.52 
3.57 
3.50 
Tryptophan 
3.27 
19.08 
3.36 
18.99 
3.28 
18.95 
3.37 
22.16 
3.33 
18.71 
4.95 
5.09 
5.11 
5.05 
5.14 
5.18 
5.10 
B
TM
A
 
1.80 
3.64 
2.21 
4.02 
2.02 
3.54 
2.29 
4.10 
2.17 
4.02 
2.38 
2.70 
2.58 
2.65 
2.58 
2.63 
2.61 
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PTM
A
 
1.83 
3.92 
2.29 
4.39 
2.07 
3.84 
2.37 
4.53 
2.24 
4.42 
2.47 
2.86 
2.71 
2.80 
2.71 
2.76 
2.75 
Labetalol 
1.84 
4.77 
2.28 
5.00 
2.06 
4.58 
2.34 
5.00 
2.22 
4.81 
2.52 
2.83 
2.73 
2.76 
2.73 
2.76 
2.73 
N
adolol 
1.97 
7.17 
2.47 
7.85 
2.25 
7.20 
2.56 
8.69 
2.41 
7.71 
2.99 
3.45 
3.27 
3.38 
3.31 
3.35 
3.32 
Propranolol 
1.79 
3.93 
2.21 
4.20 
1.99 
3.77 
2.25 
4.16 
2.14 
4.05 
2.37 
2.63 
2.53 
2.57 
2.54 
2.58 
2.55 
A
denine 
2.73 
5.32 
2.79 
5.31 
2.77 
5.45 
2.81 
5.82 
2.79 
5.32 
3.38 
3.38 
3.38 
3.40 
3.40 
3.48 
3.40 
U
racil 
2.38 
3.27 
2.39 
3.27 
2.39 
3.38 
2.40 
3.51 
2.39 
3.32 
2.65 
2.65 
2.65 
2.67 
2.66 
2.73 
2.66 
Thym
ine 
2.37 
3.18 
2.37 
3.18 
2.37 
3.25 
2.38 
3.35 
2.37 
3.20 
2.60 
2.60 
2.60 
2.61 
2.61 
2.68 
2.61 
C
ytosine 
2.89 
10.91 
3.40 
11.30 
2.99 
10.50 
3.43 
12.39 
3.38 
10.92 
4.39 
4.77 
4.81 
4.78 
4.87 
4.96 
4.83 
Pindolol 
1.81 
4.21 
2.21 
4.52 
2.01 
4.09 
2.27 
4.56 
2.18 
4.41 
2.43 
2.71 
2.61 
2.66 
2.61 
2.67 
2.62 
A
lprenolol 
1.74 
3.54 
2.09 
3.75 
1.92 
3.41 
2.17 
3.71 
2.05 
3.64 
2.33 
2.48 
2.42 
2.43 
2.41 
2.46 
2.41 
Salicylic acid 
4.02 
3.70 
3.13 
3.60 
3.09 
3.51 
2.80 
3.60 
3.06 
3.50 
3.05 
2.88 
3.15 
2.88 
3.09 
3.18 
3.04 
5-M
ethylsalicylic acid 
3.71 
3.58 
3.09 
3.57 
2.93 
3.36 
2.78 
3.54 
3.02 
3.45 
2.89 
2.83 
3.10 
2.84 
3.04 
3.13 
2.99 
4-H
ydroxybenzoic acid 
2.19 
2.75 
4.06 
6.27 
2.17 
2.70 
3.59 
6.19 
3.31 
5.41 
2.25 
3.96 
3.89 
3.54 
3.91 
3.85 
3.78 
3-H
ydroxybenzoic acid 
2.34 
3.09 
3.99 
7.50 
2.25 
2.97 
3.52 
7.36 
3.58 
6.67 
2.34 
4.12 
4.37 
3.85 
4.33 
4.35 
4.21 
2,3-D
ihydroxybenzoic acid 
4.62 
4.71 
3.46 
4.54 
3.49 
4.54 
3.11 
4.50 
3.36 
4.39 
3.57 
3.27 
3.62 
3.29 
3.57 
3.69 
3.51 
2,4-D
ihydroxybenzoic acid 
3.51 
4.60 
3.44 
5.18 
2.89 
4.29 
3.09 
5.14 
3.35 
4.99 
3.04 
3.38 
3.73 
3.38 
3.67 
3.77 
3.60 
2,5-D
ihydroxybenzoic acid 
4.17 
4.77 
3.20 
4.59 
3.22 
4.62 
2.89 
4.64 
3.14 
4.46 
3.38 
3.15 
3.45 
3.17 
3.39 
3.50 
3.34 
3,4-D
ihydroxybenzoic acid 
2.33 
3.23 
4.42 
- 
2.28 
3.25 
3.88 
- 
3.56 
7.59 
2.42 
3.15 
4.47 
4.04 
4.52 
4.23 
4.39 
3,5-D
ihydroxybenzoic acid 
2.43 
3.78 
3.88 
9.69 
2.32 
3.69 
3.45 
9.80 
3.55 
8.54 
2.50 
4.31 
4.61 
4.13 
4.55 
4.34 
4.44 
B
enzoic acid 
2.29 
2.68 
4.05 
6.00 
2.19 
2.54 
3.57 
5.64 
3.58 
5.15 
2.21 
3.84 
4.14 
3.61 
4.11 
3.94 
- 
3-A
m
ino-4-hydroxybenzoic 
acid 
2.31 
3.04 
4.39 
7.69 
2.27 
3.03 
3.88 
7.63 
3.50 
6.41 
2.40 
4.48 
4.34 
3.92 
4.38 
4.06 
4.24 
G
allic acid 
2.46 
4.20 
5.13 
- 
2.41 
4.39 
4.60 
- 
3.86 
- 
2.65 
- 
5.31 
4.72 
6.98 
- 
5.54 
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4-A
m
inobenzoic acid 
2.14 
2.47 
3.71 
4.34 
2.12 
2.48 
3.36 
4.27 
2.92 
3.78 
2.20 
3.39 
3.23 
3.01 
3.25 
3.07 
3.15 
4-A
m
inosalicylic acid 
2.80 
3.59 
3.66 
5.40 
2.50 
3.32 
3.27 
5.24 
3.52 
5.01 
2.58 
3.58 
3.96 
3.55 
3.89 
3.91 
3.81 
Phthalic acid 
4.96 
3.83 
11.60 
10.35 
3.49 
3.77 
7.72 
11.14 
5.90 
7.70 
3.35 
6.01 
6.48 
5.01 
7.29 
6.41 
6.28 
Isophthalic acid 
4.07 
9.45 
18.17 
82.07 
3.11 
7.69 
10.19 
72.92 
12.55 
58.52 
3.47 
15.54 
22.79 
13.36 
20.91 
19.06 
18.64 
3-A
m
inobenzoic acid 
2.33 
2.82 
4.34 
7.51 
2.24 
2.72 
3.82 
7.25 
3.76 
6.25 
2.31 
4.40 
4.60 
4.09 
4.61 
4.32 
4.44 
Vanillic acid 
2.22 
2.76 
4.18 
6.71 
2.19 
2.69 
3.71 
6.55 
3.48 
5.59 
2.27 
4.13 
4.17 
3.72 
4.18 
3.91 
4.07 
Syringic acid 
2.30 
2.89 
4.26 
7.57 
2.23 
2.80 
3.78 
7.33 
3.66 
6.29 
2.31 
4.35 
4.50 
4.01 
4.50 
4.20 
4.34 
2-M
ethoxybenzoic acid 
2.32 
2.69 
4.67 
7.63 
2.22 
2.56 
4.06 
7.27 
3.97 
6.17 
2.23 
4.48 
4.76 
4.14 
4.80 
4.47 
4.55 
Terephthalic acid 
4.53 
- 
21.49 
112.35 
3.33 
8.18 
11.96 
97.28 
14.02 
74.27 
3.68 
19.47 
27.69 
16.36 
26.60 
23.62 
23.67 
C
affeic acid 
2.32 
3.17 
4.70 
9.62 
2.25 
3.15 
4.11 
- 
3.72 
7.60 
2.38 
4.66 
4.65 
4.15 
4.75 
4.36 
4.52 
P-Toluic acid 
2.12 
2.39 
3.85 
5.17 
2.07 
2.35 
3.42 
5.02 
3.31 
4.46 
2.11 
3.55 
3.67 
3.29 
3.68 
3.48 
3.55 
3,5-D
initrosalicylic acid 
2.91 
1.88 
2.21 
1.80 
2.36 
1.90 
2.06 
1.81 
2.19 
1.82 
2.10 
1.94 
2.02 
1.93 
1.97 
2.00 
1.98 
N
icotinic acid 
4.47 
8.72 
4.96 
14.15 
3.59 
7.32 
4.33 
13.52 
4.78 
12.31 
4.25 
5.68 
6.72 
5.67 
6.65 
6.31 
6.36 
4-H
ydroxybenzenesulfonic acid 
4.92 
5.85 
3.25 
5.16 
3.60 
6.02 
2.96 
5.41 
3.18 
5.05 
3.98 
3.30 
3.63 
3.33 
3.58 
3.53 
3.53 
4-A
m
inophenylacetic acid 
2.32 
2.83 
5.00 
8.54 
2.25 
2.58 
4.36 
8.51 
4.00 
6.79 
2.33 
4.90 
5.03 
4.39 
5.29 
4.72 
4.89 
A
cetylsalicylic acid 
- 
2.99 
- 
- 
- 
- 
- 
- 
3.39 
5.23 
2.31 
3.57 
3.93 
3.49 
- 
- 
- 
Phenylacetic acid 
2.16 
- 
4.31 
6.14 
2.09 
- 
3.79 
6.08 
3.62 
5.12 
2.13 
- 
4.20 
3.65 
4.30 
3.98 
4.12 
1,2-benzenedisulfonic acid 
- 
- 
 
- 
28.84 
- 
11.77 
- 
16.40 
- 
24.19 
12.06 
21.25 
10.71 
- 
17.77 
16.38 
P-Toluenesulfonic acid 
4.49 
3.97 
3.01 
3.58 
3.32 
3.97 
2.72 
3.62 
2.95 
3.49 
3.32 
2.82 
3.08 
2.85 
3.04 
3.01 
2.99 
2-Sulfobenzoic acid 
20.04 
17.68 
- 
47.06 
8.06 
15.80 
11.96 
40.51 
17.02 
35.25 
7.87 
13.98 
23.96 
12.12 
- 
19.51 
18.03 
Tropic acid 
2.37 
3.25 
3.99 
8.04 
2.26 
3.09 
3.54 
8.15 
3.63 
6.98 
2.37 
4.19 
4.55 
4.07 
4.41 
4.28 
4.36 
2-Phenylethylam
ine 
1.86 
4.88 
2.31 
5.34 
2.09 
4.86 
2.38 
5.42 
2.24 
5.20 
2.57 
2.94 
2.80 
2.88 
2.82 
2.72 
2.83 
Phenylalanine 
3.11 
16.39 
3.18 
16.36 
3.11 
16.56 
3.21 
17.64 
3.15 
15.60 
4.60 
4.70 
4.76 
4.72 
4.82 
4.52 
4.76 
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M
andelic acid 
3.89 
5.64 
3.96 
6.89 
3.15 
5.09 
3.52 
6.76 
3.81 
6.29 
3.39 
- 
4.54 
4.06 
4.52 
4.38 
4.36 
5-Sulfosalicylic acid 
27.58 
19.06 
7.51 
12.05 
9.51 
17.54 
4.97 
14.56 
6.41 
13.09 
9.85 
5.96 
8.35 
5.78 
7.65 
7.49 
7.21 
M
alic acid 
4.23 
3.37 
3.62 
3.65 
3.17 
3.42 
3.14 
3.94 
3.08 
3.49 
3.14 
3.01 
3.23 
2.95 
3.33 
3.20 
3.17 
N
um
bers in row
 are operating conditions of the central com
posite design (Table 2.2).  
T
able 2.5. Experim
entally obtained retention tim
es for each operating condition of the full factorial design using am
ine colum
n. 
A
nalyte  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
A
cetone 
1.88 
1.98 
1.88 
2.06 
1.89 
2.04 
1.98 
2.07 
1.93 
1.95 
1.95 
Toluene 
1.52 
1.73 
1.52 
1.80 
1.55 
1.75 
1.61 
1.76 
1.61 
1.62 
1.62 
2'-D
eoxyadenosine 
2.58 
4.96 
2.63 
5.24 
2.64 
5.83 
2.77 
6.01 
3.32 
3.33 
3.37 
2'-D
eoxycytidine 
3.08 
11.06 
3.39 
11.45 
3.19 
16.53 
3.52 
16.53 
5.00 
4.91 
4.95 
2',3'-D
ideoxyadenosine 
2.37 
3.85 
2.42 
4.08 
2.46 
4.15 
2.57 
4.24 
2.86 
2.92 
2.96 
2'-D
eoxyguanosine 
3.25 
11.91 
3.32 
12.12 
3.28 
18.52 
3.43 
17.26 
4.95 
4.82 
4.83 
3'-D
eoxyguanosine 
3.16 
11.14 
3.22 
11.32 
3.23 
17.31 
3.33 
15.81 
4.70 
4.58 
4.59 
5'-M
ethyluridine 
2.63 
5.18 
2.66 
5.19 
2.64 
7.68 
2.78 
7.07 
3.34 
3.28 
3.26 
8-H
ydroxy-2'-deoxyguanosine 
3.07 
10.44 
3.21 
10.49 
3.07 
18.25 
3.30 
16.09 
4.63 
4.48 
4.48 
A
denosine 
2.77 
6.18 
2.83 
6.28 
2.83 
8.79 
2.99 
8.20 
3.72 
3.70 
3.72 
C
ytidine 
3.51 
15.38 
3.81 
15.22 
3.70 
32.87 
3.98 
25.89 
6.02 
5.82 
5.82 
G
uanosine 
3.60 
16.29 
3.68 
15.85 
4.12 
32.85 
3.83 
26.47 
5.86 
5.61 
5.61 
Inosine 
3.31 
10.89 
3.49 
11.12 
3.34 
21.27 
3.62 
18.01 
5.10 
4.93 
4.91 
Thym
idine 
2.38 
3.87 
2.41 
3.86 
2.50 
5.05 
2.53 
4.68 
2.86 
2.85 
2.84 
U
ridine 
2.82 
5.95 
2.86 
5.85 
3.01 
10.47 
3.00 
8.91 
3.70 
3.62 
3.59 
A
drenaline 
1.86 
10.82 
7.92 
- 
2.55 
22.18 
- 
- 
6.62 
- 
5.87 
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N
oradrenaline 
1.97 
14.71 
11.32 
- 
2.82 
35.90 
- 
- 
8.95 
- 
8.27 
3'-M
ethoxytyram
ine 
1.68 
6.17 
1.78 
7.12 
2.46 
9.01 
2.26 
9.35 
2.82 
2.84 
2.96 
Isoproterenol 
1.71 
7.13 
6.30 
- 
4.47 
11.51 
- 
- 
6.08 
- 
6.39 
Fenotrole 
1.55 
5.11 
1.61 
5.29 
4.42 
6.31 
1.92 
6.29 
2.35 
2.33 
2.38 
Terbutaline 
1.63 
5.71 
1.72 
6.31 
4.54 
7.69 
2.09 
7.92 
2.64 
2.64 
2.71 
Salbutam
ol 
1.68 
6.51 
1.77 
7.43 
4.60 
9.30 
2.29 
9.66 
2.86 
2.87 
2.97 
R
itudrine 
1.48 
3.77 
1.53 
4.03 
3.56 
4.29 
1.80 
4.43 
2.09 
2.10 
2.14 
M
etaproterenol 
1.69 
6.63 
1.79 
7.47 
4.08 
9.68 
2.20 
9.84 
2.86 
2.85 
2.93 
Synephrine 
1.73 
6.84 
1.88 
8.33 
4.09 
10.47 
2.33 
11.16 
3.06 
3.08 
3.21 
D
opam
ine 
1.79 
9.23 
3.89 
- 
4.35 
17.03 
6.23 
33.35 
5.13 
4.31 
4.52 
N
-m
ethylephrine 
1.54 
3.80 
1.63 
4.44 
3.57 
4.16 
1.99 
- 
2.27 
2.33 
2.43 
N
orphenylephrine 
1.79 
8.81 
1.92 
9.63 
4.20 
14.60 
2.37 
14.27 
3.32 
3.27 
3.37 
Phenylephrine 
1.72 
6.73 
1.85 
7.96 
3.87 
9.68 
2.28 
10.45 
3.00 
3.01 
3.12 
Tyram
ine 
1.68 
6.18 
1.77 
6.99 
3.31 
8.99 
2.17 
9.62 
2.81 
2.80 
2.90 
N
orm
etanephrine 
1.79 
8.79 
1.94 
9.99 
3.10 
12.34 
2.44 
14.80 
3.42 
3.38 
3.52 
O
ctopam
ine 
1.79 
8.93 
1.92 
9.97 
2.96 
13.00 
2.42 
15.40 
3.41 
3.35 
3.47 
M
ethoxam
ine 
1.57 
4.66 
1.63 
5.06 
2.58 
5.05 
1.96 
5.92 
2.38 
2.39 
2.46 
Isoxuprine 
1.41 
2.87 
1.46 
2.65 
2.17 
2.85 
1.66 
2.79 
1.84 
1.85 
1.87 
C
eftiofur 
5.18 
12.02 
5.85 
13.28 
4.87 
7.46 
3.88 
9.11 
5.42 
5.07 
5.02 
Tyrosine 
4.51 
45.31 
5.00 
52.85 
6.07 
63.01 
5.12 
77.53 
9.98 
9.12 
9.07 
Pentoxyfylline 
1.81 
2.19 
1.84 
2.25 
2.69 
2.09 
1.94 
2.15 
1.97 
2.00 
2.02 
G
uanine 
3.23 
10.41 
3.35 
10.46 
5.45 
13.67 
3.44 
11.07 
4.88 
4.66 
4.61 
X
anthine 
2.69 
5.50 
3.45 
6.59 
5.05 
7.40 
3.36 
7.00 
4.05 
3.87 
3.81 
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C
affeine 
1.98 
2.35 
2.00 
2.42 
3.47 
2.30 
2.10 
2.32 
2.15 
2.18 
2.19 
Theophylline 
2.11 
2.78 
2.20 
2.92 
3.26 
2.84 
2.29 
2.82 
2.42 
2.42 
2.42 
Theobrom
ine 
2.22 
2.93 
2.24 
2.98 
3.34 
3.08 
2.35 
2.94 
2.53 
2.53 
2.53 
D
iphylline 
2.37 
3.75 
2.40 
3.82 
3.73 
4.09 
2.50 
3.70 
2.89 
2.86 
2.85 
7-H
ydroxyethyltheophylline 
2.15 
2.84 
2.18 
2.91 
3.52 
2.89 
2.27 
2.82 
2.45 
2.45 
2.46 
1-M
ethyluric acid 
3.12 
8.38 
13.58 
28.34 
4.24 
10.71 
8.80 
23.97 
13.61 
11.97 
11.39 
1-M
ethylguanine 
2.78 
6.15 
2.87 
6.31 
3.76 
7.16 
2.97 
6.32 
3.77 
3.69 
3.69 
9-M
ethylguanine 
2.95 
7.22 
2.98 
7.17 
4.20 
8.42 
3.08 
7.23 
4.02 
3.91 
3.90 
U
ric acid 
4.35 
18.40 
20.32 
63.57 
6.02 
29.53 
12.01 
56.88 
23.96 
20.01 
18.62 
3,7-D
im
ethyluric acid 
2.75 
5.61 
11.00 
19.06 
4.55 
7.06 
7.58 
15.66 
10.37 
9.49 
9.20 
7-M
ethylxanthine 
2.44 
3.96 
2.55 
4.08 
4.30 
4.55 
2.61 
4.17 
3.01 
2.97 
2.96 
H
ypoxanthine 
2.92 
6.56 
3.13 
6.96 
4.60 
8.48 
3.18 
7.26 
4.12 
3.98 
3.94 
Proxyphylline 
2.04 
2.61 
2.07 
2.68 
2.90 
2.60 
2.15 
2.57 
2.29 
2.30 
2.31 
1,7-D
im
ethyluric acid 
2.76 
5.67 
11.13 
18.44 
3.33 
6.27 
7.44 
14.44 
10.24 
9.31 
8.99 
1,3-D
im
ethyluric acid 
2.49 
4.75 
7.87 
13.29 
3.17 
5.55 
5.92 
10.96 
7.18 
6.71 
6.60 
1,3,7-Trim
ethyluric acid 
2.28 
3.20 
2.31 
3.30 
3.01 
3.26 
2.41 
3.18 
2.62 
2.65 
2.67 
4-N
itrophenyl-B
-D
-
glycopyranoside 
2.06 
4.02 
2.08 
4.00 
2.24 
4.23 
2.15 
- 
2.58 
2.50 
2.47 
A
cyclovir 
3.20 
10.31 
3.25 
10.18 
3.56 
13.63 
3.33 
10.80 
4.82 
4.61 
4.58 
2'-D
eoxyuridine 
2.53 
4.35 
2.56 
4.36 
3.00 
5.45 
2.63 
4.57 
3.19 
3.10 
3.07 
3'-D
eoxythym
idine 
2.12 
2.86 
2.14 
2.93 
2.72 
2.99 
2.22 
2.86 
2.41 
2.40 
2.40 
2'-D
eoxyinosine 
3.01 
8.14 
3.14 
8.40 
4.18 
11.06 
3.21 
8.89 
4.47 
4.28 
4.24 
Satolol 
1.58 
4.59 
1.65 
5.19 
2.67 
5.02 
1.95 
5.08 
2.70 
2.63 
2.64 
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7-M
ethylguanosine 
2.12 
20.51 
3.02 
29.28 
4.32 
36.27 
3.75 
32.93 
6.46 
- 
6.51 
A
tenolol 
1.71 
7.67 
1.81 
9.03 
3.91 
9.32 
2.31 
9.01 
3.09 
3.12 
3.26 
Vadarabine 
2.86 
7.34 
2.94 
7.49 
5.98 
9.63 
3.03 
7.76 
4.11 
3.98 
3.97 
Tryptophan 
3.43 
25.78 
3.63 
28.64 
7.30 
27.47 
3.72 
25.47 
6.35 
5.95 
6.06 
B
TM
A
 
1.54 
3.59 
1.62 
4.30 
3.91 
3.96 
1.99 
4.70 
2.25 
2.35 
2.47 
PTM
A
 
1.60 
4.01 
1.70 
4.88 
4.06 
4.68 
2.13 
5.11 
2.43 
2.56 
2.72 
Labetalol 
1.45 
3.44 
1.52 
3.74 
3.35 
3.36 
1.75 
3.82 
- 
- 
- 
N
adolol 
1.66 
7.26 
1.76 
8.26 
3.82 
8.30 
- 
8.14 
2.88 
2.89 
2.99 
Propranolol 
1.43 
3.19 
1.48 
3.49 
2.89 
- 
1.70 
- 
1.94 
1.94 
 
A
denine 
2.64 
5.24 
2.79 
5.47 
4.34 
5.89 
2.89 
5.72 
3.48 
3.47 
3.48 
U
racil 
2.44 
3.49 
2.48 
3.57 
3.62 
4.20 
2.56 
3.68 
2.87 
2.82 
2.79 
Thym
ine 
2.27 
3.14 
2.30 
3.19 
3.28 
3.53 
2.37 
3.24 
2.62 
2.58 
2.56 
C
ytosine 
2.86 
9.55 
3.41 
9.65 
4.44 
12.78 
3.52 
10.24 
4.89 
4.73 
4.70 
Pindolol 
1.47 
3.46 
1.52 
3.83 
2.43 
- 
1.78 
3.71 
- 
- 
- 
A
lprenolol 
1.42 
3.12 
1.47 
3.40 
2.42 
- 
1.69 
- 
1.89 
1.91 
1.95 
Salicylic acid 
5.23 
4.75 
5.72 
4.87 
5.86 
3.74 
3.73 
3.71 
4.16 
3.92 
3.77 
5-M
ethylsalicylic acid 
4.27 
4.32 
5.13 
4.63 
3.65 
3.41 
3.46 
3.56 
3.81 
3.62 
3.51 
4-H
ydroxybenzoic acid 
2.06 
2.83 
12.83 
12.62 
2.17 
2.98 
7.92 
9.82 
8.76 
7.87 
7.47 
3-H
ydroxybenzoic acid 
2.54 
3.85 
12.85 
16.93 
2.58 
4.16 
7.61 
12.32 
10.39 
9.07 
8.53 
2,3-D
ihydroxybenzoic acid 
7.45 
7.72 
10.72 
7.89 
- 
- 
5.69 
6.08 
6.32 
5.66 
5.26 
2,4-D
ihydroxybenzoic acid 
4.83 
6.30 
7.88 
8.20 
4.47 
5.62 
4.94 
6.24 
6.06 
5.51 
5.19 
2,5-D
ihydroxybenzoic acid 
6.70 
7.44 
7.13 
7.54 
5.79 
6.19 
4.63 
5.90 
5.64 
5.15 
4.87 
3,4-D
ihydroxybenzoic acid 
2.42 
4.35 
- 
- 
2.79 
5.64 
- 
- 
6.54 
- 
- 
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3,5-D
ihydroxybenzoic acid 
3.00 
5.61 
15.28 
26.92 
3.24 
6.87 
8.82 
20.76 
13.65 
11.64 
10.76 
B
enzoic acid 
2.26 
2.90 
10.44 
11.22 
2.72 
2.91 
6.61 
7.91 
7.82 
7.21 
6.75 
3-A
m
ino-4-hydroxybenzoic acid 
2.66 
3.54 
16.64 
18.60 
3.37 
3.82 
10.09 
13.58 
12.91 
11.65 
10.96 
G
allic acid 
3.11 
11.75 
- 
- 
- 
- 
- 
- 
- 
- 
- 
4-A
m
inosalicylic acid 
3.65 
2.42 
11.49 
9.40 
5.78 
4.54 
5.82 
6.82 
7.04 
6.51 
6.02 
4-A
m
inobenzoic acid 
1.94 
4.67 
9.14 
8.02 
3.30 
2.47 
7.63 
6.56 
6.67 
6.29 
6.15 
Phthalic acid 
28.57 
12.65 
- 
- 
23.29 
11.77 
- 
76.55 
118.59 
118.59 
77.34 
Isophthalic acid 
26.02 
45.91 
- 
- 
19.85 
60.27 
- 
- 
- 
- 
216.40 
3-A
m
inobenzoic acid 
2.36 
3.54 
19.73 
20.42 
3.04 
4.02 
12.05 
16.59 
13.64 
12.20 
11.40 
Vanillic acid 
2.14 
2.95 
13.62 
13.81 
2.81 
3.08 
8.37 
10.37 
9.37 
8.59 
8.17 
Syringic acid 
2.30 
3.32 
14.42 
16.38 
3.05 
3.46 
8.90 
11.82 
10.47 
9.62 
9.17 
2-M
ethoxybenzoic acid 
2.59 
3.31 
15.12 
16.76 
3.36 
3.41 
9.25 
11.86 
11.59 
10.55 
9.92 
Terephthalic acid 
27.80 
43.25 
- 
- 
21.23 
60.88 
- 
- 
- 
- 
- 
C
affeic acid 
2.17 
3.70 
- 
- 
3.09 
4.12 
- 
- 
- 
- 
- 
P-Toluic acid 
1.92 
2.48 
8.32 
8.91 
2.33 
2.43 
5.52 
6.38 
5.93 
5.64 
5.47 
3,5-D
initrosalicylic acid 
2.50 
1.85 
2.72 
1.84 
2.15 
1.72 
2.18 
1.75 
1.93 
1.94 
1.92 
N
icotinic acid 
11.59 
19.61 
20.48 
39.71 
8.63 
19.98 
12.43 
26.99 
21.19 
19.04 
17.87 
4-H
ydroxybenzenesulfonic acid 
9.75 
9.99 
8.43 
8.88 
5.84 
9.28 
5.27 
7.51 
6.75 
6.06 
5.61 
4-A
m
inophenylacetic acid 
2.87 
3.85 
21.76 
24.13 
2.73 
4.16 
13.30 
17.63 
16.68 
15.30 
14.46 
A
cetylsalicylic acid 
3.25 
4.37 
10.90 
13.90 
2.92 
4.24 
6.84 
9.32 
8.99 
8.31 
7.89 
Phenylacetic acid 
2.17 
2.78 
11.17 
12.40 
2.14 
2.75 
7.15 
8.74 
8.25 
7.78 
7.48 
1,2-benzenedisulfonic acid 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
P-Toluenesulfonic acid 
6.86 
5.56 
5.48 
4.96 
4.45 
4.43 
3.73 
- 
4.25 
4.02 
3.83 
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2-Sulfobenzoic acid 
- 
204.10 
- 
- 
174.15 
- 
- 
- 
- 
- 
- 
Tropic acid 
3.01 
4.88 
13.73 
21.66 
2.80 
5.09 
8.41 
- 
12.09 
10.90 
10.27 
2-Phenylethylam
ine 
1.58 
4.59 
1.67 
5.12 
1.87 
5.18 
2.01 
5.61 
2.39 
2.43 
2.49 
Phenylalanine 
3.84 
27.46 
4.10 
29.47 
3.94 
- 
4.19 
28.39 
7.19 
6.75 
6.78 
M
andelic acid 
8.18 
11.72 
12.66 
16.60 
6.36 
- 
7.79 
11.77 
10.79 
9.62 
8.88 
5-Sulfosalicylic acid 
- 
104.06 
- 
- 
- 
- 
- 
- 
61.83 
48.61 
40.67 
M
alic acid 
10.57 
5.91 
72.42 
16.93 
5.95 
5.82 
27.26 
14.30 
24.02 
19.27 
15.92 
N
um
bers in row
 are operating conditions of the full factorial design (Table 2.3). 
T
able 2.6. Experim
entally obtained retention tim
es for each operating condition of the full factorial design using zw
itterionic colum
n. 
A
nalyte 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
A
cetone 
1.91 
1.92 
1.88 
1.91 
1.89 
1.88 
1.87 
1.89 
1.89 
1.89 
1.85 
Toluene 
1.60 
1.69 
1.56 
1.68 
1.57 
1.63 
1.55 
1.64 
1.59 
1.59 
1.56 
2'-D
eoxyadenosine 
2.58 
4.93 
2.52 
5.01 
2.57 
5.33 
2.55 
5.35 
3.23 
3.22 
3.16 
2'-D
eoxycytidine 
3.21 
10.59 
3.00 
10.82 
3.23 
13.28 
3.04 
13.23 
4.37 
4.47 
4.49 
2',3'-D
ideoxyadenosine 
2.46 
3.71 
2.35 
3.70 
2.43 
3.88 
2.39 
3.87 
2.88 
2.81 
2.73 
2'-D
eoxyguanosine 
2.95 
11.69 
2.98 
12.21 
2.95 
14.01 
2.99 
14.12 
4.28 
4.45 
4.51 
3'-D
eoxyguanosine 
2.87 
10.79 
2.89 
11.21 
2.87 
12.79 
2.90 
12.90 
4.06 
4.21 
4.26 
5'-M
ethyluridine 
2.41 
4.73 
2.43 
4.88 
2.42 
5.65 
2.44 
5.64 
2.93 
3.02 
3.03 
8-H
ydroxy-2'-deoxyguanosine 
2.78 
10.61 
2.83 
11.19 
2.79 
12.92 
2.84 
13.11 
3.94 
4.13 
4.21 
A
denosine 
2.68 
6.05 
2.65 
6.23 
2.68 
6.98 
2.67 
7.05 
3.47 
3.51 
3.49 
C
ytidine 
3.39 
13.99 
3.22 
14.64 
3.43 
20.20 
3.25 
20.24 
4.89 
5.09 
5.18 
G
uanosine 
3.12 
15.81 
3.20 
16.82 
3.14 
20.79 
3.20 
21.05 
4.79 
5.06 
5.23 
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Inosine 
2.86 
9.68 
2.93 
10.43 
2.89 
13.38 
2.95 
13.69 
4.13 
4.29 
4.36 
Thym
idine 
2.28 
3.63 
2.27 
3.69 
2.27 
3.93 
2.27 
3.96 
2.63 
2.67 
2.66 
U
ridine 
2.55 
5.58 
2.59 
5.81 
2.57 
7.09 
2.60 
7.10 
3.21 
3.33 
3.38 
A
drenaline 
3.44 
17.30 
6.00 
- 
3.36 
19.25 
5.07 
- 
- 
6.75 
7.03 
N
oradrenaline 
3.70 
24.97 
6.81 
- 
3.62 
- 
6.04 
- 
- 
8.14 
8.36 
3'-M
ethoxytyram
ine 
2.88 
9.30 
4.06 
11.24 
2.80 
9.04 
3.25 
10.22 
4.65 
4.39 
4.39 
Isoproterenol 
2.92 
10.57 
5.99 
- 
2.84 
- 
5.47 
- 
- 
5.42 
5.28 
Fenotrole 
2.42 
9.44 
3.11 
9.71 
2.33 
6.56 
2.52 
6.87 
3.33 
3.30 
3.37 
Terbutaline 
2.70 
9.57 
3.73 
10.83 
2.62 
7.75 
2.95 
8.59 
4.07 
3.94 
3.99 
Salbutam
ol 
2.80 
9.47 
3.89 
11.22 
2.73 
8.92 
3.11 
9.99 
4.48 
4.23 
4.24 
R
itudrine 
2.23 
5.72 
2.76 
6.13 
2.14 
4.39 
2.29 
4.63 
2.88 
2.79 
2.80 
M
etaproterenol 
2.87 
11.52 
4.12 
13.29 
2.80 
9.71 
3.20 
10.85 
4.57 
4.45 
4.55 
Synephrine 
3.00 
10.59 
4.46 
13.20 
2.93 
10.42 
3.46 
12.14 
5.11 
4.84 
4.90 
D
opam
ine 
3.21 
15.02 
5.23 
- 
3.15 
15.89 
4.22 
- 
- 
5.75 
5.91 
N
-m
ethylephrine 
2.45 
4.73 
3.29 
5.53 
2.38 
4.53 
2.70 
4.93 
3.55 
3.22 
3.12 
N
orphenylephrine 
3.16 
15.24 
4.76 
16.80 
3.09 
13.80 
3.57 
15.02 
5.38 
5.27 
5.45 
Phenylephrine 
2.95 
10.41 
4.36 
12.63 
2.89 
9.81 
3.38 
11.19 
4.94 
4.67 
4.73 
Tyram
ine 
2.83 
9.55 
4.08 
11.44 
2.77 
9.10 
3.18 
10.23 
4.50 
4.32 
4.37 
N
orm
etanephrine 
3.23 
14.14 
4.98 
16.89 
3.16 
14.11 
3.73 
15.68 
5.74 
5.51 
5.65 
O
ctopam
ine 
3.21 
14.85 
4.97 
17.55 
3.14 
14.62 
3.67 
16.25 
5.58 
5.47 
5.66 
M
ethoxam
ine 
2.46 
6.46 
3.24 
6.95 
2.38 
5.53 
2.61 
5.86 
3.46 
3.27 
3.23 
Isoxuprine 
2.01 
3.65 
2.27 
3.14 
1.93 
3.05 
1.97 
2.66 
- 
2.24 
2.18 
C
eftiofur 
2.01 
5.60 
1.88 
6.32 
1.95 
5.49 
1.95 
5.87 
2.38 
2.48 
2.50 
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Tyrosine 
3.64 
37.59 
3.93 
45.22 
3.61 
52.33 
3.86 
60.52 
7.10 
7.25 
7.46 
Pentoxyfylline 
1.86 
2.06 
1.89 
2.06 
1.84 
1.99 
1.82 
2.00 
1.95 
1.92 
1.87 
G
uanine 
3.04 
10.87 
3.20 
11.55 
3.04 
12.56 
3.09 
13.19 
4.27 
4.43 
4.51 
X
anthine 
2.46 
5.13 
2.65 
5.96 
2.49 
6.29 
2.58 
7.45 
3.16 
3.24 
3.27 
C
affeine 
2.00 
2.20 
2.04 
2.21 
1.98 
2.18 
1.97 
2.19 
2.11 
2.08 
2.03 
Theophylline 
2.09 
2.60 
2.16 
2.66 
2.07 
2.63 
2.08 
2.68 
2.27 
2.25 
2.22 
Theobrom
ine 
2.20 
2.74 
2.26 
2.76 
2.19 
2.86 
2.19 
2.88 
2.43 
2.43 
2.38 
D
iphylline 
2.28 
3.36 
2.35 
3.41 
2.27 
3.66 
2.28 
3.71 
2.66 
2.66 
2.61 
7-H
ydroxyethyltheophylline 
2.13 
2.64 
2.19 
2.66 
2.11 
2.68 
2.11 
2.70 
2.33 
2.28 
2.25 
1-M
ethyluric acid 
2.46 
6.32 
2.92 
16.52 
2.47 
8.22 
3.09 
23.50 
4.66 
4.86 
5.05 
1-M
ethylguanine 
2.70 
5.92 
2.82 
6.17 
2.69 
6.60 
2.71 
6.85 
3.46 
3.48 
3.45 
9-M
ethylguanine 
2.84 
7.06 
2.96 
7.23 
2.83 
7.82 
2.84 
8.03 
3.70 
3.73 
3.72 
U
ric acid 
2.80 
12.21 
3.31 
37.50 
2.83 
21.02 
3.59 
64.44 
6.38 
6.97 
7.36 
3,7-D
im
ethyluric acid 
2.35 
4.39 
2.82 
10.84 
2.35 
5.68 
2.93 
15.20 
4.21 
4.23 
4.30 
7-M
ethylxanthine 
2.33 
3.65 
2.45 
3.82 
2.33 
4.09 
2.35 
4.22 
2.74 
2.75 
2.72 
H
ypoxanthine 
2.68 
6.08 
2.87 
6.61 
2.69 
7.36 
2.76 
7.92 
3.52 
3.58 
3.58 
Proxyphylline 
2.04 
2.42 
2.11 
2.46 
2.02 
2.42 
2.02 
2.43 
2.20 
2.17 
2.13 
1,7-D
im
ethyluric acid 
2.30 
4.33 
2.70 
10.12 
2.29 
5.00 
2.82 
13.16 
3.97 
4.02 
4.10 
1,3-D
im
ethyluric acid 
2.26 
3.96 
2.61 
7.92 
2.26 
4.60 
2.64 
9.97 
3.49 
3.47 
3.51 
1,3,7-Trim
ethyluric acid 
2.25 
2.89 
2.32 
2.95 
2.23 
3.04 
2.24 
3.06 
2.54 
2.49 
2.43 
4-N
itrophenyl-B
-D
-
glycopyranoside 
2.02 
3.65 
2.11 
3.75 
2.01 
3.67 
1.99 
3.76 
2.27 
2.32 
- 
A
cyclovir 
2.91 
9.70 
3.08 
10.25 
2.93 
11.92 
2.96 
12.62 
4.15 
4.24 
4.25 
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2'-D
eoxyuridine 
2.37 
4.15 
2.52 
4.29 
2.39 
4.73 
2.41 
4.93 
2.84 
2.92 
2.91 
3'-D
eoxythym
idine 
2.08 
2.65 
2.16 
2.70 
2.07 
2.71 
2.06 
2.75 
2.26 
2.27 
2.21 
2'-D
eoxyinosine 
2.70 
7.32 
2.88 
7.96 
2.73 
9.26 
2.77 
10.02 
3.73 
3.82 
3.82 
Satolol 
2.50 
6.72 
3.44 
7.45 
2.43 
5.65 
2.69 
6.05 
3.62 
3.41 
3.37 
7-M
ethylguanosine 
4.06 
32.69 
6.07 
43.71 
4.03 
38.45 
4.82 
50.77 
9.43 
9.01 
9.15 
A
tenolol 
2.96 
11.62 
4.31 
14.13 
2.89 
10.92 
3.35 
12.09 
5.28 
4.83 
4.71 
Vadarabine 
2.79 
7.63 
2.90 
8.17 
2.80 
8.83 
2.78 
9.30 
3.75 
3.84 
3.83 
Tryptophan 
3.23 
23.75 
3.48 
27.60 
3.17 
25.79 
3.30 
29.17 
5.32 
5.42 
5.54 
B
TM
A
 
2.61 
4.94 
3.74 
5.80 
2.58 
5.10 
3.02 
5.39 
4.13 
3.55 
3.30 
PTM
A
 
2.81 
5.61 
4.23 
6.66 
2.80 
6.26 
3.41 
6.78 
4.88 
4.06 
3.74 
Labetalol 
2.20 
- 
2.64 
5.25 
2.14 
- 
2.23 
- 
2.70 
2.63 
2.60 
N
adolol 
2.76 
10.34 
3.91 
11.86 
2.69 
9.17 
3.03 
10.01 
4.53 
4.22 
4.14 
Propranolol 
2.20 
4.14 
2.62 
4.52 
2.14 
- 
2.23 
- 
2.66 
2.60 
2.57 
A
denine 
2.79 
5.48 
2.85 
5.84 
2.79 
5.82 
2.73 
6.04 
3.44 
3.44 
3.37 
U
racil 
2.31 
3.35 
2.45 
3.58 
2.32 
3.73 
2.34 
3.91 
2.62 
2.68 
2.67 
Thym
ine 
2.18 
2.98 
2.30 
3.16 
2.19 
3.16 
2.20 
3.27 
2.41 
2.46 
2.45 
C
ytosine 
3.37 
9.39 
3.23 
9.78 
3.39 
11.54 
3.11 
12.24 
4.29 
4.37 
4.34 
Pindolol 
2.29 
5.22 
2.49 
4.08 
2.25 
- 
2.41 
4.43 
3.02 
2.90 
2.86 
A
lprenolol 
2.17 
3.75 
2.50 
4.11 
2.06 
- 
2.19 
- 
2.54 
2.57 
2.55 
Salicylic acid 
2.07 
3.14 
1.97 
3.44 
2.00 
3.06 
2.00 
3.22 
2.16 
2.30 
2.38 
5-M
ethylsalicylic acid 
1.94 
2.88 
1.89 
3.29 
1.89 
2.81 
1.93 
2.99 
2.07 
2.19 
2.19 
4-H
ydroxybenzoic acid 
1.80 
2.39 
2.82 
7.90 
1.78 
2.59 
2.77 
8.48 
3.35 
3.41 
3.62 
3-H
ydroxybenzoic acid 
1.84 
2.80 
2.70 
10.31 
1.82 
3.42 
2.75 
10.42 
3.53 
3.78 
3.99 
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2,3-D
ihydroxybenzoic acid 
2.43 
4.76 
2.24 
5.31 
2.28 
4.68 
2.37 
4.96 
2.64 
2.86 
2.99 
2,4-D
ihydroxybenzoic acid 
2.10 
4.39 
2.25 
6.33 
2.04 
4.60 
2.32 
5.64 
2.69 
2.97 
3.10 
2,5-D
ihydroxybenzoic acid 
2.33 
4.99 
2.16 
5.68 
2.23 
4.92 
2.24 
5.26 
2.56 
2.82 
2.91 
3,4-D
ihydroxybenzoic acid 
1.92 
3.17 
3.52 
25.37 
1.90 
4.13 
3.98 
- 
- 
4.97 
5.77 
3,5-D
ihydroxybenzoic acid 
1.96 
4.01 
2.99 
19.42 
1.93 
5.48 
3.06 
19.48 
4.27 
4.78 
5.21 
B
enzoic acid 
1.75 
2.20 
2.45 
6.17 
1.72 
2.46 
2.50 
6.26 
3.00 
3.10 
3.16 
3-A
m
ino-4-hydroxybenzoic 
acid 
1.97 
2.93 
3.60 
13.59 
1.95 
3.26 
3.53 
11.92 
4.33 
4.71 
5.14 
G
allic acid 
2.10 
5.29 
- 
- 
2.06 
- 
6.60 
- 
- 
- 
- 
4-A
m
inobenzoic acid 
1.82 
2.21 
2.92 
5.56 
1.80 
2.26 
2.78 
5.93 
3.10 
3.07 
3.22 
4-A
m
inosalicylic acid 
1.99 
3.50 
2.57 
7.64 
1.94 
3.99 
2.64 
6.64 
3.15 
3.52 
3.71 
Phthalic acid 
2.15 
3.21 
2.88 
13.25 
2.09 
4.91 
3.16 
- 
4.23 
4.25 
4.44 
Isophthalic acid 
2.10 
8.74 
5.96 
218.91 
2.04 
28.86 
6.40 
- 
16.34 
19.40 
22.16 
3-A
m
inobenzoic acid 
1.91 
2.65 
3.19 
11.20 
1.89 
3.44 
3.25 
15.68 
4.64 
4.52 
4.74 
Vanillic acid 
1.82 
2.40 
2.87 
8.47 
1.79 
2.67 
2.88 
8.96 
3.58 
3.65 
3.82 
Syringic acid 
1.86 
2.58 
2.96 
9.89 
1.83 
2.95 
3.02 
10.23 
3.94 
4.03 
4.19 
2-M
ethoxybenzoic acid 
1.79 
2.23 
2.67 
7.49 
1.76 
2.62 
2.74 
8.57 
3.48 
3.54 
3.59 
Terephthalic acid 
2.16 
9.45 
6.89 
276.85 
2.10 
30.65 
7.47 
- 
20.73 
24.54 
28.54 
C
affeic acid 
1.85 
2.87 
3.16 
18.78 
1.82 
3.35 
3.47 
- 
- 
4.23 
4.82 
P-Toluic acid 
1.69 
2.03 
2.26 
4.89 
1.67 
2.14 
2.28 
4.90 
2.65 
2.68 
2.70 
3,5-D
initrosalicylic acid 
1.58 
1.58 
1.51 
1.64 
1.57 
1.54 
1.51 
1.61 
1.50 
1.55 
1.52 
N
icotinic acid 
3.02 
8.58 
3.34 
19.89 
2.90 
13.91 
3.63 
23.69 
5.93 
6.35 
6.30 
4-H
ydroxybenzenesulfonic acid 
2.56 
6.42 
2.18 
6.45 
2.49 
6.81 
2.29 
7.13 
2.67 
3.01 
3.14 
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4-A
m
inophenylacetic acid 
2.06 
2.76 
3.67 
10.05 
2.04 
3.39 
3.69 
14.63 
5.11 
5.12 
5.32 
A
cetylsalicylic acid 
1.82 
2.63 
2.38 
6.29 
1.78 
3.32 
2.47 
7.09 
3.10 
3.25 
3.25 
Phenylacetic acid 
1.73 
2.12 
2.51 
5.74 
1.71 
2.32 
2.54 
6.52 
3.11 
3.25 
3.13 
1,2-benzenedisulfonic acid 
6.04 
50.10 
3.26 
47.32 
4.58 
76.16 
3.56 
- 
6.23 
7.69 
8.53 
P-Toluenesulfonic acid 
2.19 
3.47 
1.90 
3.26 
2.13 
3.43 
1.97 
3.51 
2.13 
2.31 
- 
2-Sulfobenzoic acid 
2.93 
16.38 
4.19 
79.31 
2.80 
56.66 
4.53 
- 
9.48 
11.22 
12.19 
Tropic acid 
1.89 
2.90 
2.58 
9.65 
1.86 
3.78 
2.69 
11.37 
3.62 
3.80 
3.83 
2-Phenylethylam
ine 
2.53 
6.54 
3.52 
7.63 
2.47 
5.76 
2.75 
6.52 
3.65 
3.50 
3.40 
Phenylalanine 
3.17 
20.01 
3.36 
24.38 
3.14 
26.21 
3.29 
29.92 
- 
5.41 
5.32 
M
andelic acid 
2.30 
5.07 
2.41 
8.07 
2.18 
- 
2.58 
- 
- 
3.52 
3.54 
5-Sulfosalicylic acid 
4.71 
30.28 
2.68 
30.61 
3.81 
33.50 
3.01 
34.31 
4.61 
5.82 
6.50 
M
alic acid 
2.33 
3.24 
2.13 
4.99 
2.27 
3.79 
2.28 
9.22 
2.60 
2.77 
2.78 
N
um
bers in row
 are operating conditions of the full factorial design (Table 2.3). 
 T
able 2.7. Experim
entally obtained retention tim
es for each operating condition of the full factorial design using bare silica colum
n. 
A
nalyte  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
A
cetone 
1.12 
1.14 
1.12 
1.13 
1.11 
1.12 
1.14 
1.14 
1.11 
1.20 
1.12 
Toluene 
0.98 
1.02 
0.98 
1.02 
0.98 
1.00 
0.99 
1.00 
0.98 
1.07 
0.99 
2'-D
eoxyadenosine 
1.41 
2.57 
1.42 
2.58 
1.43 
2.70 
1.45 
2.75 
1.69 
1.80 
1.71 
2'-D
eoxycytidine 
1.54 
4.32 
1.52 
4.50 
1.55 
5.86 
1.56 
6.89 
2.00 
2.12 
2.04 
2',3'-D
ideoxyadenosine 
1.48 
2.34 
1.46 
2.29 
1.48 
2.24 
1.47 
2.11 
1.68 
1.79 
1.69 
2'-D
eoxyguanosine 
1.38 
3.82 
1.44 
4.06 
1.42 
5.46 
1.48 
6.52 
1.85 
1.95 
1.88 
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3'-D
eoxyguanosine 
1.37 
3.54 
1.41 
3.75 
1.39 
5.05 
1.45 
5.96 
1.78 
1.88 
1.81 
5'-M
ethyluridine 
1.22 
1.87 
1.25 
1.94 
- 
2.44 
1.29 
2.80 
1.40 
1.50 
1.42 
8-H
ydroxy-2'-deoxyguanosine 
1.31 
3.11 
1.36 
3.36 
1.34 
4.78 
1.40 
6.02 
1.68 
1.81 
1.72 
A
denosine 
1.38 
2.69 
1.41 
2.76 
1.41 
3.18 
1.45 
3.52 
1.70 
1.85 
1.73 
C
ytidine 
1.53 
4.83 
1.53 
5.19 
1.55 
7.99 
1.59 
10.86 
2.07 
2.23 
2.12 
G
uanosine 
1.38 
4.22 
1.45 
4.62 
1.42 
7.26 
1.50 
9.65 
1.90 
2.04 
1.94 
Inosine 
1.35 
3.31 
1.42 
3.62 
1.39 
5.22 
1.47 
7.13 
1.78 
1.93 
1.82 
Thym
idine 
1.20 
1.67 
1.23 
1.70 
1.22 
1.89 
1.26 
2.04 
1.34 
1.50 
1.36 
U
ridine 
1.24 
2.03 
1.29 
2.13 
1.28 
2.87 
1.33 
3.60 
1.47 
1.63 
1.49 
A
drenaline 
1.68 
6.73 
- 
- 
1.63 
7.22 
5.77 
- 
3.15 
3.93 
3.66 
N
oradrenaline 
1.67 
7.30 
- 
- 
1.62 
8.96 
5.10 
- 
3.13 
4.19 
3.93 
3'-M
ethoxytyram
ine 
1.58 
4.86 
2.30 
5.59 
1.54 
4.18 
1.98 
4.63 
2.34 
2.70 
2.39 
Isoproterenol 
1.55 
4.63 
- 
- 
1.51 
4.37 
4.89 
- 
2.84 
3.71 
3.37 
Fenotrole 
1.30 
2.72 
1.58 
2.83 
1.27 
2.50 
1.40 
2.47 
1.59 
1.80 
1.61 
Terbutaline 
1.44 
3.53 
1.96 
4.00 
1.42 
3.26 
1.68 
3.53 
1.96 
2.24 
1.98 
Salbutam
ol 
1.57 
4.59 
2.25 
5.35 
1.53 
4.17 
1.90 
4.65 
2.30 
2.63 
2.33 
R
itudrine 
1.28 
2.47 
1.55 
2.56 
1.25 
2.04 
1.38 
1.99 
1.53 
1.76 
1.54 
M
etaproterenol 
1.49 
4.10 
2.08 
4.74 
1.47 
3.93 
1.78 
4.44 
2.13 
2.43 
2.15 
Synephrine 
1.60 
5.20 
2.43 
6.37 
1.58 
4.67 
2.04 
5.53 
2.52 
2.94 
2.58 
D
opam
ine 
1.59 
5.62 
- 
- 
1.58 
5.79 
3.28 
12.20 
2.63 
3.24 
2.97 
N
-m
ethylephrine 
1.58 
3.90 
2.40 
4.48 
1.55 
2.82 
2.01 
2.74 
2.28 
2.73 
2.31 
N
orphenylephrine 
1.57 
5.26 
2.25 
6.08 
1.55 
5.31 
1.90 
6.22 
2.38 
2.80 
2.42 
Phenylephrine 
1.58 
4.92 
2.36 
5.96 
1.55 
4.39 
1.99 
5.05 
2.43 
2.88 
2.48 
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Tyram
ine 
1.53 
4.54 
2.18 
5.19 
1.49 
4.03 
1.84 
4.51 
2.21 
2.61 
2.26 
N
orm
etanephrine 
1.63 
5.85 
2.45 
6.88 
1.59 
5.71 
2.11 
6.83 
2.59 
3.04 
2.66 
O
ctopam
ine 
1.59 
5.52 
2.32 
6.47 
1.55 
5.62 
1.99 
6.82 
2.45 
2.86 
2.52 
M
ethoxam
ine 
1.46 
3.61 
1.96 
3.90 
1.42 
2.89 
1.67 
2.82 
1.93 
2.29 
1.96 
Isoxuprine 
1.25 
2.11 
1.40 
1.75 
1.20 
1.68 
1.27 
1.38 
1.37 
1.61 
1.38 
C
eftiofur 
1.06 
2.23 
0.99 
2.37 
1.09 
2.41 
1.08 
2.59 
1.22 
1.38 
1.22 
Tyrosine 
1.61 
13.03 
1.76 
16.70 
1.66 
18.83 
1.96 
28.23 
2.86 
3.31 
2.97 
Pentoxyfylline 
1.18 
1.32 
1.17 
1.31 
1.18 
1.24 
1.18 
1.18 
1.20 
1.40 
1.21 
G
uanine 
1.43 
3.64 
1.47 
3.83 
1.47 
4.90 
1.52 
5.81 
1.86 
2.08 
1.88 
X
anthine 
1.26 
2.04 
1.30 
2.29 
1.28 
2.69 
1.35 
3.59 
1.49 
1.69 
1.51 
C
affeine 
1.23 
1.39 
1.22 
1.37 
1.23 
1.33 
1.24 
1.27 
1.27 
1.47 
1.28 
Theophylline 
1.21 
1.46 
1.22 
1.48 
1.23 
1.48 
1.24 
1.47 
1.28 
1.49 
1.30 
Theobrom
ine 
1.28 
1.60 
1.29 
1.59 
1.31 
1.63 
1.32 
1.60 
1.38 
1.59 
1.39 
D
iphylline 
1.28 
1.87 
1.31 
1.90 
1.33 
1.95 
1.34 
1.97 
1.46 
1.68 
1.47 
7-H
ydroxyethyltheophylline 
1.25 
1.54 
1.26 
1.54 
1.28 
1.55 
1.28 
1.50 
1.34 
1.55 
1.36 
1-M
ethyluric acid 
1.23 
2.37 
1.25 
4.99 
1.28 
3.11 
1.39 
10.56 
1.82 
2.06 
1.76 
1-M
ethylguanine 
1.43 
2.86 
1.45 
2.92 
1.48 
3.17 
1.48 
3.36 
1.74 
1.99 
1.76 
9-M
ethylguanine 
1.46 
3.10 
1.48 
3.15 
1.57 
3.64 
1.52 
3.87 
1.80 
2.05 
1.82 
U
ric acid 
1.28 
3.83 
1.29 
9.13 
1.34 
6.48 
1.47 
28.11 
2.18 
2.44 
2.25 
3,7-D
im
ethyluric acid 
1.25 
2.18 
1.29 
4.35 
1.30 
2.52 
1.43 
7.10 
1.83 
2.08 
1.87 
7-M
ethylxanthine 
1.28 
1.84 
1.30 
1.88 
1.32 
2.08 
1.33 
2.20 
1.44 
1.66 
1.46 
H
ypoxanthine 
1.38 
2.67 
1.42 
2.84 
1.43 
3.33 
1.46 
3.87 
1.70 
1.95 
1.72 
Proxyphylline 
1.23 
1.45 
1.22 
1.45 
1.25 
1.43 
1.24 
1.38 
1.29 
1.51 
1.30 
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1,7-D
im
ethyluric acid 
1.21 
1.99 
1.24 
3.89 
1.26 
2.22 
1.37 
6.07 
1.73 
1.95 
1.76 
1,3-D
im
ethyluric acid 
1.22 
1.92 
1.25 
3.36 
1.27 
2.14 
1.36 
4.71 
1.62 
1.86 
1.65 
1,3,7-Trim
ethyluric acid 
1.37 
1.90 
1.38 
1.89 
1.42 
1.84 
1.40 
1.78 
1.51 
1.77 
1.52 
4-N
itrophenyl-B
-D
-
glycopyranoside 
1.10 
1.50 
1.12 
1.56 
1.14 
1.73 
1.14 
1.79 
1.20 
1.38 
1.21 
A
cyclovir 
1.44 
3.84 
1.49 
4.02 
1.52 
5.19 
1.54 
6.00 
1.92 
2.22 
1.94 
2'-D
eoxyuridine 
1.23 
1.80 
1.26 
1.85 
1.30 
2.17 
1.30 
2.41 
1.41 
1.65 
1.43 
3'-D
eoxythym
idine 
1.19 
1.44 
1.20 
1.45 
1.23 
1.51 
1.22 
1.51 
1.27 
1.50 
1.28 
2'-D
eoxyinosine 
1.36 
3.05 
1.42 
3.25 
1.43 
4.07 
1.46 
4.84 
1.76 
2.04 
1.79 
Satolol 
1.48 
3.77 
2.04 
4.27 
1.44 
3.02 
1.75 
3.05 
2.05 
2.45 
2.07 
7-M
ethylguanosine 
2.06 
13.44 
3.09 
18.27 
2.12 
15.84 
2.71 
24.52 
4.28 
5.18 
4.43 
A
tenolol 
1.79 
7.35 
2.76 
8.59 
1.83 
5.92 
2.31 
6.25 
3.03 
3.72 
3.08 
Vadarabine 
1.40 
3.00 
1.43 
3.11 
1.49 
3.75 
1.47 
4.17 
1.77 
2.05 
1.79 
Tryptophan 
1.51 
8.91 
1.59 
10.50 
1.58 
9.89 
1.71 
11.91 
2.32 
2.71 
2.38 
B
TM
A
 
2.08 
5.70 
3.48 
6.13 
2.10 
3.87 
2.77 
3.68 
3.17 
3.85 
3.23 
PTM
A
 
2.33 
6.83 
4.18 
7.43 
2.38 
4.85 
3.29 
4.75 
3.78 
4.68 
3.88 
Labetalol 
1.29 
- 
1.56 
2.50 
1.29 
1.91 
1.39 
- 
1.53 
1.85 
1.54 
N
adolol 
1.65 
5.75 
2.41 
6.71 
1.32 
4.78 
2.03 
4.92 
1.61 
3.04 
2.57 
Propranolol 
1.33 
2.58 
1.64 
2.72 
1.33 
1.96 
1.44 
- 
1.61 
1.97 
1.61 
A
denine 
1.52 
2.80 
1.51 
2.81 
1.59 
2.90 
1.54 
2.92 
1.80 
2.14 
1.81 
U
racil 
1.22 
1.57 
1.24 
1.61 
1.31 
1.81 
1.28 
1.96 
1.34 
1.60 
1.36 
Thym
ine 
1.19 
1.46 
1.21 
1.49 
1.27 
1.62 
1.23 
1.69 
1.28 
1.52 
1.29 
C
ytosine 
1.68 
4.19 
1.59 
4.09 
1.74 
5.25 
1.64 
5.91 
2.06 
2.42 
2.08 
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Pindolol 
1.37 
2.80 
1.74 
2.97 
1.40 
2.15 
1.53 
2.10 
1.56 
2.08 
1.72 
A
lprenolol 
1.30 
2.46 
1.59 
2.58 
1.32 
1.90 
1.41 
- 
1.56 
1.91 
1.57 
Salicylic acid 
1.03 
1.34 
0.97 
1.36 
1.13 
1.46 
1.05 
1.53 
1.09 
1.26 
1.11 
5-M
ethylsalicylic acid 
1.03 
1.31 
0.96 
1.34 
1.09 
1.40 
1.04 
1.46 
1.08 
1.29 
1.09 
4-H
ydroxybenzoic acid 
1.03 
1.24 
1.14 
2.34 
1.12 
1.28 
1.25 
3.38 
1.38 
1.62 
1.41 
3-H
ydroxybenzoic acid 
1.04 
1.40 
1.11 
2.77 
1.16 
1.47 
1.22 
4.14 
1.43 
1.69 
1.46 
2,3-D
ihydroxybenzoic acid 
1.09 
1.55 
1.01 
1.63 
1.08 
1.87 
1.15 
2.11 
1.18 
1.40 
1.20 
2,4-D
ihydroxybenzoic acid 
1.05 
1.54 
1.00 
1.66 
1.13 
1.77 
1.09 
2.26 
1.18 
1.41 
1.19 
2,5-D
ihydroxybenzoic acid 
1.06 
1.56 
0.99 
1.57 
1.13 
1.91 
1.07 
2.17 
1.16 
1.34 
1.17 
3,4-D
ihydroxybenzoic acid 
1.06 
1.44 
1.22 
7.44 
1.14 
1.61 
1.77 
- 
1.63 
2.11 
1.90 
3,5-D
ihydroxybenzoic acid 
1.05 
1.60 
1.11 
3.39 
1.08 
1.85 
1.23 
7.09 
1.48 
1.73 
1.52 
B
enzoic acid 
1.03 
1.30 
1.11 
2.39 
1.10 
1.28 
1.22 
2.77 
1.39 
1.63 
1.41 
3-A
m
ino-4-hydroxybenzoic acid 
1.08 
- 
1.23 
3.43 
1.17 
1.46 
1.38 
4.91 
1.69 
1.97 
1.73 
G
allic acid 
1.08 
1.94 
1.41 
- 
1.10 
3.28 
2.81 
- 
2.23 
3.50 
3.35 
4-A
m
inobenzoic acid 
1.05 
1.53 
1.04 
1.93 
1.13 
1.60 
1.15 
2.52 
1.29 
1.60 
1.30 
4-A
m
inosalicylic acid 
1.05 
1.19 
1.18 
1.94 
1.13 
1.20 
1.29 
2.52 
1.33 
1.51 
1.37 
Phthalic acid 
1.03 
1.55 
1.11 
5.19 
1.18 
2.09 
1.36 
18.18 
1.58 
1.84 
1.68 
Isophthalic acid 
1.08 
5.29 
1.36 
39.85 
1.14 
6.87 
1.72 
130.25 
3.83 
4.00 
4.00 
3-A
m
inobenzoic acid 
1.08 
1.37 
1.25 
3.34 
1.11 
1.48 
1.43 
5.87 
1.62 
1.93 
1.67 
Vanillic acid 
1.04 
1.29 
1.16 
2.63 
1.14 
1.31 
1.30 
3.61 
1.48 
1.72 
1.50 
Syringic acid 
1.06 
1.40 
1.20 
3.25 
1.13 
1.41 
1.36 
4.16 
1.60 
1.87 
1.63 
2-M
ethoxybenzoic acid 
1.05 
1.37 
1.19 
3.08 
1.22 
1.36 
1.33 
3.97 
1.59 
1.86 
1.61 
Terephthalic acid 
1.09 
5.17 
1.42 
44.71 
1.11 
6.94 
1.85 
165.37 
4.40 
4.92 
4.60 
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C
affeic acid 
1.04 
- 
1.16 
5.36 
1.07 
1.45 
1.57 
10.16 
1.53 
1.89 
1.66 
P-Toluic acid 
1.02 
1.21 
1.09 
2.10 
0.99 
1.18 
1.19 
2.22 
1.31 
1.57 
1.33 
3,5-D
initrosalicylic acid 
0.92 
0.90 
0.88 
0.89 
1.63 
0.96 
0.94 
0.97 
0.91 
1.09 
0.91 
N
icotinic acid 
1.48 
5.66 
1.43 
8.25 
1.17 
5.84 
1.67 
11.45 
2.63 
3.03 
2.63 
4-H
ydroxybenzenesulfonic acid 
1.05 
1.55 
0.98 
1.56 
1.22 
2.37 
1.08 
2.82 
1.16 
1.37 
1.17 
4-A
m
inophenylacetic acid 
1.13 
1.58 
1.40 
4.39 
1.14 
1.57 
1.61 
6.25 
2.03 
2.49 
2.07 
A
cetylsalicylic acid 
1.05 
1.62 
1.12 
2.74 
1.11 
1.57 
1.25 
3.26 
1.48 
1.76 
1.49 
Phenylacetic acid 
1.03 
1.30 
1.16 
2.75 
1.38 
1.25 
1.29 
3.02 
1.50 
1.88 
1.51 
1,2-benzenedisulfonic acid 
1.21 
7.59 
1.08 
7.74 
1.11 
22.68 
1.28 
33.70 
1.83 
2.17 
1.87 
P-Toluenesulfonic acid 
1.03 
1.29 
0.96 
1.27 
1.11 
1.57 
1.04 
1.64 
1.08 
1.36 
1.09 
2-Sulfobenzoic acid 
1.07 
7.13 
1.25 
19.63 
1.26 
17.23 
1.54 
144.59 
2.79 
3.35 
2.89 
Tropic acid 
1.07 
1.70 
1.16 
3.68 
1.14 
1.70 
1.31 
5.11 
1.62 
2.04 
1.64 
2-Phenylethylam
ine 
1.51 
3.84 
2.08 
4.11 
1.53 
3.05 
- 
3.18 
2.06 
2.70 
2.08 
Phenylalanine 
1.62 
10.04 
1.71 
10.87 
1.76 
11.79 
1.91 
14.77 
2.62 
3.19 
2.72 
M
andelic acid 
1.18 
2.43 
1.11 
2.81 
1.28 
2.72 
1.28 
3.90 
1.48 
1.84 
1.50 
5-Sulfosalicylic acid 
1.08 
3.80 
0.96 
3.78 
1.23 
8.93 
1.13 
12.54 
1.40 
1.69 
1.42 
M
alic acid 
1.06 
1.32 
1.01 
1.87 
1.16 
1.71 
1.14 
5.19 
1.20 
1.51 
1.22 
N
um
bers in row
 are operating conditions of the full factorial design (Table 2.3). 
T
able 2.8. Experim
entally obtained retention tim
es for each operating condition of the full factorial design using diol colum
n.
  
A
nalyte 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
A
cetone 
2.23 
2.19 
2.23 
2.19 
2.23 
2.19 
2.23 
2.19 
2.18 
2.20 
2.20 
Toluene 
2.67 
2.22 
2.67 
2.22 
2.67 
2.22 
2.68 
2.22 
2.35 
2.36 
2.37 
	 
 
86 
2'-D
eoxyadenosine 
2.22 
3.52 
2.21 
3.51 
2.22 
3.57 
2.21 
3.51 
2.49 
2.55 
2.55 
2'-D
eoxycytidine 
2.06 
3.53 
2.01 
3.57 
2.05 
3.73 
2.01 
3.66 
2.29 
2.33 
2.34 
2',3'-D
ideoxyadenosine 
2.49 
3.77 
2.47 
3.73 
2.48 
3.78 
2.47 
3.69 
2.74 
2.82 
2.82 
2'-D
eoxyguanosine 
1.99 
3.26 
1.99 
3.34 
1.99 
3.46 
1.98 
3.44 
2.23 
2.27 
2.27 
3'-D
eoxyguanosine 
1.99 
3.15 
1.99 
3.22 
1.99 
3.34 
1.98 
3.32 
2.22 
2.25 
2.25 
5'-M
ethyluridine 
1.94 
2.35 
1.94 
2.37 
1.94 
2.41 
1.94 
2.41 
2.06 
2.08 
2.08 
8-H
ydroxy-2'-deoxyguanosine 
1.96 
2.97 
1.96 
3.05 
1.95 
3.13 
1.95 
3.13 
2.17 
2.20 
2.20 
A
denosine 
2.10 
3.20 
2.10 
3.24 
2.10 
3.30 
2.09 
3.27 
2.34 
2.39 
2.39 
C
ytidine 
1.93 
3.07 
1.93 
3.19 
1.93 
3.60 
1.93 
3.31 
2.21 
2.19 
2.26 
G
uanosine 
1.99 
3.33 
1.95 
3.43 
1.98 
3.31 
1.95 
3.58 
2.16 
2.25 
2.20 
Inosine 
1.93 
2.78 
1.93 
2.88 
1.92 
2.95 
1.92 
2.98 
2.13 
2.16 
2.16 
Thym
idine 
1.99 
2.37 
1.99 
2.38 
1.99 
2.41 
1.99 
2.41 
2.10 
2.12 
2.12 
U
ridine 
1.91 
2.35 
1.92 
2.38 
1.92 
2.42 
1.91 
2.42 
2.05 
2.07 
2.07 
A
drenaline 
2.27 
4.89 
2.83 
6.50 
2.21 
4.86 
2.51 
6.16 
2.92 
3.10 
3.15 
N
oradrenaline 
2.23 
4.86 
2.71 
6.35 
2.17 
4.86 
2.41 
5.91 
2.83 
2.98 
3.02 
3'-M
ethoxytyram
ine 
2.42 
5.46 
3.05 
6.77 
2.37 
5.35 
2.71 
6.42 
3.12 
3.33 
3.37 
Isoproterenol 
2.34 
4.40 
2.97 
5.53 
2.28 
4.22 
2.64 
4.97 
2.90 
3.04 
3.07 
Fenotrole 
2.35 
3.78 
2.80 
4.01 
2.28 
3.53 
2.49 
3.67 
2.70 
2.81 
2.84 
Terbutaline 
2.35 
4.06 
2.85 
4.71 
2.29 
3.83 
2.53 
4.29 
2.80 
2.93 
2.96 
Salbutam
ol 
2.37 
4.62 
2.92 
5.49 
2.31 
4.43 
2.59 
5.03 
2.95 
3.11 
3.15 
R
itudrine 
2.48 
4.11 
3.02 
4.51 
2.41 
3.81 
2.68 
4.06 
2.84 
2.98 
3.01 
M
etaproterenol 
2.32 
4.23 
2.81 
4.99 
2.26 
4.03 
2.50 
4.56 
2.80 
2.94 
2.97 
Synephrine 
2.36 
5.17 
2.97 
6.58 
2.31 
5.04 
2.64 
6.35 
3.04 
3.24 
3.29 
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D
opam
ine 
2.31 
5.05 
2.88 
6.42 
2.26 
4.99 
2.55 
6.05 
2.95 
3.12 
3.16 
N
-m
ethylephrine 
2.71 
5.75 
3.85 
7.31 
2.69 
5.53 
3.41 
6.74 
3.65 
3.96 
4.03 
N
orphenylephrine 
2.32 
5.04 
2.85 
6.38 
2.26 
4.94 
2.53 
5.89 
2.92 
3.09 
3.13 
Phenylephrine 
2.38 
5.06 
3.01 
6.51 
2.32 
4.93 
2.67 
6.24 
3.05 
3.24 
3.29 
Tyram
ine 
2.41 
5.37 
3.02 
6.56 
2.36 
5.21 
2.67 
6.26 
3.06 
3.25 
3.29 
N
orm
etanephrine 
2.31 
5.22 
2.86 
6.58 
2.26 
5.15 
2.54 
6.16 
2.97 
3.16 
3.20 
O
ctopam
ine 
2.30 
5.09 
2.82 
6.43 
2.24 
4.99 
2.50 
5.85 
2.93 
3.10 
3.14 
M
ethoxam
ine 
2.60 
5.39 
3.34 
6.47 
2.55 
5.17 
2.94 
6.10 
3.24 
3.46 
3.50 
Isoxuprine 
2.73 
4.25 
3.30 
3.70 
2.67 
3.92 
2.97 
3.47 
2.93 
3.12 
3.14 
C
eftiofur 
1.96 
2.51 
1.68 
2.60 
1.98 
2.65 
- 
2.74 
1.91 
1.91 
1.90 
Tyrosine 
2.07 
6.78 
2.08 
8.12 
2.06 
7.43 
2.08 
8.22 
2.60 
2.66 
2.67 
Pentoxyfylline 
2.44 
2.60 
2.43 
2.59 
2.44 
2.59 
2.45 
2.58 
2.42 
2.47 
2.47 
G
uanine 
2.13 
3.84 
2.12 
3.96 
2.13 
4.04 
2.12 
4.05 
2.43 
2.49 
2.48 
X
anthine 
2.02 
2.67 
2.01 
2.78 
2.02 
2.76 
2.02 
2.84 
2.19 
2.22 
2.22 
C
affeine 
2.40 
2.65 
2.39 
2.64 
2.40 
2.65 
2.40 
2.63 
2.44 
2.48 
2.48 
Theophylline 
2.25 
2.66 
2.25 
2.68 
2.25 
2.67 
2.26 
2.69 
2.35 
2.38 
2.38 
Theobrom
ine 
2.22 
2.65 
2.22 
2.65 
2.22 
2.67 
2.22 
2.66 
2.33 
2.37 
2.37 
D
iphylline 
2.10 
2.67 
2.10 
2.69 
2.10 
2.71 
2.10 
2.70 
2.25 
2.29 
2.29 
7-H
ydroxyethyltheophylline 
2.21 
2.63 
2.20 
2.63 
2.21 
2.64 
2.21 
2.63 
2.31 
2.35 
2.35 
1-M
ethyluric acid 
1.99 
2.62 
1.77 
3.82 
1.99 
2.69 
1.84 
3.99 
2.17 
2.18 
2.17 
1-M
ethylguanine 
2.23 
3.70 
2.22 
3.76 
2.23 
3.81 
2.23 
3.80 
2.52 
2.58 
2.57 
9-M
ethylguanine 
2.22 
3.64 
2.21 
3.71 
2.21 
3.80 
2.21 
3.78 
2.48 
2.55 
2.55 
U
ric acid 
1.91 
2.75 
1.67 
4.49 
1.91 
2.89 
1.76 
4.81 
2.09 
2.10 
2.09 
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3,7-D
im
ethyluric acid 
2.03 
2.65 
1.85 
3.90 
2.03 
2.71 
1.93 
4.05 
2.28 
2.30 
2.29 
7-M
ethylxanthine 
2.10 
2.67 
2.10 
2.70 
2.10 
2.72 
2.11 
2.73 
2.25 
2.28 
2.29 
H
ypoxanthine 
2.11 
3.24 
2.11 
3.35 
2.11 
3.36 
2.12 
3.41 
2.36 
2.41 
2.41 
Proxyphylline 
2.24 
2.58 
2.23 
2.57 
2.24 
2.58 
2.24 
2.57 
2.31 
2.35 
2.35 
1,7-D
im
ethyluric acid 
2.07 
2.62 
1.85 
3.88 
2.06 
2.66 
1.92 
3.97 
2.29 
2.30 
2.29 
1,3-D
im
ethyluric acid 
2.05 
2.60 
1.92 
3.61 
2.05 
2.66 
1.98 
3.75 
2.27 
2.29 
2.28 
1,3,7-Trim
ethyluric acid 
2.49 
2.99 
2.46 
2.95 
2.49 
2.97 
2.47 
2.92 
2.58 
2.62 
2.63 
4-N
itrophenyl-B
-D
-
glycopyranoside 
2.00 
2.27 
2.00 
2.30 
2.00 
2.32 
2.00 
2.33 
2.05 
2.08 
2.08 
A
cyclovir 
2.03 
3.29 
2.03 
3.39 
2.03 
3.48 
2.03 
3.48 
2.27 
2.32 
2.32 
2'-D
eoxyuridine 
1.96 
2.36 
1.96 
2.39 
1.96 
2.41 
1.96 
2.41 
2.08 
2.10 
2.10 
3'-D
eoxythym
idine 
2.10 
2.37 
2.10 
2.38 
2.10 
2.39 
2.11 
2.39 
2.17 
2.19 
2.20 
2'-D
eoxyinosine 
1.98 
2.92 
1.98 
3.01 
1.98 
3.05 
1.98 
3.08 
2.19 
2.23 
2.24 
Satolol 
2.40 
4.32 
2.99 
5.01 
2.34 
4.10 
2.65 
4.59 
2.91 
3.07 
3.11 
7-M
ethylguanosine 
2.24 
6.43 
2.59 
8.49 
2.19 
6.66 
2.37 
8.03 
3.02 
3.22 
3.30 
A
tenolol 
2.41 
5.79 
3.04 
7.08 
2.36 
5.61 
2.70 
6.57 
3.16 
3.38 
3.45 
Vadarabine 
2.06 
3.25 
2.06 
3.31 
2.06 
3.35 
2.06 
3.33 
2.31 
2.35 
2.36 
Tryptophan 
2.28 
7.07 
2.28 
8.21 
2.27 
7.56 
2.28 
8.26 
2.81 
2.90 
2.92 
B
TM
A
 
2.95 
7.23 
4.15 
8.71 
2.98 
7.08 
3.68 
8.18 
4.04 
4.49 
4.63 
PTM
A
 
2.90 
7.44 
4.09 
9.02 
2.93 
7.32 
3.63 
8.48 
4.07 
4.54 
4.70 
Labetalol 
2.74 
4.43 
3.54 
4.88 
2.68 
4.11 
3.10 
4.40 
3.13 
3.32 
3.37 
N
adolol 
2.47 
5.48 
3.15 
6.74 
2.42 
5.30 
2.78 
6.39 
3.18 
3.38 
3.45 
Propranolol 
2.96 
5.20 
4.09 
6.37 
2.92 
4.87 
3.58 
5.68 
3.57 
3.83 
3.90 
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A
denine 
2.56 
4.75 
2.57 
4.77 
2.55 
4.76 
2.57 
4.71 
2.97 
3.07 
3.07 
U
racil 
2.03 
2.39 
2.03 
2.40 
2.03 
2.41 
2.04 
2.42 
2.13 
2.16 
2.17 
Thym
ine 
2.08 
2.40 
2.08 
2.41 
2.08 
2.42 
2.08 
2.42 
2.16 
2.19 
2.19 
C
ytosine 
2.25 
4.30 
2.20 
4.38 
2.23 
4.45 
2.20 
4.44 
2.57 
2.64 
2.65 
Pindolol 
2.65 
4.66 
3.43 
5.49 
2.60 
4.33 
3.03 
4.91 
3.16 
3.35 
3.40 
A
lprenolol 
2.89 
4.83 
3.91 
5.69 
2.85 
4.50 
3.43 
5.14 
3.41 
3.64 
3.70 
Salicylic acid 
2.08 
2.28 
1.74 
2.22 
2.09 
2.34 
- 
2.30 
1.92 
1.92 
1.91 
5-M
ethylsalicylic acid 
2.19 
2.33 
1.75 
2.29 
2.20 
2.38 
- 
2.37 
1.97 
1.97 
1.96 
4-H
ydroxybenzoic acid 
2.15 
2.22 
1.93 
3.03 
2.15 
2.23 
1.99 
3.12 
2.20 
2.23 
2.24 
3-H
ydroxybenzoic acid 
2.16 
2.26 
1.80 
3.25 
2.15 
2.27 
1.89 
3.36 
2.14 
2.16 
2.16 
2,3-D
ihydroxybenzoic acid 
1.98 
2.24 
1.70 
2.14 
1.99 
2.29 
- 
2.24 
1.86 
1.86 
1.86 
2,4-D
ihydroxybenzoic acid 
2.05 
2.27 
- 
2.30 
2.06 
2.31 
- 
2.38 
1.89 
1.90 
1.89 
2,5-D
ihydroxybenzoic acid 
1.92 
2.17 
1.64 
2.10 
1.93 
2.26 
- 
2.23 
1.82 
1.82 
1.82 
3,4-D
ihydroxybenzoic acid 
2.07 
2.21 
1.82 
3.02 
2.07 
2.22 
1.89 
3.15 
2.11 
2.13 
2.14 
3,5-D
ihydroxybenzoic acid 
2.04 
2.22 
1.72 
2.99 
2.03 
2.23 
1.77 
3.12 
2.00 
2.00 
2.00 
B
enzoic acid 
2.32 
2.32 
1.98 
3.64 
2.32 
2.32 
- 
3.71 
2.38 
2.40 
2.40 
3-A
m
ino-4-hydroxybenzoic acid 
2.09 
2.22 
1.89 
3.05 
2.08 
2.23 
1.95 
3.18 
2.17 
2.20 
2.22 
G
allic acid 
2.00 
2.20 
1.72 
3.19 
1.99 
2.22 
1.81 
- 
2.04 
2.05 
2.05 
4-A
m
inobenzoic acid 
2.17 
2.21 
2.06 
2.70 
2.17 
2.21 
2.11 
2.76 
2.21 
2.24 
2.25 
4-A
m
inosalicylic acid 
2.16 
2.26 
1.73 
2.47 
2.15 
2.28 
- 
2.55 
1.96 
1.96 
1.96 
Phthalic acid 
1.82 
1.88 
1.66 
2.94 
1.85 
2.00 
1.76 
3.59 
1.84 
1.86 
1.88 
Isophthalic acid 
2.15 
2.73 
1.60 
10.95 
2.14 
2.85 
1.75 
12.22 
2.21 
2.25 
2.26 
3-A
m
inobenzoic acid 
2.19 
2.28 
1.88 
3.58 
2.19 
2.28 
1.97 
3.70 
2.30 
2.31 
2.32 
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Vanillic acid 
2.17 
2.25 
1.93 
3.25 
2.16 
2.25 
2.01 
3.34 
2.27 
2.29 
2.29 
Syringic acid 
2.16 
2.27 
1.91 
3.49 
2.16 
2.29 
1.99 
3.58 
2.30 
2.31 
2.32 
2-M
ethoxybenzoic acid 
2.28 
2.28 
1.92 
3.57 
2.27 
2.29 
2.01 
3.73 
2.33 
2.34 
2.35 
Terephthalic acid 
2.15 
2.78 
- 
9.71 
2.10 
2.86 
1.74 
10.65 
2.23 
2.26 
2.27 
C
affeic acid 
2.11 
2.23 
1.90 
3.31 
2.10 
2.24 
1.98 
3.44 
2.23 
2.24 
2.24 
P-Toluic acid 
2.40 
2.33 
2.14 
3.66 
2.40 
2.33 
2.22 
3.74 
2.50 
2.50 
2.50 
3,5-D
initrosalicylic acid 
- 
1.58 
1.67 
1.53 
- 
1.63 
- 
1.58 
1.69 
1.67 
1.68 
N
icotinic acid 
2.31 
4.27 
1.94 
7.45 
2.30 
4.39 
2.07 
7.52 
2.81 
2.80 
2.79 
4-H
ydroxybenzenesulfonic acid 
1.66 
1.87 
1.56 
1.82 
1.70 
1.99 
1.65 
1.92 
1.70 
1.69 
1.69 
4-A
m
inophenylacetic acid 
2.16 
2.27 
1.98 
4.07 
2.15 
2.29 
2.07 
4.28 
2.45 
2.46 
2.49 
A
cetylsalicylic acid 
2.22 
2.31 
1.80 
3.26 
2.22 
2.33 
1.91 
3.33 
2.18 
2.18 
- 
Phenylacetic acid 
2.26 
2.26 
- 
3.96 
2.26 
- 
2.20 
4.07 
2.53 
2.53 
2.54 
1,2-benzenedisulfonic acid         - 
2.70 
- 
2.78 
- 
3.27 
- 
3.18 
- 
1.76 
1.76 
P-Toluenesulfonic acid 
1.75 
1.87 
1.61 
1.82 
1.75 
- 
1.71 
1.91 
1.74 
1.73 
- 
2-Sulfobenzoic acid 
1.73 
2.25 
- 
5.22 
1.73 
2.68 
- 
6.09 
2.50 
1.93 
1.95 
Tropic acid 
2.14 
2.34 
1.83 
3.95 
2.13 
- 
1.94 
4.08 
2.27 
2.28 
2.28 
2-Phenylethylam
ine 
2.64 
5.86 
3.49 
7.04 
2.59 
5.68 
3.08 
6.57 
3.44 
3.62 
3.69 
Phenylalanine 
2.25 
7.36 
2.26 
8.63 
2.24 
7.89 
2.27 
8.70 
2.85 
2.93 
2.96 
M
andelic acid 
2.10 
2.68 
1.74 
3.04 
2.08 
- 
1.86 
3.15 
2.08 
2.08 
2.08 
5-Sulfosalicylic acid              - 
2.08 
1.49 
2.07 
- 
- 
1.55 
- 
1.64 
1.62 
1.62 
M
alic acid 
1.74 
1.82 
1.60 
1.88 
1.75 
1.92 
1.71 
2.04 
1.74 
1.73 
1.73 
N
um
bers in row
 are operating conditions of the full factorial design (Table 2.3).
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R2013b (The Mathworks Inc., Natick, MA, USA) was utilised to select the 
most important descriptors and to build the QSRR models for each 
stationary phase material. Statistical evaluation of the data and multivariate 
data analysis has also been performed in Matlab. 
2.2.2 Calculation of molecular descriptors 
The procedure for the generation of molecular descriptors in this study 
was as follows. The structures of the molecules were sketched in 
MarvinSketch. Initial conformational searches to find the 50 lowest energy 
structures were performed using Balloon with a Merck Molecular Force 
Field (MMff94) [6-9]. The lowest energy conformer was taken as the input 
structure for geometry optimisation using a semi-empirical PM7 method 
implemented in MOPAC [12], the resulting geometry was further refined 
with the Gaussian program applying the Becke 3-parameter (exchange) with 
correlation by Lee Yang and Parr, (B3LYP) [18-21] functional and the 6-
31G-(d) basis set [22]. Optimisations were performed in acetonitrile using 
the integral equation formalism variant of the polarisable continuum model 
(IEFPCM) [23]. Following each geometry optimisation, harmonic frequency 
analysis was carried out to confirm the nature of each stationary point as an 
equilibrium structure. 
The resulting minimum energy conformations of the compounds in this 
study were input into Dragon to calculate molecular descriptors. Dragon 
software [16] was able to calculate 2,687 molecular descriptors, consisting 
of constitutional, topological, geometrical, electrostatic, physical, shape, and 
quantum chemical descriptors. The Handbook of Molecular Descriptors [24] 
details the calculation procedure. 
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To minimize subsequent problems of chance correlation, descriptors with 
constant or near constant values, descriptors with a standard deviation less 
than 0.0001, descriptors which were strongly correlated to other descriptors 
(using a correlation coefficient >0.90) and those descriptors not available for 
all compounds were excluded. After this reduction step, 321 molecular 
descriptors were obtained. Before statistical analysis, all the descriptors 
were scaled to zero mean and unit variance (auto-scaling procedure) 
because the numerical values of the descriptors varied significantly. The 
resulting descriptor sets were used to build predictive models for the 
experimental chromatographic retention data. 
2.2.3 Genetic algorithm (GA) 
The GA, introduced by Holland [25], is a stochastic search procedure 
inspired by the rules of natural selection to select features without making 
any assumptions about the search space. The foundation of the procedure is 
based on assignment of greater reproductive opportunities to solutions that 
have higher fitness. In genetic terms, each variable is called a gene (bit), and 
a set of variables is called a chromosome (bit string). In the first step of the 
GA optimisation, an initial population of chromosomes is generated by a 
random choice of each variable. Then, pairs of chromosomes are chosen 
randomly from the original population as parents and crossover operations 
performed to produce a new generation of child chromosomes with better 
fitness. The last step involves a mutation process to maintain genetic 
diversity from the initial random population to the next generations. The 
cycle of the evaluation, selection, crossover, and mutation processes is then 
repeated until a stopping criterion is satisfied. 
One limitation of the GA is that it relies on a randomly generated initial 
population, which can potentially limit its capability to find the most 
relevant variables within a large search domain. As a consequence the final 
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results of replicate runs can be substantially different. To reach a suitable 
subset of descriptors within a reasonable computational time, 100 runs with 
different initial populations were generated and the frequency with which 
each variable was selected as the top chromosome of each run was 
calculated and PLS regression was used to determine the set of the most 
relevant descriptors, and to create the final model. More details of this 
approach are available elsewhere [26, 27]. This approach is termed GA-
PLS.  
2.2.4 Partial least square regression (PLS) 
 PLS regression was employed as a multivariate method to decrease the 
dimensionality of the large set of independent molecular variables by 
extracting a small number of latent variables (see below) that are correlated 
with the dependent variable (i.e., chromatographic retention time). In 
addition, PLS rotates the latent variables by maximising the covariance 
between molecular descriptors and the dependent variable. This ensures that 
the molecular descriptors which are highly correlated to the dependent 
variable are retained in the first few latent variables. The PLS method is 
presented in equations (1.9) and (1.10). 
The optimum number of latent variables for each model was selected 
using 4-fold cross validation. PLS models with a number of latent variables 
up to 5 were investigated and the optimum number of LVs in each model 
was selected by applying the first standard deviation rule [28, 29] to avoid 
overfitting. 
2.2.5 Model validation 
The first step in the modelling involves defining a training set for 
calibration and a test set for validation. It has also been emphasized that an 
external set is required to validate the predictive power of a quantitative-
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property model [30-32]. For this purpose, we applied an independent set, 
separate from the training samples. The training set was used to select the 
descriptors for QSRR modelling and to build the models. Then the 
experimental chromatographic data of the test compounds were collected 
and compared with their predicted data calculated from derived QSRR 
models.  
The final models were evaluated for their predictive ability using the 
mean absolute error (MAE) and the root-mean-square error prediction 
(RMSEP) defined [33] as 
!"# = %& '()* − %& ,-.*/ +																								 (2.1) 
								7!8#9 = %& '()* − %& ,-.*%& '()* :;<=> / ×	100	 % 														 2.2  
where yi(obsd) and yi(pred) are the observed and predicted retention 
times and n is the number of analytes. The calibration models were 
examined for their quality by root-mean-square error cross validation 
(RMSECV) in percentage and absolute terms, and the squared correlation 
coefficient Q2 defined as 
								7!8#KL(%) = %& '()* − %& ,-.*%& '()* :;<=> / ×	100	 % 						 2.3  
7!8#KL = (%& '()* − %&(,-.*)):;<=> / 														(2.4)	
O: = 1 −	 %& '()* − %& ,-.* :;<=> %& '()* − % P.Q/ :;<=> +																	 (2.5)	
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determined from the predicted retention times yi(pred) of the test set 
analyte(s) (i.e. those analytes left out of the training set) during cross 
validation. The y(mean) is the average value of the observed retention 
times. 
Model validation includes Y-randomisation tests to evaluate the 
statistical significance of the estimated predictive power based on a 
response variable randomisation process. For this purpose, the response 
variable was randomised, and a 4-fold cross-validation was performed with 
the entire model development procedure [34]. As our data sorted in the real 
order gave better prediction results that randomly permuted data, it can be 
concluded that the prediction model is significant. 
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3 Prediction of retention in hydrophilic interaction liquid 
chromatography using solute molecular descriptors based on 
chemical structures 
3.1 Introduction 
HILIC [1] has become an important alternative to reversed-phase liquid 
chromatography (RPLC) for polar analytes. Recent developments have 
meant that this method is now well-recognized as a powerful and selective 
technique, which has been employed successfully for the separation of 
numerous polar compounds [2, 3] including β-adrenergic agonists and 
related compounds [4-8]. The availability of a broad range of HILIC 
stationary phases provides opportunities for meaningfully different retention 
and separation selectivity. As a consequence, many mixtures of polar 
compounds may be separated by means of HILIC. However, an outcome of 
the development of new stationary phases is that it is now more challenging 
to select the most suitable stationary phase. 
In order to screen stationary phases, trial and error optimisation is used 
frequently, although this may take many attempts, with subsequent loss of 
time. Another approach, based on column characterisation and classification 
methods, guides users to identify either similar or diverse stationary phases 
depending on method development needs [5, 9, 10]. However, the 
application of these methods is limited only to those analytes having 
available experimental descriptors or molecules with properties somewhat 
comparable to those studied. In addition, because of limited understanding 
of the HILIC mechanism, the quality of these approaches, which depend 
strongly on a priori knowledge of the retention mechanism, is doubtful. 
Consequently there is a strong demand for a powerful tool to handle 
stationary phase selection based on more objective criteria. Statistically-
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derived quantitative structure-retention relationships (QSRRs) represent a 
popular chemometric approach in High-Performance Liquid 
Chromatography (HPLC) method development [11] and may be put into 
practice to accelerate the screening of stationary phases in liquid 
chromatography method development by predicting retention of target 
analytes across available chromatographic columns. 
QSRR is a powerful theoretical tool capable of prediction of the 
chromatographic behaviour of a given chromatographic system, which then 
can be used for future retention predictions of new compounds. The aim of 
developing a QSRR model is to construct a statistically significant 
mathematical relationship between a chromatographic parameter (eg., 
retention time) and some molecular descriptors characterising the molecular 
structure of the analytes. Molecular descriptors are either determined 
experimentally or computed theoretically. QSRR studies start from the 
calculation and selection of appropriate descriptors, followed by regression 
analysis to derive mathematical models of retention parameters as a function 
of these descriptors. 
A wide variety of analyte descriptors has been used in QSRR studies, 
ranging from physicochemical properties of analytes (such as molecular 
weight, polar surface area, logP, logD, etc) to molecular descriptors 
calculated from chemical structures optimised using density functional 
theory (DFT). Advances in computational chemistry permit the calculation 
of more than 4000 theoretical descriptors for an individual analyte, based 
only on chemical structure, which can be used in QSRR modelling [12]. 
Some of these descriptors may be redundant, be irrelevant, or represent 
noise. Thus, for proper QSRR modelling an appropriate method of selection 
of the most important descriptors prior to regression analysis is crucial to 
eliminate unnecessary descriptors. Although several such variable selection 
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techniques and regression methods have been applied in QSRR studies in 
various modes of chromatography [13, 14], the current work is based on the 
use of a partial least squares modelling approach (PLS) with a genetic 
algorithm (GA) employed as a widely and successfully utilised approach to 
variable selection [15, 16]. PLS has been chosen as a regression method for 
QSRR modelling because of its utility in handling large sets of collinear 
descriptors, as well as having small demands on computational time and 
effort [17]. 
Only a few reports demonstrating the application of QSRR techniques for 
prediction of retention of analytes in HILIC have been published. Kaliszan 
et al. [18] and Burgess et al. [19] constructed linear models for the 
prediction of metabolite retention times in HILIC for the purpose of 
removing false identification during the interpretation of metabolomics data. 
Jinno et al. [20] reviewed the development of retention prediction models of 
adrenoreceptor agonists and antagonists in HILIC systems using selected 
molecular descriptors. More recently, Cao et al. [21] established a QSRR 
model based on the Random Forest algorithm for the prediction of retention 
time in HILIC, allowing peak annotation of metabolites. However, a study 
of the application of a GA as a variable selection method in QSRR 
methodology for HILIC method development has, to the best of our 
knowledge, not yet been published. Therefore, the main aim of this study, 
which is part of a broader structure-retention relationship design project, 
was to establish a QSRR model based on molecular descriptors computed 
from chemical structures optimised using DFT for the prediction of 
retention of a class of compounds for five different HILIC stationary phases 
utilising a GA coupled with PLS for variable selection. The second aim of 
this work was to present for the first time a strategy to optimise the GA 
descriptor sets in QSRR models and to compare the performance of this 
optimised approach with more common approaches. Finally, in order to 
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obtain some insight into the HILIC mechanism, the selected molecular 
descriptors in the QSRR models have been investigated in each HILIC 
system. 
This study has been undertaken using β-adrenergic agonists as one 
classification of analytes. β-adrenergic agonists are structurally related 
compounds with low log D values presenting hydrophilic properties. These 
species are synthetic phenethanolamine compounds used as bronchodilator 
and tocolytic agents in human as well as in veterinary medicine. 
Furthermore, they are employed by the livestock industries to improve feed 
efficiency and growth rates [22, 23]. However, they may provide human 
health risks [22] because of their growth-promoting effects. As a result, β-
adrenergic agonists should be monitored and controlled strictly. European 
Union countries [24] have prohibited β-adrenergic agonists as growth 
promoters in food producing animals according to toxicological data. 
Reversed phase liquid chromatography (RPLC) coupled to mass 
spectrometry has been the most popular analytical method to monitor the 
illicit usage of β-adrenergic agonists and related compounds [25-28]. 
However, these methods face some issues related to co-elution of analytes 
resulting from the high polarity of these compounds. HILIC is therefore the 
preferred separation mode, but selection of the suitable stationary phase, as 
a starting point for method development for simultaneous determination of 
β-adrenergic agonists, constitutes a significant analytical challenge. 
3.2 Method 
Five data sets composed of a training set made up of 16 analytes and a 
test set with 6 analytes with experimental retention times over five HILIC 
stationary phases (bare silica, amine, amide, diol and zwitterionic) were 
used. These data involved β-adrenergic agonists and related compounds, as 
seen in Table 3.1 and Figure 3.1. The isocratic eluent contained 90:10 
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acetonitrile−formate buffer solution. Formate buffer 100 mM was prepared 
with an adapted volume of ammonium formate and the pH adjusted to 3.0 
with formic acid. Details of collected data are presented in Chapter 2.  
The retention times observed on each stationary phase are provided in 
Table 3.1. 
For the modelling step, an unmodified GA-PLS method was used and the 
details of this approach are stated in Chapter 2. As a slightly modified 
approach, the GA-PLS procedure was performed 10 times and those 
descriptors which appeared in every iteration (i.e., with 100% selection 
frequency) were chosen as an optimum subset of descriptors. This set of 
descriptors was then used to build the final PLS model for retention 
prediction. This approach is termed Optimised GA-PLS. For reference 
purposes, PLS was also applied to the full set of descriptors without the use 
of any variable selection method. This approach is termed Full PLS. These 
three modelling approaches are shown schematically in Figure 3.2. 
3.3 Result and discussion 
3.3.1 Analytes and retention behaviour 
Figure 3.1 shows the chemical structures of the β-adrenergic agonists 
studied. Chromatographic retention prediction of these compounds was 
evaluated on five HILIC stationary phases: amide, amine, diol, bare silica 
and zwitterionic (see Chapter 2 for definitions). These phases were chosen 
primarily based on differences in their chemistries to reasonably cover the 
HILIC chromatographic space (Figure 3.3). The amine and zwitterionic 
columns carry charged functionalities, whereas the diol, amide and bare 
silica columns are neutral under the chromatographic conditions used in this 
study. 
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Table 3.1. The experimental retention times of the training and test set on five 
different HILIC stationary phases. 
         Column                
Analyte 
Diol Bare 
silica 
Amine Amide Zwitterionic 
Training set tRexp. tRexp. tRexp. tRexp. tRexp. 
adrenaline 4.89 6.73 10.82 7.75 17.30 
noradrenaline 4.86 7.30 14.71 9.81 24.97 
3-methoxytyramine 5.46 4.86 6.17 5.98 9.30 
isoproterenol 4.40 4.63 7.13 6.40 10.57 
fenotrole 3.78 2.72 5.11 6.75 9.44 
salbutamol 4.62 4.59 6.51 6.49 9.47 
ritudrine 4.11 2.47 3.77 5.43 5.72 
metaproterenol 4.23 4.10 6.63 6.41 11.52 
synephrine 5.17 5.20 6.84 6.32 10.59 
dopamine 5.05 5.62 9.23 7.64 15.02 
norfenefrine 5.04 5.26 8.81 7.58 15.24 
phenylephrine 5.06 4.92 6.73 6.06 10.41 
normetanephrine 5.22 5.85 8.79 7.55 14.14 
isoxuprine 4.25 2.11 2.87 3.98 3.65 
etilefrine 6.43 4.11 4.99 4.67 8.34 
N-methylephedrine 5.75 3.90 3.80 3.98 4.73 
Test set     
terbutaline 4.06 3.53 5.71 5.88 9.57 
tyramine 5.37 4.54 6.18 6.26 9.55 
octopamine 5.09 5.52 8.93 7.93 14.85 
metanephrine 6.29 5.54 5.89 5.73 10.67 
phenylethylamine 5.43 3.98 4.02 5.27 6.51 
3-methylphen ethylamine  6.50 3.61 3.59 4.40 5.72 
Chapter	 3	 	 	 	 	 Prediction	 of	 retention	 in	 hydrophilic	 interaction	 liquid	
chromatography	using	solute	molecular	descriptors	based	on	chemical	structures	
 106 
 
 
Figure 3.1. Structures of the studied β-adrenergic agonists and related compounds.
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Figure 3.2. Scheme of QSRR modelling in this study. 
 
 
 
 
 
 
Figure 3.3. Structures of the Thermo Fisher HILIC stationary phases studied. 
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A comparison of the retention factors of the β-adrenergic agonists on the 
five stationary phases is shown in Figure 3.4. As seen in the figure, the 
retention factors of the β-adrenergic agonists are increased on the amide 
column compared to the diol column, indicating higher hydrophilic 
partitioning. In addition, there are cases where the order of elution differed 
between these two neutral stationary phases. One such pair of molecules is 
etilefrine and ritudrine. An increased retention factor in the bare silica 
system was observed compared to neutral columns, which may be partially 
attributable to the electrostatic attraction between the positively charged 
basic and the possibly negatively charged silanol groups [5]. Another 
observation is a significant increase in the retention factor of almost all β-
adrenergic agonists when the stationary phase type was changed from a 
neutral column to a zwitterionic column, due possibly to electrostatic 
attraction between the positively charged bases and the negative charges on 
the surface of zwitterionic stationary phase. Another interesting result was 
observed for the amine phase, where a general increase in the retention 
factor of β-adrenergic agonists compared to neutral phases was noted. These 
results suggested that the anticipated electrostatic repulsion between the 
positively charged β-adrenergic agonists and the positively charged amino 
phase was significantly diminished, possibly due to interaction of the 
formate counterion in the eluent with the amine group of the surface. Our 
result is consistent with the literature in which it can be seen that a high salt 
concentration (10 mM formate) has been shown to promote stronger 
hydrophilic partitioning [57]. This would account for the observation that 
basic β-adrenergic agonists are better retained in the positively charged 
amine column compared with the neutral columns. These experimental 
results indicated that significant changes in retention and separation 
selectivity can occur depending on the stationary phase chemistry.
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3.3.2 QSRR modelling 
QSRR models based on the three variable selection approaches (see 
Figure 3.2) were generated for each HILIC system. These models were 
generated using the experimental chromatographic retention times for 
sixteen β-adrenergic agonists - the training set - on five HILIC stationary 
phases, (see Table 3.1) together with molecular descriptors calculated for 
these analytes. Also included in Table 3.1 are the observed retention times 
for the six compounds comprising the analyte test set. The aim of this work 
was to generate models that could predict β-adrenergic agonist retention 
times directly from molecular structure data and that could also assist in 
explaining the main interactions that take place in HILIC systems. External 
validation of the predictive power of the different QSRR models was 
evaluated using the test analytes, which were not utilised in either descriptor 
feature selection or model generation. The appropriate descriptor values 
selected by the modelling approach were inserted into the correlation 
equation, and the respective retention times were calculated and compared 
to measured experimental retention times. The predicted retention times of 
the test set of analytes are shown in Table 3.2, for each of the three 
modelling approaches. A summary of the overall performance of each 
modelling approach for each stationary phase is given in Table 3.3. The 
number of descriptors included in the models ranged from 321 (for the Full 
PLS model) to 6 (for the Optimised GA-PLS model on the diol column). 
The number of descriptors used for modelling decreased in the order Full 
PLS > GA-PLS > Optimised GA-PLS. Although the relevance of some of 
the chosen descriptors is still not completely clear in terms of their 
significance to the HILIC retention process, other descriptors are clearly 
linked with chemical properties that are relevant to the HILIC experimental 
system. These implied relationships are discussed in more detail in the 
following section. 
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Table 3.3 lists the mean absolute error (MAE, s) for each modelling 
approach and stationary phase, and this error was consistently lowest for the 
optimised- GA-PLS approach, despite the fact that this approach used the 
fewest descriptors. This shows clearly that it is the relevance of the 
descriptors used for modelling, not the number of descriptors, which 
determines the predictive quality of the final model.  
Table 3.3 also lists the errors as RMSEP (see Eqn. 2.4) which scales the 
errors to the observed retention time of each analyte and is expressed as a 
percentage. The RMSEP for the optimised GA-PLS approach was again 
consistently the lowest of the three modelling approaches. The obtained 
results indicate that the optimised GA-PLS approach provided an acceptable 
level of accuracy of retention time prediction using a relatively small 
descriptor set, while not requiring excessive computational resources (for 
example, compared to alternative approaches for example reference [16]). 
The average CPU time for optimised GA-PLS modelling was 381 s. Figures 
3.5 and 3.6 show correlation plots between observed and predicted retention 
times. 
To the authors’ knowledge, this is the first published application of GA-
PLS with an optimised descriptor set in QSRR, and GA feature selection in 
general in the HILIC mode. While some retention time prediction studies 
have been made through QSRR models in HILIC [20, 29-31], it is difficult 
to compare the accuracy of these models since the same prediction error 
statistics are not always reported. One QSRR model has been reported with 
relative errors of prediction more than 100% for an eight-min range of 
retention times [18]. Better accuracy has been achieved for adrenoreceptor 
agonists and antagonists on three HILIC systems using artificial neural 
networks and multiple linear regression to develop QSRR models based on
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Figure 3.4. Retention factors of β-adrenergic agonists on zwitterionic, amine, 
amide, diol and bare silica HILIC stationary phases. 
 
Table 3.2. The predicted retention times of the test compounds on five different 
HILIC stationary phases applying optimised GA-PLS, GA-PLS and full PLS. 
       Column 
Test analyte 
Diol Bare 
silica 
Amine Amide Zwitterionic 
Optimised GAPLS tRPred. tRPred. tRPred. tRPred. tRPred. 
terbutaline 4.11 3.31 6.08 6.10 10.37 
tyramine 5.14 4.30 5.76 5.91 9.42 
octopamine 5.02 6.05 9.51 7.83 15.66 
metanephrine 6.14 5.24 5.79 5.78 9.25 
phenylethylamine 6.04 3.75 3.59 4.92 5.29 
3-methylphen ethylamine  6.28 3.62 4.21 5.16 6.32 
GAPLS      
terbutaline 4.20 3.77 5.75 6.36 9.39 
tyramine 5.16 4.40 7.50 6.00 10.37 
octopamine 5.14 5.77 10.40 7.85 16.32 
metanephrine 5.18 4.88 6.00 5.91 9.34 
phenylethylamine 5.42 3.66 3.21 4.94 8.45 
3-methylphen ethylamine  5.63 3.72 3.35 5.44 6.90 
Full PLS      
terbutaline 4.39 3.90 5.71 6.51 9.02 
tyramine 5.23 5.31 8.11 6.31 13.00 
octopamine 5.23 5.94 9.79 7.73 16.05 
metanephrine 5.06 4.81 6.88 5.90 10.68 
phenylethylamine 5.53 5.20 7.33 4.95 11.48 
3-methylphen ethylamine  5.42 4.98 6.90 5.14 10.68 
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Table 3.3. QSRR models performance summary 
       Approach      
Column (a, b) 
nVar MAE  
(s) 
RMSEP 
Diol (4.90, 0.67)    
Optimised GA-PLS 6 13 4.88 
GA-PLS 43 24 9.28 
Full PLS 
Bare silica (4.65, 1.43) 
321 30 11.13 
   
Optimised GA-PLS 17 15 6.07 
GA-PLS 63 17 6.94 
Full PLS 321 49 22.25 
Amine (7.06, 2.97)    
Optimised GA-PLS 10 25 9.55 
GA-PLS 22 40 14.03 
Full PLS 321 78 52.56 
Amide (6.42, 1.50)    
Optimised GA-PLS 16 19 8.06 
GA-PLS 17 24 10.75 
Full PLS 321 21 8.67 
Zwitterionic (11.28, 5.26)    
Optimised GA-PLS 9 50 11.12 
GA-PLS 25 69 16.56 
Full PLS 321 151 49.60 
Method abbreviations explained in the text. nVar is the number of selected 
variables (descriptors). a and b are the average retention and standard deviation, 
respectively, observed in the training set. 
 
 
 
 
Figure 3.5. Predictive ability of optimised GA-PLS models, best GA-PLS models 
and full PLS models for an external validation set of β-adrenergic agonists over 
five different HILIC systems. RMSEPavr. is the average value of RMSEP of test β-
adrenergic agonists over five HILIC stationary phases.
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Figure 3.6. Predictive ability of optimised GA-PLS models, best GA-PLS models 
and full PLS models for an external validation set of β-adrenergic agonists over 
five different HILIC systems. 
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pre-defined descriptors [29-31]. All of the analysed compounds in these 
studies had retention factors less than one for all reported chromatographic 
conditions [29-31]; therefore the models were constructed with compounds 
that interacted only weakly with the chromatographic system. In contrast, 
the retention factors in our study range from 0.46 to 12.02 with the majority 
of retention factors being greater than 1 (see Figure 3.4). Our results from 
the QSRR modelling section indicate that the optimised GA-PLS models 
generated for these experimental systems were very well correlated with the 
experimental data, reliable, and strongly robust, and are capable of making 
good a priori predictions for β-adrenergic agonists. To illustrate this, Figure 
3.7 shows the predicted retention times of the six test analytes (indicated by 
circles) on five HILIC columns. The level of accuracy of prediction is 
sufficient for the QSRR approach to be used to determine which of the five 
HILIC stationary phases are likely to yield a suitable best separation. 
Further experimental studies would then be necessary to identify the precise 
composition of the optimal eluent. 
To test the reliability of the built QSRR models, a number of plots were 
generated. First, variable importance to projection (VIP) [32] plots were 
used (Figure 3.8) to gain an understanding of the relative importance of each 
descriptor for the GA-PLS models being generated, based on optimised 
molecular descriptors. As seen in the figure, some molecular descriptors had 
VIP values lower than the threshold of 1 [33-35] but were retained in order 
to balance the multivariate models. 
Second, a complete correlation map between the descriptors and the 
response (i.e. retention time) (Figure 3.9) showed the presence of collinear 
descriptors. The presence of a number of collinear descriptors in the final 
model is very common and may play an important role in adding reliability 
to QSRR models [36]. 
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Next, to demonstrate the absence of chance correlation in the QSRR 
models, Y-randomization tests (Figure 3.10) each with 1000 iterations were 
applied with randomly assigned retention times to the training sets. For each 
iteration, a GA-PLS calculation with an optimised descriptor set was 
performed on the permuted retention time data. This yielded average cross-
validated RMSE values of 25 – 69% for the five columns. This further 
confirmed the predictive ability of the models, given that RMSE values for 
the actual dataset were shown to be significantly lower than those obtained 
for the same dataset with randomized retention data. 
Finally, an applicability domain of the optimised GA-PLS models and 
the reliability of predictions was evaluated by the leverage approach 
expressed as a Williams plot [37]. In the Williams plot, standardised 
residuals versus leverage values ℎ"	are plotted. The leverage value (hat 
value), ℎ", was defined as: ℎ" = &"' ('( &", where &" is the descriptor 
vector of the considered compound and ( is the descriptor matrix derived 
from the training set descriptor values. A leverage greater than the critical 
leverage value ℎ∗ warns the potential extrapolation of the model and the 
predicted response may not be reliable. A critical leverage value was 
determined as: ℎ∗ = 3+/-, in which - is the number of observations used 
to generate the model and + is the number of parameters in the model. The 
standardised residual reflects the prediction quality, and the acceptable 
range is usually (±3σ). Figure 3.11 presents the Williams plots of the 
compounds under study with ±3σ, and ℎ∗ (0.5, 1.6, 1.0, 1.5 and 0.9 for 
diol, bare silica, amine, amide and zwitterionic systems, respectively) as 
warning limits. It is obvious that only one compound, noradrenaline, in the 
training set has a hat value higher than the warning ℎ∗ value of 1.0 in the 
amine system and 0.9 in the zwitterionic system, and thus is regarded as a 
structural outlier. This compound with a small residual belongs to the 
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Figure 3.7. Predicted retention times (red circles) of optimised GA-PLS models for 
an external validation set of β-adrenergic agonists: A, 3-methylphenylamine; B, 2-
phenylethylamine; C, terbutaline; D, metanephrine; E, tyramine; F, octopamine; on 
five HILIC stationary phases. 
 
 
 
 
 
Figure 3.8. PLS variable importance to projection for the optimised GA-PLS 
models generated.
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Figure 3.9. Correlation between the independent variables (descriptors) and the 
response variable (retention time, variable no. 1) retained in the optimised GA-PLS 
models over five different HILIC systems. Numbering of descriptors: 2, MATS2p; 
3, MATS6p; 4, MATS2i; 5, TDB08s; 6, HATS7u; 7, CATS2D_08_DL for diol 
system; numbering of descriptors: 2, JGI2; 3, MLOGP; 4, JGI5; 5, G3i; 6, R6u+; 7, 
R5e+; 8, HATS3s; 9, R6m+; 10, GATS3p; 11, AROM; 12, G3u; 13, PCR; 14, 
SpMax_B(m); 15, MATS1e; 16, GATS3e; 17, PW3; 18, J_D for bare silica 
system; numbering of descriptors: 2, ATSC1e; 3, MATS1m; 4, MATS3i; 5, 
MATS1s; 6, JGI2; 7, SpMax3_Bh(s); 8, AROM; 9, G3v; 10, HATS3s; 11, SaasC 
for amine system; numbering of descriptors: 2, MATS3i; 3, ATSC1e; 4, 
SpPosA_B(m); 5, Hy; 6, MATS1m; 7, MATS1e; 8, MATS1s; 9, Mor22s; 10, 
Mor28u; 11, Mor31s; 12, AMW; 13, SpMax_B(v); 14, GATS3p; 15, Mor23s; 16, 
qnmax; 17, MLOGP for amide system and numbering of descriptors: 2, ATSC1e; 
3, MATS1m; 4, GATS3e; 5, JGI2; 6, SpMax3_Bh(s); 7, Mor22s; 8, Mor23s; 9, 
Hy; 10, DLS_02 for zwitterionic system. 
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training set, so it is a good leverage compound [37]. All other compounds in 
the training and test sets over all HILIC systems have a hat value lower than 
the warning ℎ∗ value. There are a few response outliers, which are very 
close to the critical response value (3σ) and have small residuals. 
3.3.3 Potential insights into the HILIC retention mechanism 
By examination of the descriptors appearing in the proposed models for 
each stationary phase, some insight can be gained into the factors that 
influence the retention of β-adrenergic agonists on these HILIC systems. 
Many of the descriptors utilised are auto-correlation descriptors, both 2D 
and 3D. These descriptors are weighted by ionization potential, 
electronegativity, polarisability, mass, and I-state. In addition topological 
descriptors, property descriptors, and detailed 3D descriptors are also built 
into the final models. The molecular descriptors used and their contributions 
in the final QSRR models are shown in Table 3.4. The definition of each 
molecular descriptor is available in Table 3.5. 
3D Descriptors used in the final models. 3DMoRSE (3D-Molecule 
Representation of Structures based on Electron diffraction) descriptors 
provide information derived from the weighted three-dimensional atomic 
coordinates by using the same transformation used in electron diffraction to 
prepare theoretical scattering curves [38]. For the amide system the 
descriptors used were Mor22s, Mor28u, Mor31s and Mor23s and for the 
zwitterionic system Mor22s and Mor23s (Table 3.5). These descriptors with 
high VIP values (Figure 3.8) are either unweighted or weighted by I-state 
and may show the importance of the electrostatic interaction between β-
adrenergic agonists and HILIC stationary phases. 
GETAWAY (Geometry, Topology, and Atom-Weights AssemblY) 
descriptors are geometrical descriptors that capture information on the
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Figure 3.10. Y-randomization plot. Y-randomized data (royal blue lines), and the 
actual data (red line). 
 
 
 
Figure 3.11. Williams plots for the optimised GA-PLS models with ±3σ, and h* 
(0.5, 1.6, 1.0, 1.5 and 0.9 for diol, bare silica, amine, amide and zwitterionic 
systems, respectively) as warning limits. Diamonds represent training set 
observations (n=16), and triangles represent external validation set observations 
(n=6). 
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effective position of substituents and fragments in the molecular space, and 
also information on molecular size and shape combined with the 
information on specific physicochemical atomic properties: atomic mass, 
atomic van der Waals volume, atomic electronegativity, and atomic 
polarisability [39, 40]. The GETAWAY descriptors utilised for the bare 
silica descriptors are either unweighted or weighted by mass, 
electronegativity, and I-state. The amine and diol systems also utilise 
GETAWAY descriptors – specifically HATS7u for the amine system and 
HATS3s for the diol system (Table 3.5). 
The weighted holistic invariant molecular (WHIM) descriptors are 
calculated in such a way as to encode relevant molecular 3D information 
concerning molecular size, shape, symmetry, and atom distribution with 
respect to invariant reference frames [41, 42]. Symmetry-related WHIM 
descriptors in the models represent the role of the degree of the compactness 
of the molecules. Based on the positive sign (Table 3.4) assigned to the 
symmetry related WHIM descriptors G3i and G3u in the model for the bare 
silica system, and the G3v descriptor in the GAPLS model for the amine 
system it is expected that β-adrenergic agonists with higher values of these 
descriptors will have higher retention time values. 
The geometrical descriptor AROM (aromaticity index) [43], refers to the 
electronic cyclic delocalization present in all aromatic species [44, 45]. As 
shown in table 3.4 there is a negative contribution of this descriptor to the 
predicted retention time values in the developed QSRR models in both 
amine and bare silica systems. The final 3D descriptor TDB08s appears in 
the final model for the diol system (Table 3.5). It belongs to a group of 3D 
autocorrelation descriptors that combine chemical information given by  
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property values in specified molecule regions, and structural information 
[46]. This descriptor is a topological distance descriptor weighted by the I-
state and therefore relates to the local electronic characteristics of the 
studied compounds [47]. 
2D Descriptors used in the final models. 2D autocorrelation descriptors 
provide information about the distribution of a selected physicochemical 
property along a topological map of a molecular structure [12]. These 
properties are atomic masses, polarisabilities, charges, and 
electronegativities. The appearance of the atomic mass, electronegativity-
weighted, polarisability-weighted and charge-related 2D autocorrelation 
descriptors in the developed models (Table 3.5) represents the role of 
atomic size and electronic properties in the retention behaviour of β-
adrenergic agonists in HILIC systems. 
As shown in Table 3.4 and Table 3.5, a large number of different 2D 
autocorrelation descriptors were utilised in the models for the different 
systems. The index for the mean topological charge JGI2 was selected for 
the model for the bare silica system, the amine system and the zwitterionic 
system while JGI5 was only selected for the bare silica system (Table 3.5). 
GATS3p, weighted by polarisability, was selected for use in the bare silica 
and amide systems but with very low importance (Table 3.4, Table 3.5, 
Figure 3.8). GATS3e, weighted by electronegativity, had a much higher 
importance but was only utilised in the model for the bare silica column 
(Table 3.4, Table 3.5). 
A Moran autocorrelation index weighted by electronegativity (MATS1e) 
was utilised in the models for both the bare silica and the amide systems, 
while similar indices weighted by mass and I-state (MATS1m and 
MATS1s) were utilised in the models for the amine, amide and zwitterionic 
systems (Table 3.4, Table 3.5). Two different Moran autocorrelation indices 
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weighted by ionization potential (MATS2i and MATS3i) were utilised for 
the diol, amine, and amide system models but indices weighted by 
polarisability were only utilised in the model for the diol system (Table 3.4, 
Table 3.5). The inclusion of the Moran autocorrelation indices in all models 
with the different weightings used suggest slightly different mechanisms at 
play in the different column types. 
Similar 2D autocorrelation indices are the Geary and the Centred Broto-
Moreau autocorrelation. The Centred Broto-Moreau autocorrelation index is 
included in the models for the amine, amide and zwitterionic systems 
(ATSC1e weighted by electronegativity), while Geary indices (GATS3p and 
GATS3e) are included in the bare silica and amide columns (Table 3.4, 
Table 3.5). GATS3e weighed by electronegativity is of far higher 
importance (by VIP) and only present in the bare silica system model (Table 
3.4, Table 3.5, Figure 3.8). 
The 2D matrix-based descriptors are topological indices calculated from 
different graph-theoretical matrices derived from the H-depleted molecular 
graph of molecules [48]. They encode information about atom connectivity 
[12]. It is evident from the sign of regression coefficient of the participating 
descriptors SpMax_B(m) and J_D in the model for the bare silica system, 
and SpMax_B(v) and SpPosA_B(m) in the model for the amide system that 
the descriptors from this class have contributed positively to the retention 
time (Table 3.4).  
SpMax3_Bh(s) belongs to the set of Burden eigenvalues. These 
descriptors are calculated from the connectivity matrix using Burden [49] 
procedures and encode information about the structure topology, including 
the bond order. The VIP value of the SpMax3_Bh(s) descriptor indicates 
that this descriptor has the lowest importance in the developed QSRR 
models in the zwitterionic and amine systems (Figure 3.8). 
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Descriptor PW3 incorporated in the QSRR model generated for the bare 
silica system (Table 3.4, Table 3.5) belongs to the category of topological 
indices [50, 51]. This descriptor is measured by applying the ratios of the 
atomic path count over the atomic walk count and the number of non-H 
atoms [52]. 
The Chemically Advanced Template Search (CATS) 2D descriptors are 
topological descriptors calculated based on the distance between all possible 
pairs of pharmacophore elements in a molecule [53]. The pharmacophore 
elements are anions, cations, hydrogen bond acceptors, hydrogen bond 
donors, and hydrophobic atoms. The CATS2D_08_DL descriptor from the 
CATS2D class is one of the most important factors for retention time in the 
diol system, and represents the hydrogen bond effect with the present of 
heteroatom, O, and the lipophilicity interaction (Table 3.4, Table 3.5). The 
negative regression of the CATS2D_08_DL descriptor (Table 3.4) indicates 
that a higher positive value is correlated with a decreased retention time. 
This result is not surprising because it is well known that hydrogen bonding 
and hydrophobic partitioning describe the retention mechanism of β-
adrenergic agonists and related compounds in HILIC systems [5, 8]. 
Atom-type E-state indices, SaasC, selected for the amine system model, 
are proposed as molecular descriptors encoding topological and electronic 
information related to particular atom types in the molecule [54]. The high 
VIP value (Figure 3.8) of this descriptor presents the importance of 
electrostatic interactions between β-adrenergic agonists and amine 
stationary phases. 
Other Descriptors used in the final models. Important molecular 
properties incorporated in the QSRR models are reflected by the structural 
descriptors MLOGP (Moriguchi octanol-water partition coeff. (logP)) and 
Hy (hydrophilic factor). The MLOGP is a measure of the lipophilicity of the 
Chapter	 3	 	 	 	 	 Prediction of retention in hydrophilic interaction liquid 
chromatography using solute molecular descriptors based on chemical structures	
 128 
molecule, which is estimated using the Moriguchi method based on he 
structure-logP relationship of 1230 organic molecules [55]. LogP is the 
main factor influencing the retention behaviour of β-adrenergic agonists in 
the bare silica system with a VIP value of 1.38 (Figure 3.8). This descriptor 
also is incorporated in the equation constructed for amide system as one of 
the highest contributing descriptors (Table 3.4, Table 3.5), and has been 
reported to contribute to HILIC mechanism previously [18, 19, 21]. As 
shown in Table 3.4, LogP has a negative coefficient in both final QSRR 
models. The lower the logP values, the greater the retention times. This is 
consistent with the fact that compounds with high logP values have low 
hydrophilicity and therefore low retention in the water-enriched layer in 
HILIC mode [18]. Descriptor Hy has been found to be one of the most 
important parameters in QSRR models developed for the zwitterionic and 
amide systems with a positive contribution to the retention time (Table 3.4, 
Table 3.5). This well-known descriptor in HILIC mechanism reflects the 
ability of a solute to participate in hydrophilic partitioning between a water-
enriched layer immobilized at the stationary phase surface and the bulk 
organic-rich mobile phase [1]. 
The constitutional descriptor, AMW contributed to the model prediction 
in the amide system and reflects the chemical composition of a compound 
independent from its molecular geometry or atom connectivity. AMW 
represents average molecular weight, which contributes to dispersive 
intermolecular interactions [56] and inclusion of this descriptor has a 
positive effect on predicted retention time with a VIP value of 0.97 (Table 
3.4, Table 3.5, Figure 3.8). 
Descriptor qnmax (maximum negative charge) belongs to the category of 
charge descriptors and encodes features responsible for electrostatic and 
ionic interactions between molecules [57]. The descriptor qnmax has 
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negative values and a negative coefficient (Table 3.4) in the QSRR model 
derived for the amide system. Therefore a lower value of this descriptor 
increases the predicted retention time.  
Drug-like indices are calculated based on rules defined for drug 
elements: H-bond donors, H-bond acceptors, molecular weight, MLOGP, 
rotatable bond number and polar surface area [58]. The descriptor DLS_02 
of this class negatively contributes to the final model derived for the 
zwitterionic system (Table 3.4, Table 3.5) with a VIP value more than 1 
(Figure 3.8). Thus, it can be concluded that the β-adrenergic agonist having 
lower value of this descriptor will be retained in the stationary phase longer. 
Walk and path counts, PCR, in the final QSRR model calculated for the 
bare silica system (Table 3.4, Table 3.5) characterises structural aspects of a 
molecule by investigating the bond paths between atoms in the molecule 
[51]. 
It can be seen from the above discussion that the mechanisms that are 
likely to govern the retention behaviour of β-adrenergic agonists in HILIC 
systems are complex and that a complex model such as that built through 
the optimised GA-PLS method is necessary to predict retention. 
3.3.4 Conclusions 
Our QSRR methodology can be used to predict the retention of β-
adrenergic agonists with a high degree of accuracy and precision over five 
HILIC systems. The models are easily derived from a small set of β-
adrenergic agonists and their experimentally measured retention times. 
Quick theoretical calculations provide models that allow a researcher to 
readily distinguish suitable stationary phases for the study under 
development. 
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One of the novelties of the method described herein is the application of 
GA to select an optimised descriptor set for the QSRR models. The 
employment of optimised GA-PLS allowed us to identify the most relevant 
descriptors before obtaining the model, and to propose robust QSRR 
models, despite the high complexity of retention mechanisms in HILIC 
systems. In addition, models from GA-PLS based on the optimised 
descriptor sets outperformed those from GA-PLS and full PLS calculations, 
therefore we suggest the use of the former in the development of HILIC 
studies. Furthermore, the feature selection approach represented is shown to 
be a powerful tool to capture the general aspects of interactions for different 
HILIC systems. 
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4 Rapid method development in hydrophilic interaction 
liquid chromatography for pharmaceutical analysis using a 
combination of quantitative structure-retention relationships 
and design of experiments 
4.1 Introduction  
The process of finding optimal separation conditions on the basis of 
reliable theoretical predictions is an important step in rational method 
development for high-performance liquid chromatography (HPLC). 
Accordingly, the possibility of prediction of retention and separation in 
HPLC in the absence of any prior experiments with a sufficient accuracy to 
support method development is continuously moving further into the focus 
of theoretical and experimental chemists [1]. Since adoption of Quality-by-
Design (QbD) concepts in the pharmaceutical industry by the International 
Conference on Harmonisation (ICH) guidelines Q8(R2) [2], an important 
prerequisite to identify optimal separation conditions has been the 
applicability of QbD principles which allow for more robust and reliable 
analytical methods with fewer method failures or method transfer issues. A 
QbD-based treatment of the robustness of an HPLC method requires the 
application of the Design of Experiments (DoE) philosophy to establish a 
comprehensive design space, which can be further analysed to determine the 
experimental conditions that provide the required optimal level of 
performance in terms of separation of analytes [3]. DoE is a standard 
methodology for reversed phase liquid chromatography (RPLC) method 
development [4], both in academia and industry. This concept has currently 
been employed in the commercial optimisation software Drylab [5]. 
To date, researchers have highlighted the possibility of applying QbD 
concepts to those analytes having experimental data available in order to 
Chapter	 4	 	 	 	  Rapid	 method	 development	 in	 hydrophilic	 interaction	 liquid	
chromatography	for	pharmaceutical	analysis	using	a	combination	of	quantitative	
structure-retention	relationships	and	design	of	experiments 
 
 
 
138 
determine their retention under changing chromatographic conditions [6-8]. 
However, there exist strategies capable of developing relationships linking 
chromatographic parameters and analyte properties, and to automate their 
use in the prediction of retention parameters of new analytes. To the best of 
our knowledge, quantitative structure-retention relationships (QSRR) based 
on theoretically generated molecular descriptors [9] have so far attracted 
attention in only two QbD studies [10, 11]. Such a technique, however, has 
been successfully applied in LC method development [12, 13]. Thus, an 
approach that combines both DoE and QSRR methodologies might be of 
help to overcome the limitations of QbD techniques that are based solely on 
DoE modelling equations and can only predict the retention of known 
analytes under new conditions and not the retention of new analytes. 
The retention time prediction accuracy of a QSRR model may sometimes 
not be sufficient to support detailed method development [9]. However, 
QSRR models built using a method that clusters compounds according to 
structural similarity may overcome this limitation [10, 14, 15]. In this study, 
a novel compound-classification based QSRR modelling strategy is 
presented applying the concept of molecular similarity [16]. 
Hydrophilic interaction liquid chromatography (HILIC) is quickly 
becoming popular in the pharmaceutical industry due to its suitability for the 
separation of polar molecules [17]. A mixture of pharmaceuticals analysed 
in the HILIC mode was chosen as test analytes for this study (see Section 
4.2 for details). First, DoE principles were applied to derive a response 
equation for prediction of retention times over a design space of mobile 
phase compositions selected using a central composite design experimental 
plan. The accuracy of prediction was evaluated for mobile phase 
compositions not used in the derivation of the model. Next, it is shown that 
cluster-based QSRR modelling (where analytes are clustered according to 
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structural similarity) can be used to predict HILIC retention times for new 
analytes, based only on their chemical structures, and that these predicted 
retention times can then be used in DoE modelling. This combination of 
cluster-based QSRR and DoE allows the prediction of retention for new 
analytes and new mobile phase compositions not used in the derivation of 
the models. Finally, the QSRR-DoE-computed retention times of the test 
probes and subsequently calculated separation selectivity were used to make 
a prediction about the robust areas of the design space. Experiments 
performed to evaluate the validity of the QbD predictions showed 
convincing agreement between experiment and theory.  
This chapter demonstrates that discovery of optimal conditions for 
separation of new analytes not used in any of the modelling steps can be 
accelerated by integration of DoE and QSRR methods. 
4.2 Method 
4.2.1 Data set 
A data set composed of 50 pharmaceutical compounds using a HILIC 
amide stationary phase was used. This data involved 1, 2’-deoxyadenosine; 
2, 2’,3’-dideoxyadenosine; 3, 2’-deoxyguanosine; 4, 3’-deoxyguanosine; 5, 
5-methyluridine; 6, adenosine; 7, guanosine; 8, inosine; 9, thymidine; 10, 
uridine; 11, 3’-deoxythymidine; 12, 2’-deoxyuridine; 13, 2’-deoxyinosine; 
14, acyclovir; 15, salicylic acid; 16, 5-methylsalicylic acid; 17, 4-
hydroxybenzoic acid; 18, 3-hydroxybenzoic acid; 19, 2,4-dihydroxybenzoic 
acid; 20, 2,5-dihydroxybenzoic acid; 21, 2,3-dihydroxybenzoic acid; 22, 
3,5-dihydroxybenzoic acid; 23, benzoic acid; 24, 4-aminosalicylic acid; 25, 
3-amino-4-hydroxybenzoic acid; 26, 4-aminobenzoic acid; 27, 3-
aminobenzoic acid; 28, p-toluic acid; 29, vanillic acid; 30, syringic acid; 31, 
2-methoxybenzoic acid; 32, 3-methoxytyramine; 33, adrenaline; 34, 
dopamine; 35, isoproterenol; 36, metaproterenol; 37, N-methylephedrine; 
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38, noradrenaline; 39, norfenefrine; 40, phenylephrine; 41, ritudrine; 42, 
salbutamol; 43, synephrine; 44, tyramine; 45, normetanephrine; 46, 
fenotrole; 47, terbutaline; 48, octopamine; 49, methoxamine; 50, isoxuprine. 
Experimental retention data collected under the 17 chromatographic 
conditions of the studied central composite design using the amide column 
were utilised for this study. The levels studied for the selected critical 
chromatographic parameters and a diagram of a central composite design 
with 17 independent trials are shown in Table 2.1, Table 2.2 and Figure 2.1. 
More information about the collected data is presented in Chapter 2.  
4.2.2 Compound classification 
In the classification analysis step, Exclusion Spheres [18] cluster analysis 
was modified (see below) and carried out using ChemAxon hashed 
fingerprint [19] descriptors and the Tanimoto similarity coefficient [20]. 
The key points in the Exclusion Spheres clustering method were 
identification of the cluster centroid, which is the molecule with the largest 
number of similar neighbours and specification of the Tanimoto threshold 
needed for the algorithm execution. However, this method tends, in some 
cases, to create heterogeneity within a cluster, since it considers the 
Tanimoto value of similarity of each molecule to just the centroid molecule. 
In this chapter, a new clustering algorithm applying the exclusion spheres 
principles is introduced in which homogeneity within a cluster reflects the 
desired Tanimoto index of similarity between all members in the cluster.  
The in-house algorithm considered the following steps: 
Step 1: Generation of a matrix of pairwise similarities. To generate a 
matrix of pairwise similarities, each compound’s pairwise Tanimoto 
similarity index to each other compound in the dataset was calculated using 
Chapter	 4	 	 	 	  Rapid	 method	 development	 in	 hydrophilic	 interaction	 liquid	
chromatography	for	pharmaceutical	analysis	using	a	combination	of	quantitative	
structure-retention	relationships	and	design	of	experiments 
 
 
 
141 
JChem for Excel (ChemAxon, Budapest, Hungary). The initial dataset 
includes more than 500 compounds collected from HILIC literature.  
Step 2: Identifying the compounds with the largest number of neighbours. 
To identify such a molecule, the number of neighbours for each molecule in 
the dataset was calculated using the Tanimoto similarity threshold value of 
0.5 (defined as a clustering parameter). The dataset was then sorted in 
descending order, so that the compound with the largest number of 
neighbours was placed at the top of the list.  
Step 3. Cluster Algorithm. This step started with the first compound in 
the sorted list from step 2 as the initial cluster member. The set of its 
neighbours was sorted in descending order based on their pairwise 
Tanimoto values to the first member of the cluster, so that the compound 
with the highest Tanimoto value was labeled as the nearest neighbour. The 
next step was to count the nearest neighbour as another member of the 
cluster, so that now the cluster had two members. Then, pairwise similarities 
of the second nearest neighbour to each member of the cluster were 
computed and if all pairwise Tanimoto values were above, or equal to, the 
threshold value, it became another member of that cluster; otherwise it was 
discarded. This step was iterated until all other neighbours had been either 
selected or excluded. In the next step, this process was repeated for the 
excluded neighbours to keep those which were similar to at least 80% 
(defined by user) of all the members in that cluster based on the threshold 
value. Once the first cluster was formed, the members of that cluster were 
removed from any further comparisons and the same process was repeated 
for all other remaining molecules. The overall approach is illustrated in 
Figure 4.1 and Figure 4.2 shows the Tanimoto similarity matrix for the final 
clustered dataset. This compound classification step is followed by 
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generation of a QSRR model on each obtained cluster. Details of the model 
generation are presented in Chapter 2. 
Following data collection (experimental retention data are shown in 
Table 4.1), DoE models were constructed by applying multiple linear 
regression [21], which is the most common regression technique used in 
DoE studies [6, 22, 23]. A test condition, separated from the training 
conditions (which are listed in Table 2.2) was used to validate the final 
models for their predictive ability by calculating RMSEP% as defined in 
Chapter 2. 
4.2.3 QbD methodology   
The purpose of this study was to develop a HILIC method in accordance 
with QbD principles for the separation of the studied pharmaceutical targets, 
quickly providing robust HILIC mobile phase regions that will give 
flexibility in routine work. The QbD workflow followed is represented 
schematically in Figure 1.2. 
The initial step consisted of the selection of a critical quality attribute 
(CQA) [2], which was defined as the best separation of all targets. 
Selectivity factor values (!) were calculated using ! = #$/#&, where #$ 
and #& are the retention factors of analyte a and analyte b. The critical 
value was defined as ! ≥ 1.15 in order to identify the set of experimental 
conditions with acceptable method performance. 
One of the essential elements of QbD is to apply the DoE approach, 
discussed earlier. The collected data using DoE principles was then used as 
an input for the next step. 
A QSRR model was generated and used to predict the retention time and 
consequently the selectivity factor (!) between new target analytes not 
considered in previous modelling steps. The predicted GA-PLS data were 
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Figure 4.1. Scheme of in-house clustering algorithm. 
 
 
Figure 4.2. Tanimoto similarity matrix for the datasets studied. Pairwise Tanimoto 
values are shown, with all values >0.4 being shaded according to the color code at 
the bottom of the Figure. The darkest shading represents Tanimoto values >0.5. 
Numbering of compounds is available in Section 4.2.1.
  
 
144 
Table 4.1. Experim
entally obtained retention tim
es for each operating condition of the central com
posite design. 
nr. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
1 
1.92 
5.98 
2.39 
6.55 
2.17 
6.16 
2.47 
7.19 
2.33 
6.64 
2.78 
3.21 
2.63 
3.15 
3.07 
3.04 
3.07 
2 
1.93 
6.40 
2.44 
7.20 
2.21 
6.66 
2.54 
8.45 
2.36 
7.20 
2.86 
3.33 
3.13 
3.24 
3.15 
3.15 
3.15 
3 
1.91 
6.75 
2.33 
6.83 
2.15 
6.83 
2.41 
7.42 
2.30 
6.85 
2.79 
3.13 
3.00 
3.07 
3.01 
2.98 
3.03 
4 
1.91 
5.88 
2.32 
6.25 
2.15 
5.98 
2.40 
6.70 
2.28 
6.22 
2.74 
3.10 
2.96 
3.04 
2.97 
2.95 
2.99 
5 
1.93 
6.49 
2.39 
6.99 
2.20 
6.68 
2.48 
7.62 
2.35 
6.99 
2.86 
3.29 
3.12 
3.22 
3.13 
3.11 
3.14 
6 
1.94 
6.41 
2.37 
6.86 
2.18 
6.62 
2.46 
7.46 
2.33 
6.88 
2.84 
3.24 
3.08 
3.18 
3.09 
3.07 
3.11 
7 
2.02 
7.64 
2.57 
8.38 
2.28 
8.16 
2.61 
9.54 
2.48 
8.60 
3.09 
3.52 
3.43 
3.49 
3.41 
3.39 
3.42 
8 
1.81 
3.98 
2.25 
4.34 
2.04 
3.89 
2.31 
4.40 
2.19 
4.26 
2.43 
2.79 
2.66 
2.71 
2.65 
2.64 
2.68 
9 
1.99 
7.58 
2.48 
8.12 
2.25 
7.99 
2.57 
9.06 
2.41 
8.23 
3.02 
3.51 
3.31 
3.43 
3.34 
3.31 
3.35 
10 
1.94 
6.06 
2.41 
6.75 
2.18 
6.24 
2.50 
7.28 
2.35 
6.73 
2.82 
3.30 
3.11 
3.21 
3.12 
3.10 
3.14 
11 
1.92 
6.26 
2.39 
6.90 
2.17 
6.46 
2.47 
7.60 
2.33 
6.98 
2.79 
3.25 
3.07 
3.17 
3.09 
3.07 
3.10 
12 
1.98 
7.55 
2.49 
8.24 
2.26 
7.97 
2.58 
9.18 
2.43 
8.31 
3.04 
3.55 
3.35 
3.47 
3.37 
3.35 
3.38 
13 
1.99 
7.93 
2.50 
8.63 
2.26 
8.40 
2.59 
9.75 
2.44 
8.78 
3.06 
3.58 
3.38 
3.50 
3.40 
3.38 
3.41 
14 
1.86 
5.04 
2.27 
5.39 
2.09 
5.01 
2.34 
5.67 
2.23 
5.33 
2.58 
2.92 
2.79 
2.86 
2.80 
2.79 
2.82 
15 
1.76 
3.98 
2.10 
3.46 
1.97 
3.84 
2.15 
3.51 
2.08 
3.48 
2.32 
2.45 
2.42 
2.45 
2.42 
2.42 
2.44 
16 
4.02 
3.70 
3.13 
3.60 
3.09 
3.51 
2.80 
3.60 
3.06 
3.50 
3.05 
2.88 
3.15 
2.88 
3.09 
3.18 
2.97 
17 
3.71 
3.58 
3.09 
3.57 
2.93 
3.36 
2.78 
3.54 
3.02 
3.45 
2.89 
2.83 
3.10 
2.84 
3.04 
3.13 
2.93 
18 
2.19 
2.75 
4.06 
6.27 
2.17 
2.70 
3.59 
6.19 
3.31 
5.41 
2.25 
3.96 
3.89 
3.54 
3.91 
3.85 
3.62 
19 
4.62 
4.71 
3.46 
4.54 
3.49 
4.54 
3.11 
4.50 
3.36 
4.39 
3.57 
3.27 
3.62 
3.29 
3.57 
3.69 
3.38 
20 
3.51 
4.60 
3.44 
5.18 
2.89 
4.29 
3.09 
5.14 
3.35 
4.99 
3.04 
3.38 
3.73 
3.38 
3.67 
3.77 
3.49 
21 
2.43 
3.78 
3.88 
9.69 
2.32 
3.69 
3.45 
9.80 
3.55 
8.54 
2.50 
4.31 
4.61 
4.13 
4.55 
4.34 
4.25 
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22 
2.29 
2.68 
4.05 
6.00 
2.19 
2.54 
3.57 
5.64 
3.58 
5.15 
2.21 
3.84 
4.14 
3.61 
4.11 
3.94 
3.74 
23 
2.31 
3.04 
4.39 
7.69 
2.27 
3.03 
3.88 
7.63 
3.50 
6.41 
2.40 
4.48 
4.34 
3.92 
4.38 
4.06 
4.02 
24 
2.33 
2.82 
4.34 
7.51 
2.24 
2.72 
3.82 
7.25 
3.76 
6.25 
2.31 
4.40 
4.60 
4.09 
4.61 
4.32 
4.20 
25 
2.22 
2.76 
4.18 
6.71 
2.19 
2.69 
3.71 
6.55 
3.48 
5.59 
2.27 
4.13 
4.17 
3.72 
4.18 
3.91 
3.83 
26 
2.30 
2.89 
4.26 
7.57 
2.23 
2.80 
3.78 
7.33 
3.66 
6.29 
2.31 
4.35 
4.50 
4.01 
4.50 
4.20 
4.13 
27 
2.32 
2.69 
4.67 
7.63 
2.22 
2.56 
4.06 
7.27 
3.97 
6.17 
2.23 
4.48 
4.76 
4.14 
4.80 
4.47 
4.29 
28 
2.12 
2.39 
3.85 
5.17 
2.07 
2.35 
3.42 
5.02 
3.31 
4.46 
2.11 
3.55 
3.67 
3.29 
3.68 
3.48 
3.40 
29 
2.54 
3.98 
2.55 
3.96 
2.55 
4.03 
2.57 
4.07 
2.56 
3.95 
2.96 
2.95 
2.95 
2.98 
2.95 
2.94 
2.90 
30 
2.87 
8.70 
2.87 
8.51 
2.87 
9.74 
2.90 
9.79 
2.87 
8.81 
3.87 
3.86 
3.86 
3.93 
3.88 
3.86 
3.78 
31 
2.46 
4.16 
2.45 
4.13 
2.46 
4.58 
2.48 
4.52 
2.46 
4.27 
2.89 
2.88 
2.88 
2.93 
2.90 
2.89 
2.85 
32 
2.68 
5.46 
2.67 
5.42 
2.68 
5.99 
2.71 
5.93 
2.68 
5.55 
3.35 
3.33 
3.33 
3.40 
3.35 
3.34 
3.28 
33 
2.99 
10.91 
2.99 
10.70 
2.99 
12.84 
3.03 
12.67 
2.99 
11.22 
4.26 
4.26 
4.24 
4.34 
4.28 
4.25 
4.15 
34 
2.72 
6.91 
2.73 
6.91 
2.73 
8.12 
2.76 
8.09 
2.73 
7.29 
3.57 
3.59 
3.56 
3.65 
3.59 
3.58 
3.51 
35 
2.38 
3.53 
2.37 
3.51 
2.38 
3.77 
2.39 
3.73 
2.38 
3.58 
2.71 
2.70 
2.69 
2.73 
2.70 
2.70 
2.67 
36 
2.48 
4.30 
2.47 
4.27 
2.48 
4.85 
2.50 
4.76 
2.48 
4.46 
2.95 
2.95 
2.93 
3.00 
2.96 
2.95 
2.91 
37 
2.78 
7.60 
2.79 
7.18 
2.80 
8.18 
2.82 
8.77 
2.80 
7.58 
3.66 
3.70 
3.65 
3.71 
3.70 
3.73 
3.64 
38 
2.28 
2.95 
2.29 
2.90 
2.29 
2.97 
2.30 
3.01 
2.29 
2.92 
2.48 
2.48 
2.48 
2.49 
2.49 
2.52 
2.47 
N
um
bers in row
s are the operating conditions of the central com
posite design (Table 2.2). N
um
bering (in colum
n 1) of com
pounds is 
presented in Section 4.2.1.
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imported into MODDE [24], and DoE models were constructed using 
Monte Carlo simulations [25] with standard settings from the MODDE 
software. This step was followed by investigation of the knowledge space, 
the definition of the design space, robustness testing and finally the 
experimental realization of the predicted results, all of which are discussed 
in detail in the following sections. The overall combined QSRR-DoE 
approach is illustrated in Figure 4.4. 
4.3 Results and discussion 
4.3.1 Generation of DoE models  
The base DoE equation was derived, which contains the three variables 
(pH, percentage of acetonitrile, and salt content) as well as their interaction 
and quadratic terms. A multiple linear regression was performed, removing 
terms and optimising the model based on f-tests of statistical significance 
for the model and p-tests for the individual coefficients. The result of this 
regression is shown in eq 4.1. 
tR = β0 + β1×X1 + β2×X2 + β3×X3 + β4×X12 + β5×X22 + β6×X1X2 + 
    β7×X1X3+β8×X2X3                                 (4.1) 
where X1 and X3 are acetonitrile content and salt concentration in the 
mobile phase, respectively, and X2 is pH of the aqueous phase. The values 
of model regression coefficients marked as β0-8 with their statistical 
evaluations are given in Table 4.2. 
A plot of experimentally measured values for retention times of the 
training set analytes, compared to those predicted by the DoE equations, is 
depicted in Figure 4.5 and demonstrates a high correlation between the 
predicted and experimentally observed retention times, with %& ≥ 0.95. 
The model also passes the f-test at a 95% confidence level. 
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Figure 4.4. Scheme of the combined QSRR-DoE modelling approach followed in 
this work. The QSRR-DoE model was used to predict tR of new analytes under new 
chromatographic conditions. 
 
Figure 4.5. Predicted retention times versus measured retention times of 
DoE models for all compounds in the training set. A total of 646 data points 
is included.
  
 
148 
Table 4.2. C
oefficients of the obtained D
oE m
odels for the training set and their statistical evaluation. 
nr. 
β
0 (p) 
β
1 (p) 
β
2 (p) 
β
3 (p) 
β
4 (p) 
β
5 (p) 
β
6 (p) 
β
7 (p) 
β
8 (p) 
Q
2 
R
2 
R
2 
adj. 
1 
2.997 (0.000) 
2.124 (0.000) 
0.280 (0.000) 
0.168 (0.002) 
1.383 (0.000) 
 
0.103 (0.048) 
 
 
0.989 
0.997 
0.995 
2 
3.150 (0.000) 
2.525 (0.000) 
0.473 (0.000) 
0.116 (0.048) 
1.672 (0.000) 
 
0.323 (0.000) 
 
 
0.984 
0.996 
0.995 
3 
3.006 (0.000) 
2.358 (0.000) 
0.169 (0.000) 
0.107 (0.006) 
1.573 (0.000) 
 
 
 
 
0.995 
0.998 
0.998 
4 
2.970 (0.000) 
1.996 (0.000) 
0.211 (0.000) 
0.095 (0.002) 
1.240 (0.000) 
 
 
 
 
0.995 
0.999 
0.998 
5 
3.128 (0.000) 
2.342 (0.000) 
0.261 (0.000) 
0.130 (0.003) 
1.486 (0.000) 
 
0.087 (0.039) 
 
 
0.993 
0.998 
0.997 
6 
3.090 (0.000) 
2.295 (0.000) 
0.240 (0.000) 
0.124 (0.002) 
1.460 (0.000) 
 
 
 
 
0.994 
0.998 
0.997 
7 
3.400 (0.000) 
3.037 (0.000) 
0.342 (0.000) 
0.204 (0.013) 
2.030 (0.000) 
 
 
 
 
0.983 
0.995 
0.993 
8 
2.656 (0.000) 
1.027 (0.000) 
0.193 (0.000) 
 
0.491 (0.000) 
 
 
 
 
0.99 
0.996 
0.994 
9 
3.330 (0.000) 
2.930 (0.000) 
0.291 (0.000) 
0.183 (0.005) 
1.937 (0.000) 
 
 
 
 
0.991 
0.997 
0.995 
10 
3.120 (0.000) 
2.168 (0.000) 
0.300 (0.000) 
0.113 (0.004) 
1.325 (0.000) 
 
0.117 (0.007) 
 
 
0.993 
0.998 
0.997 
11 
3.081 (0.000) 
2.291 (0.000) 
0.300 (0.000) 
0.133 (0.008) 
1.467 (0.000) 
 
0.125 (0.019) 
 
 
0.99 
0.997 
0.996 
12 
3.362 (0.000) 
2.951 (0.000) 
0.324 (0.000) 
0.185 (0.004) 
1.938 (0.000) 
 
0.133 (0.036) 
 
 
0.99 
0.997 
0.996 
13 
3.393 (0.000) 
3.170 (0.000) 
0.342 (0.000) 
0.207 (0.006) 
2.133 (0.000) 
 
0.151 (0.047) 
 
 
0.987 
0.997 
0.995 
14 
2.798 (0.000) 
1.566 (0.000) 
0.200 (0.000) 
0.062 (0.021) 
0.924 (0.000) 
 
 
 
 
0.994 
0.998 
0.997 
15 
2.418 (0.000) 
0.820 (0.000) 
 
 
0.415 (0.000) 
 
 
 
 
0.965 
0.988 
0.982 
16 
3.010 (0.000) 
0.181 (0.000) 
-0.137(0.002) 
-0.172(0.000) 
0.392 (0.000) 
 
0.147 (0.002) 
0.131 
(0.004) 
0.100 
(0.019) 
0.630 
0.955 
0.920 
17 
2.946 (0.000) 
0.197 (0.000) 
-0.066(0.024) 
-0.162(0.000) 
0.358 (0.000) 
 
0.118 (0.002) 
0.106 
(0.004) 
0.082 
(0.014) 
0.786 
0.966 
0.939 
18 
3.745 (0.000) 
0.800 (0.000) 
1.201 (0.000) 
 
0.624 (0.001) 
-0.630(0.001) 
0.464 (0.000) 
 
 
0.925 
0.973 
0.96 
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19 
3.460 (0.000) 
0.464 (0.000) 
-0.205(0.002) 
-0.202(0.002) 
0.613 (0.000) 
 
0.168 (0.010) 
0.158 
(0.014) 
 
0.684 
0.963 
0.935 
20 
3.542 (0.000) 
0.792 (0.000) 
0.190 (0.000) 
-0.166(0.000) 
0.708 (0.001) 
-0.252(0.001) 
0.163 (0.001) 
0.079 
(0.028) 
0.068 
(0.049) 
0.977 
0.994 
0.988 
21 
4.422 (0.000) 
1.986 (0.000) 
1.640 (0.000) 
 
1.557 (0.000) 
-1.083(0.002) 
1.180 (0.000) 
 
 
0.926 
0.974 
0.962 
22 
3.885 (0.000) 
0.633 (0.000) 
1.120  
(0.000) 
-0.161(0.039) 
0.532 (0.001) 
-0.810(0.000) 
0.410 (0.000) 
 
 
0.933 
0.978 
0.965 
23 
4.170 (0.000) 
1.144 (0.000) 
1.500 (0.000) 
 
0.810 (0.001) 
-0.706(0.002) 
0.695 (0.000) 
 
 
0.931 
0.975 
0.964 
24 
4.364 (0.000) 
1.005 (0.000) 
1.491 (0.000) 
 
0.697 (0.002) 
-0.948(0.000) 
0.704 (0.000) 
 
 
0.93 
0.974 
0.962 
25 
3.976 (0.000) 
0.852 (0.000) 
1.316 (0.000) 
 
0.611 (0.002) 
-0.723(0.001) 
0.541 (0.000) 
 
 
0.929 
0.973 
0.961 
26 
4.275 (0.000) 
1.064 (0.000) 
1.476 (0.000) 
 
0.750 (0.001) 
-0.893(0.000) 
0.712 (0.000) 
 
 
0.932 
0.975 
0.963 
27 
4.470 (0.000) 
0.910 (0.000) 
1.610 (0.000) 
 
0.698 (0.005) 
-1.015(0.000) 
0.682 (0.000) 
 
 
0.919 
0.969 
0.955 
28 
3.501 (0.000) 
0.463 (0.000) 
1.000 (0.000) 
 
0.422 (0.004) 
-0.633(0.000) 
0.297 (0.002) 
 
 
0.919 
0.969 
0.955 
29 
2.950 (0.000) 
0.722 (0.000) 
 
0.023 (0.011) 
0.330 (0.000) 
 
 
 
 
0.998 
0.999 
0.998 
30 
3.863 (0.000) 
3.118 (0.000) 
 
0.243 (0.000) 
2.130 (0.000) 
 
 
0.286 
(0.000) 
 
0.996 
0.998 
0.997 
31 
2.890 (0.000) 
0.934 (0.000) 
 
0.090 (0.000) 
0.508 (0.000) 
 
 
0.098 
(0.000) 
 
0.996 
0.998 
0.998 
32 
3.340 (0.000) 
1.493 (0.000) 
 
0.115 (0.000) 
0.838 (0.000) 
 
 
0.126 
 
0.997 
0.998 
0.998 
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(0.000) 
33 
4.256 (0.000) 
4.334 (0.000) 
 
0.404 (0.000) 
3.080 (0.000) 
 
 
0.482 
(0.000) 
 
0.995 
0.997 
0.996 
34 
3.580 (0.000) 
2.367 (0.000) 
 
0.252 (0.000) 
1.520 (0.000) 
 
 
0.293 
(0.000) 
 
0.996 
0.998 
0.997 
35 
2.700 (0.000) 
0.623 (0.000) 
 
0.051(0.000) 
0.303 (0.000) 
 
 
0.054 
(0.000) 
 
0.996 
0.998 
0.998 
36 
2.950 (0.000) 
1.024 (0.000) 
 
0.114 (0.000) 
0.554 (0.000) 
 
 
0.126 
(0.000) 
 
0.995 
0.998 
0.997 
37 
3.684 (0.000) 
2.533 (0.000) 
 
0.228 (0.003) 
1.646 (0.000) 
 
 
0.265 
(0.003) 
 
0.985 
0.994 
0.992 
38 
2.487 (0.000) 
0.330 (0.000) 
 
0.017 (0.024) 
0.133 (0.000) 
 
 
 
 
0.99 
0.996 
0.994 
N
um
bering (in colum
n) of com
pounds is available in Section 4.2.1. D
oE m
odel is tR  = β
0  + β
1  × acetonitrile content + β
2  × pH
 + β
3  × 
salt concentration + β
4  × (acetonitrile content) 2 + β
5  × (pH
) 2 + β
6  × (acetonitrile content × pH
) + β
7  × (acetonitrile content × salt 
concentration) + β
8  × (acetonitrile content × pH
). p is the significance of the variables in the m
odel.
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Figure 4.6. DoE model term ranking chart for each compound in the training set. 
In model term ranking, the variable that has the highest coefficient value is 
assigned a ranking of 1, and other variables are ranked based on the experimental 
data.  
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The model term ranking chart, presented in Figure 4.6 allows 
determination of the most significant factors in determining retention of 
analytes. The data in Figure 4.6 indicate that the linear and the quadratic 
terms of the acetonitrile content were significant factors in determining 
retention of the studied analytes, in agreement with the understanding that 
both hydrophilic partitioning as well as adsorption take part in the overall 
retention mechanism in HILIC mode. No ion-exchange interactions are 
present for the nucleosides and ion-exchange interactions are only present to 
a small extent for the beta-agonists. The retention of the benzoic acids on 
the other hand is significantly influenced by pH and ion-exchange 
interactions. For benzoic acids with !"# > 4, a large positive coefficient 
was observed for the pH suggesting increased hydrophilicity of these acids 
due to solute deprotonation in higher pH [26, 27]. In contrast, the pH term in 
the DoE models obtained for benzoic acids with !"#	 < 3 has a negative 
coefficient, possibly due to the effect of pH on diminishing the repulsion of 
these analytes from charged silanol groups on the stationary phase [26].  
To evaluate experimentally the predictive power of the DoE models, 
retention times of the training set compounds were measured using the 
HILIC condition of 10 mmol L-1 ammonium formate (pH 4) containing 85% 
v/v acetonitrile, which was different from conditions used to derive the DoE 
models. The results include 38 measured retention times, which were 
compared with the predicted values and an average RMSEP% value of 9.26 
was obtained as shown in Figure 4.7.  
However, the original retention data used to derive the DoE models were 
acquired on the column when new and the observed differences between 
predicted and measured retention times could possibly be attributed to 
changes in the column behaviour due to its numerous uses (more than 2000 
runs). Therefore, there is a clear need to update the retention database to 
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reflect changes in the retention times resulting from changes in the column 
over time. For this purpose, a porting procedure based on our previously 
developed porting methodologies [28, 29] was applied by employing three 
analytes (least retained, middle retained and most retained compounds) as 
markers to derive porting equations for each structurally-similarity based 
cluster. Retention data of these markers were measured experimentally on 
the same column used in Figure 4.7 and the ratio of new to original values 
was calculated and used to recalibrate the predicted retention values for all 
analytes in the dataset under the test conditions. This led to a substantial 
improvement in the match between predicted and measured results and 
highlights the need to use ported retention datasets. The comparison 
between the ported predicted retention times and those observed 
experimentally for the test condition is depicted in Figure 4.8 with the 
average RMSEP% value of 3.95. The derived porting equation for each 
cluster in the dataset is listed in Table 4.3. 
However, while the above results show that DoE models are successful 
in predicting retention for new mobile phase conditions, they are unable to 
predict the retention times of new analytes not included in the modelling 
process. To overcome this drawback, we applied a two-stage approach, in 
which retention times of new analytes for each operating condition of the 
central composite design were predicted by applying the QSRR 
methodology described earlier, before their further use in the calculation of 
coefficients for the DoE models. In this way, the DoE models for the new 
analytes could be used to predict retention times for any mobile phase 
composition in the design space.
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4.3.2 Combined QSRR and DoE modelling  
QSRR models were generated, as described in the Model Generation 
section, using the experimental chromatographic retention times, with DFT-
computed molecular descriptors calculated for three datasets classified 
according to structural similarity: 15 β-adrenergic agonists, 13 benzoic acids 
and 10 nucleosides. The predictivities of the GA-PLS models obtained for 
all 17 chromatographic conditions are presented in Table 4.4 with internal 
validation by RMSECV (equation 2.5) giving an average value of 6.08% 
over all analysed HILIC conditions, which indicates that the predicted 
values for the retention of all tested analytes were in relatively good 
agreement with the experimental data. 
The reliability of the QSRR models was tested by applying to the training 
sets Y-randomization tests with 1000 iterations and randomly assigned 
retention times. The result confirmed the reliability of the models, given that 
RMSECV values for the actual dataset were shown to be significantly lower 
than those obtained for the same dataset with randomized retention data 
(Figures 4.9 – 4.11). 
External validation data sets were used to illustrate the utility of our 
approach to predict the retention time of an unstudied set of compounds for 
a set of experiments covering a large body of chromatographic conditions. 
External validation of the predictive power of the QSRR models was 
evaluated using 4 test analytes in each cluster, which had not been utilised 
in either molecular descriptor feature selection or model generation. These 
test analytes comprised β-adrenergic agonists (adrenaline, noradrenaline, 
ritudrine, synephrine), benzoic acids (3-hydroxybenzoic acid, 2,5-
dihydroxybenzoic acid, 4-aminobenzoic acid, 4-aminosalicylic acid) and 
nucleosides (2’-deoxyadenosine, 2’-deoxyguanosine, 2’-deoxyuridine, 2’-
deoxyinosine).
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Figure 4.7. Experimental values versus predicted values of external validation of 
DoE models for analysed compounds under a never analysed chromatographic 
condition: 10 mmol L-1 ammonium formate (pH 4) containing 85% v/v acetonitrile. 
 
 
Figure 4.8. Experimental retention times versus ported predicted retention times 
for external validation of DoE models under a never analysed chromatographic 
condition: 10 mmol L-1 ammonium formate (pH 4) containing 85% v/v acetonitrile. 
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Table 4.3. Summary of porting equations on the structurally-similarity based 
classified datasets. 
Dataset Porting equation 
β-agonists tRported = 0.716 tRmeasureda + 0.872 
Benzoic 
acids 
tRported = 0.931 tRmeasured + 0.015 
nucleosides tRported = 0.671 tRmeasured + 1.100 
a is measured retention time when the column was new. 
Table 4.4. Predictive performance of GA-PLS models on internal validation. 
 RMSECV (%) 
datasets: 
nr. β-agonists benzoic acids nucleosides 
1 0.43 5.83 0.64 
2 3.50 8.61 4.40 
3 0.64 12.01 0.63 
4 5.71 38.05 6.01 
5 0.59 3.79 0.87 
6 4.74 6.59 6.46 
7 0.52 5.70 0.83 
8 3.93 34.91 4.88 
9 0.64 9.88 0.66 
10 3.51 22.13 4.26 
11 1.22 3.56 0.96 
12 1.07 11.47 1.78 
13 2.81 19.55 2.12 
14 1.39 8.84 1.49 
15 1.44 16.58 1.24 
16 1.02 12.84 1.63 
17 1.09 15.35 1.42 
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Figure 4.9. Y-randomization plots of β-adrenergic agonists dataset on 17 operating 
chromatographic conditions of the studied central composite design. Y-randomized 
data (royal blue lines), and the actual data (red line). 
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Figure 4.10. Y-randomization plots of benzoic acids dataset on 17 operating 
chromatographic conditions of the studied central composite design. Y-randomized 
data (royal blue lines), and the actual data (red line). 
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Figure 4.11. Y-randomization plots of nucleosides dataset on 17 operating 
chromatographic conditions of the studied central composite design. Y-randomized 
data (royal blue lines), and the actual data (red line). 
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The appropriate descriptor values for each analyte in the test sets were 
inserted into the GA-PLS model equation, and the respective retention times 
were calculated and compared to measured experimental retention times. A 
comparison between the predicted retention times and those observed 
experimentally for each test compound using the GA-PLS model is depicted 
in Figure 4.12, while figures of merit are summarised in Table 4.5. As seen 
in Table 4.5, in general, the GA-PLS models generated for the test 
compounds over all chromatographic conditions used for data acquisition in 
the design space were very well correlated with the experimental data, 
presenting an average RMSEP% (equation 2.4) value for all analytes over 
all experimental conditions of 6.74%. The prediction errors for the benzoic 
acids in a few conditions (Table 4.5) are higher than desired, possibly due to 
a complex, multi-modal retention mechanism for this cluster. The ability to 
predict retention of new compounds for the mobile phase compositions used 
to define the design space opened the possibility of applying DoE modelling 
and hence prediction of retention of these new compounds under new 
mobile phase conditions. The above GA-PLS step was followed by the 
calculation of coefficient values for the DoE models from the corresponding 
predicted retention times. Thus, from the QSRR data, we obtained DoE 
models for each analyte in the external validation set. Coefficients of the 
obtained DoE models and their statistical evaluations for targets are 
presented in Table 4.6 and the experimental and predicted retention times of 
targets are presented in Table 4.7. The performance of the obtained QSRR-
DoE models was evaluated by prediction of the retention times of the test 
analytes under a chromatographic condition of 10 mmol L-1 ammonium 
formate (pH 4) containing 85% v/v acetonitrile (which had not been used in 
any modelling procedure). A plot of experimental data and model    
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Table 4.5. QSRR models performance summary 
  RMSEP / % in datasets: 
nr. β-agonists benzoic acids nucleosides 
1 1.41 5.35 1.38 
2 6.43 4.30 11.43 
3 1.65 2.36 1.40 
4 9.73 13.41 8.70 
5 1.63 2.89 0.81 
6 7.21 5.36 18.21 
7 1.55 7.40 1.42 
8 6.76 16.22 8.35 
9 1.70 13.69 0.90 
10 4.70 30.53 11.57 
11 2.90 4.76 3.55 
12 2.83 5.04 4.72 
13 3.44 11.10 2.87 
14 3.18 23.92 2.74 
15 3.00 10.98 5.75 
16 3.30 12.47 2.34 
17 2.87 20.64 2.77 
Method abbreviation explained in the text. nr. is the number assigned to each 
experimental condition of the applied central composite design. 
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Figure 4.12. Predictive ability of GA-PLS models for external validation 
sets of β-adrenergic agonists, benzoic acids and nucleosides over all 17 
experimental conditions of the central composite design used in this study. 
RMSEPavr.% is the average value of RMSEP% of test analytes over all 
studied conditions. A total of 204 data points is included. 
 
 
Figure 4.13. Experimental retention times versus ported predicted 
retention times for combined QSRR-DoE models for never analysed 
compounds under a never analysed condition: 10 mmol L-1 ammonium 
formate (pH 4) containing 85% v/v acetonitrile
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predictions for the test analytes is shown in Figure 4.13 and confirms good 
QSRR-DoE model performance in predicting the retention times of the 
analytes. 
4.3.3 Prediction of the optimal separation conditions by applying QSRR-
DoE-QbD methodology 
In the previous sections, the prediction abilities of the obtained QSRR-DoE 
models were investigated. The obtained result shows clearly that the 
combined QSRR-DoE methodology reproduces the experimentally obtained 
retention times with acceptable RMSEP values. This is one of the central 
results of this work: the combined QSRR-DoE method is capable of using 
the chemical structures of new analytes to predict retention times under a 
new HILIC condition with an acceptably low error. These results permit the 
combination of QSRR-DoE and QbD to determine the robustness of the  
separation over a chosen design space of mobile phase compositions. To 
investigate this approach, the optimal separation conditions for 4 test 
analytes from each analyte cluster (see above for analyte identities) were 
predicted computationally, based on the chemical structures of the analytes 
and employing QSRR-DoE and QbD. 
Retention data predicted from the QSRR-DoE modelling were converted 
to selectivity values (α) for all analyte pairs and imported into MODDE 10 
software [24] and the investigated experimental domain was explored to 
identify the optimal separation conditions. In this case the performance was 
expressed as the percentage risk of failure of the separation, with failure 
being defined as α<1.15 for any analyte pair. In accordance with QbD 
principles, the defined design space should not only provide the required 
optimal level of performance in terms of separation of test analytes, but also 
identify the robust regions to gain assurance in quality of the developed 
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Table 4.6. C
oefficients of the obtained D
oE m
odels for the test sets and their statistical evaluation. 
analytes 
β
0 (p) 
β
1 (p) 
β
2 (p) 
β
3 (p) 
β
4 (p) 
β
5 (p) 
β
6 (p) 
β
7 (p) 
Q
2 
R
2 
R
2 adj. 
A
drenaline 
3.418 (0.000) 
3.190 (0.000) 
0.447 (0.000) 
0.209 (0.008) 
2.148 (0.000) 
 
0.268 (0.004) 
 
0.986 
0.996 
0.995 
N
oradrenaline 
3.674 (0.000) 
3.960 (0.000) 
0.436 (0.000) 
0.259 (0.013) 
2.748 (0.000) 
 
0.238 (0.034) 
 
0.984 
0.996 
0.994 
R
itudrine 
2.934 (0.000) 
1.762 (0.000) 
 
 
1.034 (0.000) 
 
-0.245 
(0.001) 
 
0.975 
0.993 
0.989 
Synephrine 
3.200(0.000) 
2.353 (0.000) 
0.319 (0.000) 
0.133 (0.019) 
1.463 (0.000) 
 
0.132 (0.033) 
 
0.987 
0.996 
0.994 
3-H
ydroxybenzoic acid 
4.123 (0.000) 
1.270 (0.000) 
1.346 (0.000) 
 
1.139 (0.002) 
-1.081 (0.003) 
0.813 (0.001) 
 
0.725 
0.964 
0.928 
2,5-D
ihydroxybenzoic 
acid 
4.048 (0.000) 
1.025 (0.000) 
 
 
1.276 (0.000) 
-0.913 (0.003) 
0.413 (0.014) 
 
0.674 
0.941 
0.883 
4-A
m
inobenzoic acid 
3.617 (0.000) 
0.296 (0.004) 
0.830 (0.000) 
 
 
-0.603 (0.002) 
 
 
0.776 
0.955 
0.91 
4-A
m
inosalicylic acid 
3.258 (0.000) 
0.530 (0.010) 
0.487 (0.010) 
 
0.608 (0.010) 
 
 
 
0.589 
0.899 
0.797 
2'-deoxyadenosine 
3.225 (0.000) 
1.350 (0.000) 
 
0.094 (0.001) 
0.761 (0.000) 
 
 
0.103 
(0.001) 
0.995 
0.997 
0.996 
2'-deoxyguanosine 
4.995 (0.000) 
3.034 (0.000) 
 
 
 
 
 
 
0.655 
0.805 
0.76 
2'-deoxyuridine 
3.226 (0.000) 
1.050 (0.000) 
 
 
 
 
 
 
0.713 
0.843 
0.807 
2'-deoxyinosine 
4.050 (0.000) 
1.863 (0.000) 
 
 
 
 
 
 
0.724 
0.847 
0.812 
D
oE m
odel is tR  = β
0  + β
1  × acetonitrile content + β
2  × pH
 + β
3  × salt concentration + β
4  × (acetonitrile content) 2 + β
5  × (pH
) 2 + β
6  × 
(acetonitrile content × pH
) + β
7  × (acetonitrile content × salt concentration) + β
8  × (acetonitrile content × pH
). p is the significance of 
the variables in the m
odel.
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Table 4.7. The experim
ental and predicted retention tim
es of test com
pounds for each operating condition of the central com
posite 
design by using G
A
-PLS m
odels. 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
A
drenaline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
2.00 
7.75 
2.56 
9.38 
2.28 
8.33 
2.65 
10.39 
2.47 
9.12 
3.09 
3.69 
3.45 
3.58 
3.48 
3.45 
3.46 
tR
predicted  
2.00 
7.79 
2.54 
8.98 
2.28 
8.26 
2.62 
10.11 
2.44 
8.64 
3.07 
3.63 
3.40 
3.53 
3.43 
3.42 
3.43 
N
oradrenaline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
2.05 
9.81 
2.63 
12.26 
2.35 
10.86 
2.73 
13.45 
2.54 
11.32 
3.32 
3.96 
3.70 
3.85 
3.75 
3.71 
3.71 
tR
predicted  
2.06 
9.28 
2.64 
10.32 
2.35 
9.99 
2.71 
11.80 
2.55 
10.52 
3.30 
3.86 
3.75 
3.79 
3.67 
3.65 
3.69 
R
itudrine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
1.84 
5.43 
2.25 
5.66 
2.08 
5.37 
2.33 
6.01 
2.22 
5.63 
2.57 
2.90 
2.78 
2.84 
2.79 
2.76 
2.81 
tR
predicted  
1.89 
6.06 
2.32 
5.07 
2.14 
6.01 
2.40 
5.72 
2.28 
5.81 
2.72 
3.04 
2.95 
3.01 
2.94 
2.93 
2.95 
Synephrine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
1.94 
6.32 
2.43 
7.10 
2.19 
6.53 
2.52 
7.74 
2.36 
7.15 
2.85 
3.36 
3.16 
3.27 
3.17 
3.15 
3.18 
tR
predicted  
1.96 
6.40 
2.46 
7.06 
2.21 
6.61 
2.53 
7.83 
2.39 
7.19 
2.87 
3.36 
3.22 
3.27 
3.20 
3.20 
3.27 
3-H
ydroxybenzoic acid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
2.34 
3.09 
3.99 
7.50 
2.25 
2.97 
3.52 
7.36 
3.58 
6.67 
2.34 
4.12 
4.37 
3.85 
4.33 
4.35 
4.03 
tR
predicted  
2.34 
3.15 
3.92 
7.42 
2.25 
2.95 
3.42 
7.93 
3.71 
6.88 
2.35 
3.81 
4.31 
3.59 
4.22 
4.38 
4.04 
2,5-D
ihydroxybenzoic acid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
4.17 
4.77 
3.20 
4.59 
3.22 
4.62 
2.89 
4.64 
3.14 
4.46 
3.38 
3.15 
3.45 
3.17 
3.39 
3.50 
3.25 
tR
predicted  
4.32 
4.80 
3.27 
5.58 
3.34 
4.80 
2.98 
5.91 
3.93 
7.00 
3.43 
3.12 
4.06 
4.02 
4.10 
3.56 
4.22 
4-A
m
inosalicylic acid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
2.80 
3.59 
3.66 
5.40 
2.50 
3.32 
3.27 
5.24 
3.52 
5.01 
2.58 
3.58 
3.96 
3.55 
3.89 
3.91 
3.68 
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tR
predicted  
3.10 
3.59 
3.63 
4.84 
2.59 
3.55 
3.49 
5.11 
3.34 
4.36 
2.79 
3.42 
4.05 
3.00 
3.35 
3.08 
2.84 
4-A
m
inobenzoic acid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
2.14 
2.47 
3.71 
4.34 
2.12 
2.48 
3.36 
4.27 
2.92 
3.78 
2.20 
3.39 
3.23 
3.01 
3.25 
3.07 
3.06 
tR
predicted  
2.15 
2.67 
3.80 
4.74 
2.15 
2.62 
3.79 
4.38 
3.47 
3.92 
2.27 
3.45 
3.82 
3.81 
3.52 
3.45 
3.79 
2'-D
eoxyadenosine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
2.60 
4.73 
2.60 
4.71 
2.60 
4.93 
2.63 
4.99 
2.61 
4.75 
3.16 
3.15 
3.14 
3.19 
3.16 
3.15 
3.09 
tR
predicted  
2.63 
5.10 
2.63 
5.21 
2.63 
5.56 
2.66 
5.61 
2.63 
5.19 
3.25 
3.18 
3.21 
3.27 
3.25 
3.25 
3.16 
2'-D
eoxyguanosine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
2.89 
8.93 
2.88 
8.75 
2.89 
9.88 
2.92 
10.10 
2.89 
9.08 
3.95 
3.95 
3.93 
4.01 
3.95 
3.93 
3.85 
tR
predicted  
2.91 
8.26 
2.82 
8.01 
2.86 
10.03 
2.87 
10.02 
2.85 
8.33 
3.76 
3.60 
4.01 
3.85 
3.52 
3.51 
3.71 
2'-D
eoxyuridine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
2.39 
3.73 
2.40 
3.62 
2.41 
3.91 
2.41 
4.06 
2.40 
3.76 
2.77 
2.77 
2.75 
2.79 
2.78 
2.82 
2.75 
tR
predicted  
2.45 
4.48 
2.42 
3.97 
2.44 
5.23 
2.45 
4.49 
2.42 
4.49 
2.87 
2.86 
2.88 
2.85 
2.83 
2.88 
2.84 
2'-D
eoxyinosine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tR
m
easured  
2.63 
5.95 
2.65 
5.75 
2.66 
6.45 
2.67 
6.96 
2.65 
6.09 
3.35 
3.39 
3.34 
3.40 
3.39 
3.43 
3.33 
tR
predicted  
2.66 
5.94 
2.65 
6.06 
2.67 
6.80 
2.66 
7.20 
2.65 
5.93 
3.43 
3.37 
3.40 
3.34 
3.34 
3.37 
3.39 
N
um
bers in the first row
 are the operating conditions of the central com
posite design (Table 2.2). 
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methods. To assess this robustness, Monte Carlo simulations [25] were 
performed to propagate the model uncertainty, thus allowing the probability 
of the selected performance criteria at the optimal conditions and 
consequently the design space of the analytical method to be estimated. 
Areas of the design space where the percentage risk of failure was <2% 
were considered to provide a robust separation. Figure 4.14 shows plots of 
the percentage risk of failure over the tested range of acetonitrile 
compositions and pH for the test analytes in each cluster. For simplicity in 
displaying these data, a fixed salt concentration was used for each cluster 
and this is justified after considering that the salt concentration exerted only 
a minor effect on separation selectivity as calculated by the MODDE 
software. The optimal mobile phase composition is indicated in each plot 
and the separation obtained for each optimal composition is also shown, 
together with the retention time predicted from the modelling (red lines). In 
the case of β-adrenergic agonists, the mobile phase pH was chosen to be 
slightly lower than the national optimum to reduce peak tailing of adrenaline 
and noradrenaline. 
These results show that coupling QbD methodology with retention time 
predictions generated using QSRR-DoE is a powerful tool to predict the 
optimal separation conditions for new compounds, based on their chemical 
structures. 
4.3.4 Conclusions 
A novel QbD methodology using a compound-classification-based 
QSRR modelling approach in combination with DoE principles was 
demonstrated using HILIC separation examples. The DoE model was used 
to relate analyte retention time to mobile-phase pH, acetonitrile content and 
salt concentration. A cluster-based QSRR model was generated to create a  
Chapter	 4	 	 	 	  Rapid	 method	 development	 in	 hydrophilic	 interaction	 liquid	
chromatography	for	pharmaceutical	analysis	using	a	combination	of	quantitative	
structure-retention	relationships	and	design	of	experiments 
	
 
 
168 
 
 
Figure 4.14. Representation of the design space of pH versus acetonitrile content 
in the mobile phase, setting the salt concentration in the mobile phase at 18.7 mmol 
L-1 for β-adrenergic agonists (A), 13.3 mmol L-1 for benzoic acids (B), and 16.7 
mmol L-1 for nucleosides (C). The risk of failure map is shown for the performance 
criteria ! with acceptance limits ! ≤ 1.15. The design space is considered to be 
the area corresponding to a 2% risk of failure and the dots mark the mobile phase 
composition used to evaluate the predictive power of the models. The notional 
optimal mobile phase composition is used for (B) and (C), however for (A) a lower 
pH was used to improve peak shape. Experimental chromatograms (black peaks) 
corresponding to the selected working point: 18.7 mmol L-1 ammonium formate 
(pH 4.1) containing 87.5% v/v acetonitrile for β-adrenergic agonists (A), 13.3 
mmol L-1 ammonium formate (pH 3.5) containing 80% v/v acetonitrile for benzoic 
acids (B), and 16.7 mmol L-1 ammonium formate (pH 5) containing 88% v/v 
acetonitrile for nucleosides (C). The red lines represent the predicted retention 
times from the QSRR-DoE models under the selected working condition. 
Numbering of test compounds in graph A: 1, ritudrine; 2, synephrine; 3, adrenaline; 
4, noradrenaline; in graph B, 1, 4-aminobenzoic acid; 2, 3-hydroxybenzoic acid; 3, 
4-aminosalicylic acid; 4, 2,5-dihydroxybenzoic acid; in graph C, 1, 2’-
deoxyuridine; 2, 2’-deoxyadenosine; 3, 2’-deoxyinosine; 4, 2’-deoxyguanosine.
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relationship between the retention data and the chemical structures of the 
analytes. Extensive validation of the QSRR and DoE models demonstrated 
excellent predictive power. A combination of these cluster-based QSRR and 
DoE models was used to successfully predict the retention times of new 
analytes under new chromatographic conditions. The calculation of the 
separation selectivity using the QSRR-DoE-computed retention times of 
targets allowed identification of the design space where the maximum peak 
selectivity between the test probes was located. Finally, the optimal working 
conditions were selected and the high level of agreement between 
theoretical predictions and experimental chromatography proved the 
adequacy of the developed method. 
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5 Use of dual-filtering to create training sets leading to 
improved accuracy in quantitative structure-retention 
relationship modelling for hydrophilic interaction liquid 
chromatographic systems 
5.1 Introduction 
The motivation behind the use of quality by design (QbD) principles in 
conjunction with HPLC method development has been the desire to develop 
more robust and reliable analytical methods with minimal time and resource 
effort [1-5]. To this end, theoretical approaches have been employed for 
method development to propose different retention models that relate 
retention time/factor of an analyte to properties of the stationary phase, the 
eluent, and the analyte itself [6-8]. An important computational approach in 
predicting retention times in HPLC method development is the quantitative 
structure-retention relationship (QSRR) method, which correlates the 
retention time of an analyte to its chemical structure [9]. 
Although QSRR modelling methods have been used for more than 40 
years, the retention time prediction accuracy of such models is not yet 
sufficient to support HPLC method development [9]. As a consequence, 
QSRR methodology is still an active research area. A key component that 
can potentially lead to improvement in QSRR modelling accuracy is the 
incorporation of appropriate molecular descriptors into the models [5]. A 
large number of different kinds of molecular descriptors have been reported 
in QSRR studies, e.g. physicochemical properties [10-12], solvatochromic 
descriptors [13, 14], quantum-chemical indices [15], 2D autocorrelation 
indices [16], GEometry, Topology, Atom-Weights AssemblY (GETAWAY) 
descriptors [17] and gonane topological weighted fingerprints [18]. In 
addition, several feature selection approaches to capture the most 
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informative molecular descriptors with the goal of producing more 
predictive models have been reported [6, 19, 20]. Comparison studies 
demonstrate that the well-known genetic algorithm (GA) method performs 
better than other possible feature selection mechanisms [20, 21]. 
Another strategy to enhance the level of confidence in QSRR 
methodology is the use of the concept of molecular similarity in compound-
classification prior to QSRR modelling. The essence of the similarity 
concept is that structurally similar compounds are more likely to exhibit 
similar properties [22]. Classification according to similarity has proven to 
be a powerful tool in quantitative structure-property (activity) relationship 
(QSPR/QSAR) analysis enabling biomarker discovery, mechanistic studies, 
drug development, and technological evaluations in medicinal and 
pharmaceutical industries [23-28]. However, the use of the molecular 
similarity concept for QSRR modelling was seldom reported before Wang 
et al. [29] presented a compound classification method based on log D 
profile similarity, resulting in enhanced elution order prediction in acidic 
and basic chromatographic conditions. Muteki et al. [5] have also assessed 
the reliability of QSRR prediction and found that QSRR methodology based 
on compound classification significantly improved retention time prediction 
in comparison with the models derived from the whole dataset.  
Previous work from our group has demonstrated [30] that application of 
the federation of local models strategy, which involves scanning a database 
to find those molecules that are most structurally similar to the test analyte 
and constructing a local model for each test compound based on its top 
ranked similar molecules, may help to improve the prediction accuracy of 
QSRR models. This compound-classification-based QSRR strategy 
successfully utilised Tanimoto [31] cluster analysis to predict retention 
times of studied test probes in a HILIC database using an amide column 
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([32], and Chapter 4). However the further application of the proposed 
modelling approach in datasets collected from other HILIC stationary 
phases or other test analytes showed varying degrees of success, possibly 
due to the complex retention mechanisms at play in the HILIC mode [33].  
A comparison of global modelling (using the whole dataset for model 
production), modelling based on Tanimoto similarity (TS) clustering, and 
modelling based on a newly proposed retention time (tR) similarity 
clustering method applied to a HILIC dataset has shown that while 
Tanimoto clustering shows an improvement in error compared to the global 
model, retention time clustering is by far the most successful method [34]. 
However, retention time clustering is unable to be applied to a real-life 
situation because the retention time of the compound under investigation is 
not known and so far no method has been found to successfully utilise 
retention time clustering as part of a dual-filtering approach. 
In this study, a novel dual-filtering based QSRR modelling strategy has 
been applied successfully to a range of HILIC systems. The proposed dual-
filtering approach involves selecting structurally similar training neighbours 
to a target according to calculated Tanimoto pairwise values, followed by 
further filtering according to tR similarity found by utilising the correlation 
of molecular descriptors to retention time. The application of the proposed 
dual-filtering based QSRR modelling approach is illustrated by the 
prediction of retention time for various analytes on HILIC stationary phases, 
utilising a GA coupled with PLS for variable selection. By using this dual-
filtering approach, reliable and accurate GA-PLS models have been 
established over a wide range of HILIC datasets. The performance of the 
GA-PLS models derived from both diverse and global datasets, and TS-
based QSRR models, is also compared to dual-filtering based QSRR 
models. Finally, in order to obtain some insight into the HILIC mechanism, 
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the selected molecular descriptors in the proposed dual-filtering process 
have been investigated. 
5.2 Method 
5.2.1 Data set 
Five data sets composed of 98 analytes presented in Table 5.1 with 
experimental retention times over five HILIC stationary phases (bare silica, 
amine, amide, diol and zwitterionic) were used. The isocratic eluent 
contained 90:10 acetonitrile−formate buffer solution. Formate buffer 100 
mM was prepared with an adapted volume of ammonium formate and the 
pH adjusted to 3.0 with formic acid. Details of collected data are presented 
in Chapter 2.  
The retention times observed on each stationary phase are provided in 
Table 5.1. 
5.2.2 Model generation  
5.2.2.1 Similarity searching 
In the similarity searching procedure, the test analyte was matched 
against each compound of the database in turn, with the chosen similarity 
measure being used to compute the degree of resemblance in each case; the 
resulting set of similarity scores was then ranked in decreasing similarity 
order. Structural similarity searching was carried out using ChemAxon 
hashed fingerprint [35] descriptors and the Tanimoto similarity coefficient 
[31] with a threshold cutoff value of 0.5.  
In the case of tR similarity searching, the absolute value of the ratio of 
each training compound’s retention factor (k) with the k-value of the test 
analyte was utilised as the tR similarity measure with the threshold value of 
k-ratio < 1.5. This process was followed by construction of a predictive 
QSRR model on the filtered training set for each target compound. 
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5.2.2.2 Dual-filtering based QSRRs 
A dual-filtering strategy was applied using a combination of structural 
similarity searching and tR similarity searching. The scheme of the proposed 
method is depicted in Figure 5.1, which involves the adoption of four main 
steps: (A) Tanimoto similarity (TS) searching to filter compounds into 
classes having similar structures to the test compound (primary filter in 
Figure 5.1); (B) searching the nearest neighbour to the test analyte utilising 
a high correlated molecular descriptor to retention time ;(C) tR similarity 
searching using the nearest neighbour as a reference to classify top ranked 
structurally similar compounds into subclasses having similar retention time 
(tR) (secondary filter in Figure 5.1); (D) GA-PLS to predict the test 
compound’s retention time based on compound properties. The method of 
combining TS and tR similarity allows the identification of the most 
appropriate compound subclass modelling and the minimisation of the 
retention time prediction error. 
5.3 Results and discussion 
HILIC, unlike reversed-phase liquid chromatography (RPLC), has been 
successfully used to generate a large number of reproducible retention data 
of a wide range of hydrophilic compounds. In this work, such data were 
analysed using a dual-filtering based QSRR modelling approach to obtain 
local models describing the behaviour of 98 pharmaceutical compounds for 
various stationary phases. 
In this section, first the concept of structural similarity in QSRR 
modelling is discussed. The results for a wide range of HILIC systems agree 
with previous studies [30, 34] in that there is an improvement in the 
predictive power of TS-based QSRR modelling compared to global 
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Table 5.1. Experimentally obtained retention times on the five stationary phases. 
   
Retention times  
 
nr. Analyte Zwitterionic Amide Amine 
Bare 
silica Diol 
1 2'-Deoxyadenosine 5.06 4.73 4.96 2.57 3.52 
2 2'-Deoxycytidine 10.17 10.49 11.06 4.32 3.53 
3 2',3'-Dideoxyadenosine 4.00 3.98 3.85 2.34 3.77 
4 2'-Deoxyguanosine 10.58 8.93 11.91 3.82 3.26 
5 3'-Deoxyguanosine 9.74 8.70 11.14 3.54 3.15 
6 5'-Methyluridine 4.42 4.16 5.18 1.87 2.35 
7 Adenosine 5.96 5.46 6.18 2.69 3.20 
8 Cytidine 12.92 12.00 15.38 4.83 3.07 
9 Guanosine 13.59 10.91 16.29 4.22 3.33 
10 Inosine 8.91 6.91 10.89 3.31 2.78 
11 Thymidine 3.52 3.53 3.87 1.67 2.37 
12 Uridine 5.11 4.30 5.95 2.03 2.35 
13 Acyclovir 9.35 7.60 10.31 3.84 3.29 
14 2'-Deoxyuridine 3.97 3.73 4.35 1.80 2.36 
15 3'-Deoxythymidine 2.68 2.95 2.86 1.44 2.37 
16 2'-Deoxyinosine 7.10 5.95 8.14 3.05 2.92 
17 Adrenaline 19.23 7.75 10.82 6.73 4.89 
18 Noradrenaline 26.28 9.81 14.71 7.30 4.86 
19 3'-Methoxytyramine 10.30 5.98 6.17 4.86 5.46 
20 Isoproterenol 12.31 6.40 7.13 4.63 4.40 
21 Fenotrole 8.10 6.75 5.11 2.72 3.78 
22 Terbutaline 9.13 5.88 5.71 3.53 4.06 
23 Salbutamol 10.13 6.49 6.51 4.59 4.62 
24 Ritudrine 5.68 5.43 3.77 2.47 4.11 
25 Metaproterenol 10.96 6.41 6.63 4.10 4.23 
26 Synephrine 11.49 6.32 6.84 5.20 5.17 
27 Dopamine 15.78 7.64 9.23 5.62 5.05 
28 N-methylephrine 6.03 3.98 3.80 3.90 5.75 
29 Norphenylephrine 14.16 7.58 8.81 5.26 5.04 
30 Phenylephrine 11.07 6.06 6.73 4.92 5.06 
31 Tyramine 10.17 6.26 6.18 4.54 5.37 
32 Normetanephrine 14.54 7.55 8.79 5.85 5.22 
33 Octopamine 14.58 7.93 8.93 5.52 5.09 
34 Methoxamine 6.91 5.04 4.66 3.61 5.39 
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35 Isoxuprine 3.92 3.98 2.87 2.11 4.25 
36 Pentoxyfylline 2.16 2.37 2.19 1.32 2.60 
37 Guanine 9.90 9.73 10.41 3.64 3.84 
38 Xanthine 4.85 5.39 5.50 2.04 2.67 
39 Caffeine 2.31 2.50 2.35 1.39 2.65 
40 Theophylline 2.67 3.02 2.78 1.46 2.66 
41 Theobromine 2.85 3.11 2.93 1.60 2.65 
42 Diphylline 3.48 3.50 3.75 1.87 2.67 
43 7-Hydroxyethyltheophylline 2.75 2.92 2.84 1.54 2.63 
44 1-Methyluric acid 6.46 7.36 8.38 2.37 2.62 
45 1-Methylguanine 5.98 6.18 6.15 2.86 3.70 
46 9-Methylguanine 6.96 6.57 7.22 3.10 3.64 
47 Uric acid 13.10 13.83 18.40 3.83 2.75 
48 3,7-Dimethyluric acid 4.86 5.21 5.61 2.18 2.65 
49 7-Methylxanthine 3.67 4.03 3.96 1.84 2.67 
50 Hypoxanthine 5.98 5.52 6.56 2.67 3.24 
51 Proxyphylline 2.52 2.75 2.61 1.45 2.58 
52 1,7-Dimethyluric acid 4.56 5.27 5.67 1.99 2.62 
53 1,3-Dimethyluric acid 4.13 4.72 4.75 1.92 2.60 
54 1,3,7-Trimethyluric acid 3.10 2.81 3.20 1.90 2.99 
55 Salicylic acid 2.96 3.70 4.75 1.34 2.28 
56 5-Methylsalicylic acid 2.80 3.58 4.32 1.31 2.33 
57 4-Hydroxybenzoic acid 2.59 2.75 2.83 1.24 2.22 
58 3-Hydroxybenzoic acid 3.26 3.09 3.85 1.40 2.26 
59 2,3-Dihydroxybenzoic acid 4.20 4.71 7.72 1.55 2.24 
60 2,4-Dihydroxybenzoic acid 4.29 4.60 6.30 1.54 2.27 
61 2,5-Dihydroxybenzoic acid 4.34 4.77 7.44 1.56 2.17 
62 3,4-Dihydroxybenzoic acid 3.73 3.23 4.35 1.44 2.21 
63 3,5-Dihydroxybenzoic acid 4.77 3.78 5.61 1.60 2.22 
64 Benzoic acid 2.55 2.68 2.90 1.30 2.32 
65 3-Amino-4-hydroxybenzoic acid 3.15 3.04 3.54 1.46 2.22 
66 4-Aminobenzoic acid 2.32 2.47 2.42 1.53 2.21 
67 4-Aminosalicylic acid 4.01 3.59 4.67 1.19 2.26 
68 3-Aminobenzoic acid 3.24 2.82 3.54 1.37 2.28 
69 Vanillic acid 2.70 2.76 2.95 1.29 2.25 
70 Syringic acid 3.01 2.89 3.32 1.40 2.27 
71 2-Methoxybenzoic acid 2.65 2.69 3.31 1.37 2.28 
72 P-Toluic acid 2.26 2.39 2.48 1.21 2.33 
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73 
4-Nitrophenyl-B-D-
glycopyranoside 3.37 3.48 4.02 1.50 2.27 
74 Tyrosine 36.55 24.42 45.31 13.03 6.78 
75 Satolol 7.17 4.76 4.59 3.77 4.32 
76 Atenolol 13.21 7.45 7.67 7.35 5.79 
77 Vadarabine 7.25 6.34 7.34 3.00 3.25 
78 Tryptophan 23.25 19.08 25.78 8.91 7.07 
79 BTMA 6.85 3.64 3.59 5.70 7.23 
80 PTMA 8.05 3.92 4.01 6.83 7.44 
81 Labetalol 10.60 4.77 3.44 1.91 4.43 
82 Nadolol 11.12 7.17 7.26 5.75 5.48 
83 Propranolol 4.53 3.93 3.19 2.58 5.20 
84 Adenine 5.58 5.32 5.24 2.80 4.75 
85 Uracil 3.26 3.27 3.49 1.57 2.39 
86 Thymine 2.93 3.18 3.14 1.46 2.40 
87 Cytosine 9.19 10.91 9.55 4.19 4.30 
88 Pindolol 5.47 4.21 3.46 2.80 4.66 
89 Alprenolol 4.14 3.54 3.12 2.46 4.83 
90 Nicotinic acid 12.65 8.72 19.61 5.66 4.27 
91 4-Hydroxybenzenesulfonic acid 4.85 5.85 9.99 1.55 1.87 
92 4-Aminophenylacetic acid 3.29 2.83 3.85 1.58 2.27 
93 P-Toluenesulfonic acid 2.97 3.97 5.56 1.29 1.87 
94 Tropic acid 3.64 3.25 4.88 1.70 2.34 
95 2-Phenylethylamine 7.14 4.88 4.59 3.84 5.86 
96 Phenylalanine 21.58 16.39 27.46 10.04 7.36 
97 Mandelic acid 6.00 5.64 11.72 2.43 2.68 
98 5-Sulfosalicylic acid 19.50 19.06 104.06 3.80 2.08 
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Figure 5.1. Scheme of dual-filtering based QSRR strategy in this study. 1Tanimoto 
similarity, 2retention factor, 3molecular descriptor, and 4retention time.
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modelling, however the improvement is not sufficient to enable detailed 
selection of the optimal stationary and mobile phase conditions. This may 
be due to the lack of sufficient very similar compounds in the initial 
database [34]. Second, the role of tR similarity filtering in QSRR modelling 
is studied, leading to excellent prediction accuracy in agreement with 
previous results [34]. However, retention factor filtering (referred to herein 
as k-ratio filtering) is not applicable practically as the retention time for any 
new compound is unknown, thus an alternative filtering tool is required 
which enables the identification of training set compounds having similar 
retention times to the retention time of the target. To overcome this 
drawback, a two-stage filtering approach is applied which combines the 
concept of structural similarity and retention time similarity into QSRR 
methodology and uses correlation to a molecular descriptor to search the 
nearest neighbour, which was used further as a reference in the secondary 
filtering process (Figure 5.1). The proposed QSRR model significantly 
improves the retention time predictability compared with diverse, global, 
and TS-based QSRR models. The dual-filtering based QSRR modelling is 
discussed in detail in Section 5.3.3. Finally, the dual-filtering strategy is 
investigated to provide some insight into the separation mechanisms 
operating in HILIC mode. 
5.3.1 Tanimoto similarity (TS) searching into QSRR modelling 
The Tanimoto coefficient as a measure of molecular similarity [36] was 
used to carry out Tanimoto Similarity (TS) searching. For a given test 
molecule, a subset of molecules with the Tanimoto coefficients greater than 
a preselected threshold was found from a search of the full database. In 
order to show the internal similarity of the obtained subsets with the 
Tanimoto threshold of 0.5, the distribution of the range of Tanimoto 
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pairwise values of each test analyte with all other compounds in the local 
training set is shown in Figure 5.2A. 
A local GA-PLS model based on molecular descriptors computed using 
Density Functional Theory was developed for each of the test analytes using 
a filtered training set and the local model was compared to the global model 
given by whole dataset. Statistics for the retention time predictions of 
analytes using both local and global modelling are presented in Table 5.2 
and Table 5.3 and show a total decrease of mean RMSECV (equation 2.6) 
from 2.61 to 0.60, a total increase of Q2 (equation 2.7) from 0.54 to 0.89 and 
a total decrease of average RMSEP (equation 2.4) of more than 19% from 
global to local modelling over all HILIC stationary phases. The obtained 
results indicate that the local QSRR models greatly outperform the global 
models. To be able to best investigate the impact of structural similarity on 
QSRR prediction accuracy, the local models were also compared to diverse 
models given by a training set consisting of 26 dissimilar compounds with 
an average Tanimoto value of 0.2 (Figure 5.2B), and the corresponding 
RMSEP values of the obtained QSRR models are presented in Table 5.4, 
confirming again the positive effect of structural similarity on QSRR 
accuracy. The predicted retention times of test compounds applying TS-
based, global and diverse QSRR modelling are presented in the Tables 5.5-
5.7. 
In addition, average similarity can be used as an indicator of the 
prediction confidence. Figure 5.3 shows a plot of mean absolute error of 
prediction (MAE prediction, equation 2.3) versus the average similarity 
value of the training set for all test compounds in the similar, global and 
diverse training sets over all studied chromatographic conditions. The 
higher the average similarity value in the training set, the more likely a 
suitable model with higher predictive ability will be obtained, in agreement  
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Figure 5.2. Distribution of the range of similarity for A. Tanimoto similarity based 
subsets, and B. diverse subsets with most similar values (royal blue lines), and least 
similar values (red line) in the dataset. 
 
 Table 5.2. Global and TS-based QSRR models performance summary 
 RMSEP (%)  
System Global model TS-based model 
Zwitterionic 68.46 32.22 
Amide 41.95 28.37 
Amine 56.17 52.04 
Bare silica 49.07 18.27 
Diol 17.10 4.60 
Average 
value 
46.55 27.10 
Method abbreviations explained in the text. 
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Table 5.3. Predictive performance of TS-based and global QSRRs 
 TS-based QSRR 
models with 
global QSRR models 
with 
System Q2CV RMSECV Q2CV RMSECV 
Zwitterionic 0.88 1.02 0.46 4.18 
Amide 0.91 0.61 0.50 2.48 
Amine 0.87 1.07 0.53 4.15 
Bare silica 0.84 0.22 0.48 1.52 
Diol 0.93 0.06 0.75 0.70 
 
 Table 5.4. Diverse QSRR models performance summary 
System RMSEP (%) Q2CV RMSECV (min) 
Zwitterionic 83.63 0.45 3.21 
Amide 120.52 0.82 1.98 
Amine 67.19 0.45 2.62 
Bare silica 54.45 0.48 1.01 
Diol 20.6 0.82 0.41 
Method abbreviations explained in the text 
 
Table 5.5. Median predicted retention times using the TS-based QSRR modelling 
strategy. 
   Retention times   
nr.  Analytes Zwitterio
nic 
Amide Amine Bare silica Diol 
 Nucleosides      
1 2'-Deoxyadenosine 6.78 6.06 7.34 2.93 3.47 
2 2'-Deoxycytidine 6.75 6.27 7.11 3.27 2.89 
3 2',3'-Dideoxyadenosine 3.66 3.32 4.54 2.49 3.62 
4 2'-Deoxyguanosine 10.32 9.13 11.26 3.90 3.44 
5 3'-Deoxyguanosine 10.22 7.72 11.51 3.27 3.17 
6 5'-Methyluridine 5.88 5.98 7.17 2.02 2.37 
7 Adenosine 9.35 8.99 11.86 3.59 3.49 
8 Cytidine 6.18 5.82 6.54 2.97 3.17 
9 Guanosine 9.89 8.52 11.86 3.54 2.99 
10 Inosine 8.47 7.11 10.22 3.41 2.98 
11 Thymidine 3.62 3.60 3.25 1.67 2.50 
12 Uridine 9.36 8.54 11.61 2.93 2.34 
13 Acyclovir 12.70 11.24 12.62 4.78 3.52 
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14 2'-Deoxyuridine 5.62 5.38 7.88 2.05 2.65 
15 3'-Deoxythymidine 0.04 0.91 -0.50 0.89 2.29 
16 2'-Deoxyinosine 7.74 6.00 8.06 3.19 2.69 
 β-Adrenergic Agonists     
17 Adrenaline 17.05 7.71 9.82 6.01 4.88 
18 Noradrenaline 20.58 9.21 12.05 6.57 4.84 
19 3'-Methoxytyramine 8.05 5.89 5.30 4.79 5.52 
20 Isoproterenol 15.18 6.83 8.66 5.27 4.58 
21 Fenotrole 11.03 6.36 6.92 3.28 3.79 
22 Terbutaline 12.04 6.71 7.27 4.35 4.15 
23 Salbutamol 7.21 5.29 4.20 3.22 4.31 
24 Ritudrine 3.27 6.14 3.02 2.63 4.23 
25 Metaproterenol 11.37 6.47 6.87 4.34 4.29 
26 Synephrine 11.88 6.34 7.25 5.19 5.18 
27 Dopamine 18.04 7.63 9.99 5.88 5.03 
28 N-methylephrine 4.31 3.97 3.41 4.00 5.37 
29 Norphenylephrine 16.28 7.98 9.51 5.60 5.02 
30 Phenylephrine 10.93 6.19 6.70 4.95 5.10 
31 Tyramine 8.54 6.24 5.40 3.82 5.28 
32 Normetanephrine 16.58 7.49 9.61 5.96 5.13 
33 Octopamine 16.16 8.05 10.11 6.07 5.19 
34 Methoxamine 8.27 6.13 5.77 4.42 5.31 
35 Isoxuprine 1.44 4.78 1.98 1.90 4.35 
 Xanthines and Uric Acids     
36 Pentoxyfylline 3.43 4.08 8.71 1.80 2.54 
37 Guanine 7.04 7.25 7.48 2.64 3.73 
38 Xanthine 9.78 10.07 12.23 3.27 2.80 
39 Caffeine 0.78 1.27 0.07 0.93 2.53 
40 Theophylline 2.62 2.97 2.68 1.62 2.66 
41 Theobromine 2.72 2.87 2.57 1.54 2.60 
42 Diphylline 5.02 4.76 5.48 2.30 2.76 
43 7-
Hydroxyethyltheophylli
ne 
3.45 3.66 3.66 1.58 2.58 
44 1-Methyluric acid 7.48 7.87 9.52 2.49 2.71 
45 1-Methylguanine 5.28 5.24 4.95 2.60 3.48 
46 9-Methylguanine 7.45 6.87 8.75 3.53 3.68 
47 Uric acid 6.18 7.26 7.66 2.52 2.56 
48 3,7-Dimethyluric acid 5.87 6.67 8.32 2.13 2.60 
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49 7-Methylxanthine 5.59 5.79 6.75 2.19 2.71 
50 Hypoxanthine 3.46 3.35 2.89 2.10 3.37 
51 Proxyphylline 2.34 2.81 2.36 1.47 2.66 
52 1,7-Dimethyluric acid 4.59 5.48 6.09 2.21 2.64 
53 1,3-Dimethyluric acid 4.89 5.45 5.97 1.96 2.58 
54 1,3,7-Trimethyluric acid 2.53 3.04 1.77 1.43 2.56 
 Benzoic acids      
55 Salicylic acid 3.19 3.84 5.01 1.24 2.31 
56 5-Methylsalicylic acid 2.93 3.45 4.48 1.38 2.30 
57 4-Hydroxybenzoic acid 2.66 2.75 2.90 1.34 2.24 
58 3-Hydroxybenzoic acid 3.54 3.08 4.19 1.43 2.22 
59 2,3-Dihydroxybenzoic 
acid 
4.17 4.73 7.24 1.54 2.22 
60 2,4-Dihydroxybenzoic 
acid 
4.01 4.00 6.11 1.37 2.21 
61 2,5-Dihydroxybenzoic 
acid 
4.17 4.59 7.55 1.60 2.24 
62 3,4-Dihydroxybenzoic 
acid 
3.52 3.33 4.17 1.46 2.19 
63 3,5-Dihydroxybenzoic 
acid 
4.42 3.73 5.31 1.40 2.23 
64 Benzoic acid 2.21 2.45 2.71 1.36 2.27 
65 3-Amino-4-
hydroxybenzoic acid 
3.58 3.09 4.14 1.29 2.24 
66 4-Aminobenzoic acid 2.56 2.67 2.50 1.23 2.27 
67 4-Aminosalicylic acid 3.50 3.38 4.16 1.54 2.23 
68 3-Aminobenzoic acid 2.70 2.73 3.11 1.38 2.29 
69 Vanillic acid 3.03 2.64 3.05 1.41 2.25 
70 Syringic acid 2.85 2.92 3.82 1.46 2.25 
71 2-Methoxybenzoic acid 2.83 2.83 3.03 1.29 2.32 
72 P-Toluic acid 2.36 2.55 2.77 1.37 2.28 
 
Table 5.6. Median predicted retention times using the global QSRR modelling 
strategy. 
   Retention times in  
nr.  Analytes Zwitterio
nic 
Amide Amine Bare 
silica 
Diol 
 Nucleosides      
1 2'-Deoxyadenosine 6.66 6.63 7.76 3.86 4.02 
Chapter	 5	 	 	 	 	 Use	 of	 dual-filtering	 to	 create	 training	 sets	 leading	 to	 improved	
accuracy	in	quantitative	structure-retention	relationship	modelling	for	hydrophilic	
interaction	liquid	chromatographic	systems	
 188 
2 2'-Deoxycytidine 8.24 7.44 9.02 3.80 3.34 
3 2',3'-Dideoxyadenosine 8.67 6.73 7.99 4.41 4.54 
4 2'-Deoxyguanosine 8.47 7.29 7.23 2.72 2.91 
5 3'-Deoxyguanosine 7.11 6.43 7.32 2.79 2.99 
6 5'-Methyluridine 9.05 5.70 7.42 3.10 2.50 
7 Adenosine 10.73 6.74 7.83 3.86 3.74 
8 Cytidine 7.72 5.79 7.00 3.04 2.89 
9 Guanosine 11.24 8.28 11.09 3.07 2.79 
10 Inosine 8.44 6.59 7.71 2.84 2.82 
11 Thymidine 4.26 4.21 4.35 2.93 2.56 
12 Uridine 10.69 7.03 10.55 3.56 2.41 
13 Acyclovir 10.15 8.30 12.19 3.68 3.62 
14 2'-Deoxyuridine 5.56 5.04 7.05 2.46 2.57 
15 3'-Deoxythymidine 3.58 4.18 5.16 2.66 2.86 
16 2'-Deoxyinosine 4.99 4.88 6.08 2.45 2.80 
 β-Adrenergic Agonists     
17 Adrenaline 15.90 8.54 10.73 5.93 5.02 
18 Noradrenaline 17.08 9.30 12.58 6.17 4.88 
19 3'-Methoxytyramine 11.72 5.59 6.83 4.84 5.18 
20 Isoproterenol 13.56 7.55 9.66 4.96 4.74 
21 Fenotrole 10.14 6.43 6.09 2.43 4.45 
22 Terbutaline 12.04 7.16 6.23 5.04 5.06 
23 Salbutamol 8.92 5.16 4.16 4.04 4.71 
24 Ritudrine 10.07 5.86 5.39 3.93 4.65 
25 Metaproterenol 10.85 6.73 6.67 4.58 4.70 
26 Synephrine 14.40 8.23 10.78 6.35 5.48 
27 Dopamine 14.86 7.13 9.14 5.04 4.96 
28 N-methylephrine 9.47 5.74 6.81 5.34 5.63 
29 Norphenylephrine 12.74 6.82 8.90 4.74 4.99 
30 Phenylephrine 12.22 6.35 8.02 5.40 5.20 
31 Tyramine 12.11 6.76 7.03 4.53 5.48 
32 Normetanephrine 14.01 6.90 8.20 4.97 4.87 
33 Octopamine 14.67 7.86 9.58 5.47 5.19 
34 Methoxamine 8.54 3.65 2.24 3.35 4.62 
35 Isoxuprine 5.53 3.93 1.23 2.02 4.61 
 Xanthines and Uric Acids     
36 Pentoxyfylline 4.89 5.66 8.86 3.43 3.92 
37 Guanine 8.38 6.86 8.70 3.28 3.70 
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38 Xanthine 9.55 8.46 11.70 3.57 3.04 
39 Caffeine 0.51 0.33 -0.48 1.01 2.86 
40 Theophylline 3.82 2.88 3.33 2.39 3.18 
41 Theobromine 1.99 2.74 2.44 1.75 2.83 
42 Diphylline 5.78 4.36 5.32 2.55 2.45 
43 7-
Hydroxyethyltheophylline 
2.18 2.70 2.08 2.17 2.79 
44 1-Methyluric acid 7.55 8.04 9.60 2.88 2.67 
45 1-Methylguanine 7.29 6.15 5.86 3.09 3.77 
46 9-Methylguanine 9.06 8.48 10.63 3.96 4.19 
47 Uric acid 7.95 8.12 9.53 2.95 2.87 
48 3,7-Dimethyluric acid 4.30 4.90 5.94 1.51 2.58 
49 7-Methylxanthine 5.25 6.09 6.04 2.18 2.86 
50 Hypoxanthine 6.18 5.45 7.67 2.50 3.30 
51 Proxyphylline 2.93 2.88 3.04 2.36 2.83 
52 1,7-Dimethyluric acid 5.73 5.63 6.16 2.17 2.78 
53 1,3-Dimethyluric acid 4.41 4.83 6.55 1.96 2.53 
54 1,3,7-Trimethyluric acid 2.37 3.48 2.84 1.28 2.70 
 Benzoic acids      
55 Salicylic acid 3.69 4.94 8.87 0.72 2.26 
56 5-Methylsalicylic acid 4.47 4.39 7.48 1.50 2.13 
57 4-Hydroxybenzoic acid 3.29 3.08 4.26 1.17 1.68 
58 3-Hydroxybenzoic acid 1.52 1.74 1.41 1.04 1.61 
59 2,3-Dihydroxybenzoic 
acid 
5.20 4.71 8.24 1.63 2.22 
60 2,4-Dihydroxybenzoic 
acid 
3.01 3.00 3.00 0.42 1.57 
61 2,5-Dihydroxybenzoic 
acid 
4.09 4.85 7.18 1.09 2.01 
62 3,4-Dihydroxybenzoic 
acid 
4.91 3.26 4.47 1.48 1.32 
63 3,5-Dihydroxybenzoic 
acid 
0.83 2.29 1.88 -0.30 1.19 
64 Benzoic acid 1.86 2.03 2.89 1.45 2.59 
65 3-Amino-4-
hydroxybenzoic acid 
13.39 7.54 10.39 3.95 3.27 
66 4-Aminobenzoic acid 3.59 2.97 3.50 1.56 2.80 
67 4-Aminosalicylic acid 3.36 3.13 2.91 1.06 2.20 
68 3-Aminobenzoic acid 9.76 5.92 7.82 3.59 3.58 
69 Vanillic acid 3.88 3.44 5.27 1.64 2.26 
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70 Syringic acid -0.05 0.59 -0.51 -0.48 1.85 
71 2-Methoxybenzoic acid -2.81 -0.44 -1.97 -0.52 2.07 
72 P-Toluic acid 1.47 2.08 3.06 1.50 2.72 
 
Table 5.7. Median predicted retention times using the diverse QSRR models. 
   Retention times in  
nr.  Analytes Zwitterio
nic 
Amide Amine Bare 
silica 
Diol 
 Nucleosides      
1 2'-Deoxyadenosine 8.56 6.77 4.80 2.96 3.37 
2 2'-Deoxycytidine 5.49 8.29 6.25 1.51 2.73 
3 2',3'-Dideoxyadenosine 8.38 11.11 5.52 2.94 3.96 
4 2'-Deoxyguanosine 6.29 8.34 5.08 2.48 2.92 
5 3'-Deoxyguanosine 2.30 6.04 4.86 1.93 2.76 
6 5'-Methyluridine 10.01 7.24 5.81 2.01 2.55 
7 Adenosine 5.23 6.75 6.47 3.00 3.19 
8 Cytidine 6.82 7.08 7.29 1.58 2.57 
9 Guanosine 5.63 6.57 6.64 2.59 2.46 
10 Inosine 5.17 6.82 6.12 1.46 2.44 
11 Thymidine 6.73 8.21 4.46 1.10 2.46 
12 Uridine 7.28 5.06 6.46 1.64 1.97 
13 Acyclovir 6.59 10.13 6.86 2.41 2.97 
14 2'-Deoxyuridine 4.66 10.04 5.60 1.57 2.11 
15 3'-Deoxythymidine 5.87 8.62 4.97 2.04 2.65 
16 2'-Deoxyinosine 5.77 10.15 5.68 2.28 2.82 
 β-Adrenergic Agonists     
17 Adrenaline 6.44 4.65 8.00 3.61 3.91 
18 Noradrenaline 5.68 4.73 8.06 3.61 3.74 
19 3'-Methoxytyramine 8.71 4.50 5.55 3.93 4.05 
20 Isoproterenol 8.10 4.81 8.12 4.14 4.31 
21 Fenotrole 9.34 5.83 4.66 2.91 4.17 
22 Terbutaline 10.10 5.62 6.24 6.03 4.85 
23 Salbutamol 8.17 5.35 5.57 5.72 4.00 
24 Ritudrine 11.23 5.55 5.02 4.00 4.74 
25 Metaproterenol 8.15 5.05 5.66 4.89 4.65 
26 Synephrine 5.54 4.77 5.84 3.50 4.61 
27 Dopamine 6.86 4.91 7.84 3.67 4.32 
28 N-methylephrine 5.84 3.72 4.13 4.38 4.28 
Chapter	 5	 	 	 	 	 Use	 of	 dual-filtering	 to	 create	 training	 sets	 leading	 to	 improved	
accuracy	in	quantitative	structure-retention	relationship	modelling	for	hydrophilic	
interaction	liquid	chromatographic	systems	
 191 
29 Norphenylephrine 5.15 4.70 7.28 3.61 4.14 
30 Phenylephrine 4.56 4.36 6.46 3.77 4.10 
31 Tyramine 6.64 4.66 5.06 3.91 5.06 
32 Normetanephrine 5.79 4.92 6.16 3.93 3.54 
33 Octopamine 4.44 4.59 6.19 3.28 3.82 
34 Methoxamine 6.01 3.83 3.59 4.89 4.07 
35 Isoxuprine 7.64 3.31 1.81 3.43 4.62 
 Xanthines and Uric Acids     
36 Pentoxyfylline 7.58 12.65 4.02 2.97 3.70 
37 Guanine 4.69 6.16 8.43 2.52 2.64 
38 Xanthine 4.03 5.13 7.09 3.08 3.08 
39 Caffeine 7.33 9.62 4.97 3.16 3.38 
40 Theophylline 8.18 10.22 6.16 3.90 3.58 
41 Theobromine 5.47 8.72 5.61 2.17 3.04 
42 Diphylline 8.00 6.26 5.70 2.68 3.16 
43 7-
Hydroxyethyltheophylline 
8.79 9.28 5.01 3.21 3.35 
44 1-Methyluric acid 5.15 11.74 6.94 2.29 2.14 
45 1-Methylguanine 3.20 9.87 7.03 2.23 3.02 
46 9-Methylguanine 7.73 12.82 7.79 2.87 3.52 
47 Uric acid 7.02 10.08 8.45 2.91 2.83 
48 3,7-Dimethyluric acid 1.08 10.33 5.33 2.47 2.92 
49 7-Methylxanthine 3.99 10.15 6.69 2.38 3.01 
50 Hypoxanthine 6.75 8.25 9.28 3.91 4.23 
51 Proxyphylline 8.34 11.04 3.98 2.43 3.25 
52 1,7-Dimethyluric acid 1.86 8.21 6.21 2.53 2.99 
53 1,3-Dimethyluric acid 8.92 8.34 5.54 3.02 3.24 
54 1,3,7-Trimethyluric acid 7.24 10.43 4.83 2.42 3.23 
 Benzoic acids      
55 Salicylic acid 3.18 6.02 6.92 1.54 2.53 
56 5-Methylsalicylic acid 3.59 6.00 7.08 1.62 2.43 
57 4-Hydroxybenzoic acid 4.57 5.91 8.99 1.96 2.51 
58 3-Hydroxybenzoic acid 4.73 6.37 6.04 2.04 2.55 
59 2,3-Dihydroxybenzoic 
acid 
3.50 5.78 7.19 1.84 2.74 
60 2,4-Dihydroxybenzoic 
acid 
4.23 6.86 5.50 1.95 2.71 
61 2,5-Dihydroxybenzoic 
acid 
3.38 6.99 4.59 1.82 2.47 
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62 3,4-Dihydroxybenzoic 
acid 
4.80 5.92 9.00 2.04 2.56 
63 3,5-Dihydroxybenzoic 
acid 
4.90 3.23 6.32 1.94 2.28 
64 Benzoic acid 4.54 6.98 6.66 2.03 2.71 
65 3-Amino-4-
hydroxybenzoic acid 
4.21 9.96 4.99 2.01 2.28 
66 4-Aminobenzoic acid 4.60 6.58 6.13 1.90 2.34 
67 4-Aminosalicylic acid 4.08 3.41 5.00 1.91 2.26 
68 3-Aminobenzoic acid 4.50 6.84 5.44 1.90 2.43 
69 Vanillic acid 4.06 5.12 5.26 2.01 2.63 
70 Syringic acid 3.40 6.18 3.03 2.13 2.59 
71 2-Methoxybenzoic acid 3.96 5.10 3.51 1.97 2.63 
72 P-Toluic acid 4.49 8.15 1.61 1.94 2.83 
 
 
 
Figure 5.3. MAEP (%) vs. average similarity of compounds in the training set to 
each test analyte applying global, diverse and TS-based QSRR models over all 
HILIC systems. A total of 1077 data points included on the graph.
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with previous work [34]. This is seen from the fact that the spread of MAE 
values decreases as average similarity increases. At an average similarity > 
0.5, the MAEP values are lower and less variable than when the average 
similarity was < 0.4. 
Although these results show lower RMSEP values (Table 5.2) for test 
analytes applying a TS-based QSRR modelling strategy compared with 
traditional QSRR models without compound filtering, the prediction 
accuracy achieved is generally insufficient to support detailed HILIC 
method development.  
5.3.2 Incorporation of retention time (tR) similarity searching into QSRR 
modelling 
The federation of local models strategy (which involves scanning a 
database to find those molecules that are most structurally similar to the test 
analyte and generating a local model for each test compound based on its 
top ranked similar molecules) has been evaluated previously using retention 
time (tR) similarity searching in the generation of QSRR models using a 
single HILIC stationary phase [34]. This approach was extended in the 
present study for a wider range of HILIC systems. The retention factor ratio 
(k-ratio) was used as a measure of retention time similarity with the 
threshold cut-off value set at 1.5. The aim of tR similarity-based QSRR 
modelling was to obtain predictions with the highest achievable accuracies 
by establishing a training set having the closest possible chromatographic 
similarity (as reflected by retention factor) to the test compound. The 
predicted retention time of test analytes and a summary of the model 
validation are shown in Tables 5.8 and 5.9, respectively. The correlation of 
the local QSRR models obtained based on the top ranked k-ratio similarity 
compounds is presented in Figure 5.4 with an average RMSEP value of 
5.46% being obtained over all compounds and all HILIC systems, which 
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indicates that the predicted retention values are generally in good agreement 
with the experimental data. However, while the tR similarity-based QSRR 
modelling strategy is successful, it cannot be applied in practice for 
unknown analytes with unknown retention data. To overcome this 
drawback, a two-stage filtering approach that combines both Tanimoto 
similarity and tR similarity searching tools was applied. 
5.3.3 Dual-filtering based QSRR modelling 
The proposed dual-filtering strategy involves TS searching, followed by 
tR similarity searching using the nearest neighbour in the training set, instead 
of the test analyte itself. The nearest neighbour was selected based on 
correlations between molecular descriptors and retention time (Figure 5.1). 
The rationale was to first find the most structurally similar subset for the test 
analyte based on TS as the primary filter and to then identify the subset of 
compounds having similar retention times and to remove any compound 
having a retention time significantly different from the test analyte. 
In a foundational work from this group [34], two strategies to employ tR 
similarity as a secondary filter were explored. In the first approach, the k-
ratio was calculated using the most structurally similar compound in the 
training set, instead of the test analyte itself. In the second approach, tR-
outliers were removed from the top ranked structurally similar compounds. 
These dual filters resulted in a failure to capture compounds having similar 
retention values to the target in the final filtered training set and therefore 
failed to significantly improve retention time prediction. 
In the present study, to be able to employ tR similarity as the secondary 
filter, the correlation between molecular descriptors and the retention times 
of the top ranked similar compounds for each test analyte was established
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Table 5.8. Median predicted retention times using tR-similarity-based QSRR 
models. 
   Retention times in  
nr.  Analytes Zwitterio
nic 
Amide Amine Bare 
silica 
Diol 
 Nucleosides      
1 2'-Deoxyadenosine 4.86 5.15 2.63 3.63 5.44 
2 2'-Deoxycytidine 10.71 10.73 4.55 3.38 9.94 
3 2',3'-Dideoxyadenosine 4.02 3.75 2.61 3.60 4.04 
4 2'-Deoxyguanosine 10.92 -a 3.76 3.47 10.53 
5 3'-Deoxyguanosine 8.65 11.25 3.32 3.24 10.32 
6 5'-Methyluridine 4.24 5.15 1.96 2.36 4.17 
7 Adenosine 5.37 5.98 2.59 3.12 5.28 
8 Cytidine 11.10 11.36 4.63 3.12 14.08 
9 Guanosine 10.12 11.80 4.38 3.10 12.80 
10 Inosine 6.73 11.30 3.27 2.93 10.01 
11 Thymidine 3.59 3.87 1.80 2.37 3.42 
12 Uridine 4.17 5.85 1.90 2.36 4.66 
13 Acyclovir 7.05 10.89 3.83 3.40 9.74 
14 2'-Deoxyuridine 3.55 4.45 1.77 2.36 3.94 
15 3'-Deoxythymidine 2.89 3.07 1.49 2.38 2.76 
16 2'-Deoxyinosine 6.13 7.50 3.14 3.08 6.91 
 β-Adrenergic Agonists 
    17 Adrenaline 7.57 10.83 6.61 4.89 18.55 
18 Noradrenaline 8.60 15.54 6.03 4.97 21.50 
19 3'-Methoxytyramine 6.25 6.55 4.54 5.38 10.29 
20 Isoproterenol 6.40 6.80 4.83 4.36 10.90 
21 Fenotrole 6.41 5.12 2.77 4.07 7.31 
22 Terbutaline 6.30 5.94 3.40 4.27 10.41 
23 Salbutamol 6.33 6.38 4.22 4.40 10.80 
24 Ritudrine 5.32 3.70 2.72 4.01 5.57 
25 Metaproterenol 6.50 6.75 4.03 4.19 10.66 
26 Synephrine 6.05 6.69 5.26 5.14 11.37 
27 Dopamine 7.85 10.04 5.34 5.03 15.65 
28 N-methylephrine 4.04 3.94 3.99 5.70 6.10 
29 Norphenylephrine 7.72 8.76 5.31 5.02 14.99 
30 Phenylephrine 6.24 6.91 5.00 5.11 10.88 
31 Tyramine 6.01 5.96 5.01 5.08 11.27 
Chapter	 5	 	 	 	 	 Use	 of	 dual-filtering	 to	 create	 training	 sets	 leading	 to	 improved	
accuracy	in	quantitative	structure-retention	relationship	modelling	for	hydrophilic	
interaction	liquid	chromatographic	systems	
 196 
32 Normetanephrine 7.71 8.45 5.77 5.10 14.28 
33 Octopamine 7.87 9.04 5.56 5.15 14.93 
34 Methoxamine 4.79 4.61 3.67 5.28 6.83 
35 Isoxuprine 4.01 3.02 1.78 4.64 4.21 
 Xanthines and Uric Acids 
    36 Pentoxyfylline -a -a 1.40 2.58 -a 
37 Guanine 9.41 11.03 3.90 3.66 9.35 
38 Xanthine 5.44 5.54 2.17 2.67 4.95 
39 Caffeine 2.90 -a 1.45 2.64 2.54 
40 Theophylline 3.07 2.96 1.39 2.64 2.84 
41 Theobromine 3.05 2.90 1.55 2.67 2.79 
42 Diphylline 3.51 3.84 1.94 2.61 3.54 
43 7-
Hydroxyethyltheophylline 3.02 2.63 1.58 2.65 2.62 
44 1-Methyluric acid 7.71 8.87 2.22 2.61 6.43 
45 1-Methylguanine 5.74 6.24 2.93 3.74 6.26 
46 9-Methylguanine 6.07 7.15 3.10 3.70 5.61 
47 Uric acid 12.02 17.04 3.70 2.67 13.30 
48 3,7-Dimethyluric acid 5.29 5.83 2.02 2.62 4.51 
49 7-Methylxanthine 4.14 3.96 1.85 2.62 4.09 
50 Hypoxanthine 5.37 6.02 2.84 3.64 5.68 
51 Proxyphylline 2.89 2.90 1.43 2.61 2.75 
52 1,7-Dimethyluric acid 5.17 5.68 1.89 2.63 4.82 
53 1,3-Dimethyluric acid 5.17 4.81 1.89 2.63 4.18 
54 1,3,7-Trimethyluric acid 2.86 3.16 1.92 3.48 2.69 
 Benzoic acids 
     55 Salicylic acid 3.72 4.81 1.31 2.26 2.94 
56 5-Methylsalicylic acid 3.62 4.16 1.39 2.33 2.78 
57 4-Hydroxybenzoic acid 2.75 2.88 1.27 -a 2.67 
58 3-Hydroxybenzoic acid 3.26 3.98 1.41 2.27 3.28 
59 2,3-Dihydroxybenzoic 
acid 4.72 7.39 1.55 -a 4.40 
60 2,4-Dihydroxybenzoic 
acid 4.77 6.52 1.58 2.26 4.06 
61 2,5-Dihydroxybenzoic 
acid 4.88 7.80 1.58 -a 4.30 
62 3,4-Dihydroxybenzoic 
acid 3.12 4.47 1.40 -a 3.69 
63 3,5-Dihydroxybenzoic 
acid 3.68 5.91 1.56 -a 4.13 
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64 Benzoic acid 2.67 2.91 1.35 2.34 2.59 
65 3-Amino-4-
hydroxybenzoic acid 3.16 3.46 1.48 -a 3.11 
66 4-Aminobenzoic acid 2.74 -a 1.53 -a 2.58 
67 4-Aminosalicylic acid 3.69 4.53 -a 2.26 3.88 
68 3-Aminobenzoic acid 2.74 3.58 1.37 2.27 3.25 
69 Vanillic acid 2.78 2.86 1.34 -a 2.63 
70 Syringic acid 2.67 3.27 1.41 2.28 3.12 
71 2-Methoxybenzoic acid 2.69 3.31 1.38 2.28 2.67 
72 P-Toluic acid -a 2.41 1.31 2.33 -a 
aoutliers corresponding to k-ratio more than 1.5. 
 
  
Table 5.9. Summary of tR-similarity-based QSRRs. 
System Q2CV RMSECV RMSEP% 
Zwitterionic 0.89 0.12 5.04 
Amide 0.90 0.05 3.78 
Amine 0.87 0.09 3.93 
Bare silica 0.83 0.07 3.88 
Diol 0.93 0.00 2.38 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4. Predicted retention times vs. observed retention times of the kratio 
filtering based QSRR models over all HILIC systems. RMSEPavr. is the average 
value of RMSEP of test compounds over five HILIC stationary phases. A total of 
343 data points included on the graph. 
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and a molecular descriptor showing a correlation value more than 0.8 was 
selected and used as a measure of tR similarity. This chosen descriptor was 
then used to rank the primary filter compounds and to select the nearest 
neighbour having lowest absolute difference descriptor values to the test 
analyte. The nearest neighbour was further used as a reference for tR 
similarity searching applying a k-ratio cutoff value of 1.5. QSRR-models 
were then derived using the dual-filtered-training set for the selected target. 
The scheme of dual-filtering for 2’-deoxycytidine as an example is depicted 
in Figure 5.5. Here, the test analyte was 2’-deoxycytidine and the primary 
TS filter identified 15 compounds in the dataset which showed a TS score of 
≥0.5. The retention times of these 15 compounds were strongly correlated to 
the HOMT (Harmonic Oscillator Model of Aromaticity index total) 
descriptor and this descriptor was then used to further rank the 15 
compounds to identify the nearest neighbour, compound 8, having lowest 
absolute difference of HOMT values to the test analye. The selected nearest 
neighbour was then used as a reference for further filtering of the database, 
leading to selection of a training set of 6 compounds with k-ratio values of 
less than 1.5. These 6 compounds were then used for subsequent GA-PLS 
modelling.  
The molecular descriptors utilised in this dual-filtering process for the 
various compound classes and HILIC stationary phases are shown in Tables 
5.10 and Table 5.11. The potential relevance of these descriptors in 
understanding the HILIC experimental system is discussed in the following 
section. 
The correlation data for the GA-PLS models obtained for dual filtered 
training sets for the five HILIC stationary phases are presented in Table 
5.12. The internal validation by root mean squared error (RMSECV) and Q2 
gave values of 0.03-0.34 and 0.89-0.96, respectively, over all the HILIC  
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Figure 5.5. An example of dual-filtering based QSRR strategy in this study. 
1retention time, 2Tanimoto similarity, 3numbering of compounds in training set 
indicated in Table 5.1, 4retention factor, and 5selected high correlated molecular 
descriptor. The definition of the selected molecular descriptor is available in Table 
5.11. 
 
Table 5.10. Molecular descriptors in the dual-filtering strategy In the table, it is 
observed that the same molecular descriptor was obtained for the test compounds 
from the same chemical classification. Definition of molecular descriptors are 
available in Table 5.11. 
 Stationary Phase: 
Test analytes Diol Bare silica Amine Amide Zwitterionic 
β- Agonists Hy MLOGP MLOGP Hy MLOGP 
Nucleosides HOMT HOMT HOMT HOMT HOMT 
Benzoic acids ATSC4s HATS2p ATSC4s ATSC4s ATSC1s 
Xanthines and 
Uric Acids 
MATS1v MATS1v MATS1v MATS1v MATS1v 
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Table 5.11. Highly correlated molecular descriptors utilised for the dual-filtering 
strategy. 
 
Molecular 
Descriptor 
Description Category 
MLOGP Moriguchi octanol-water partition coeff. (logP) Molecular 
properties 
HOMT HOMA (Harmonic Oscillator Model of Aromaticity 
index) total 
Geometrical 
descriptors 
HATS2p everage-weighted autocorrelation of lag 2 / weighted 
by polarisability 
GETAWAY 
descriptors 
MATS1v Moran autocorrelation of lag 1 weighted by van der 
Waals volume 
2D autocorrelations 
ATSC4s Centred Broto-Moreau autocorrelation of lag 4 
weighted by I-state 
2D autocorrelations 
Hy hydrophilic factor Molecular 
properties 
ATSC1s Centred Broto-Moreau autocorrelation of lag 1 
weighted by I-state 
2D autocorrelations 
 
 
Table 5.12. Performance summary of the dual-filtering based QSRR models 
System Q2CV RMSECV RMSEP (%) 
Zwitterionic 0.96 0.34 10.21 
Amide 0.91 0.11 13.83 
Amine 0.93 0.16 11.83 
Bare silica 0.89 0.17 13.75 
Diol 0.94 0.03 2.95 
Method abbreviations explained in Chapter 2. 
Table 5.13. Median predicted retention times using the dual-filtering based QSRR 
modelling strategy. 
   Retention times   
nr.  Analytes Zwitterio
nic 
Amide Amine Bare 
silica 
Diol 
 Nucleosides      
1 2'-Deoxyadenosine 4.71 4.14 a a 3.55 
2 2'-Deoxycytidine 10.09 10.29 11.13 4.31 3.35 
3 2',3'-Dideoxyadenosine a 4.46 4.35 a 3.59 
4 2'-Deoxyguanosine 10.58 9.80 10.86 3.80 3.28 
5 3'-Deoxyguanosine 10.34 9.56 12.00 3.68 3.24 
6 5'-Methyluridine 4.56 4.15 a a 2.36 
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7 Adenosine a 5.09 a a 3.16 
8 Cytidine 12.85 12.06 15.48 4.76 3.04 
9 Guanosine 11.66 8.38 a 3.78 3.17 
10 Inosine 7.21 a 8.18 3.17 3.05 
11 Thymidine a a a a 2.36 
12 Uridine 4.79 4.31 5.49 a 2.16 
13 Acyclovir 8.65 a 8.97 3.32 3.49 
14 2'-Deoxyuridine 3.85 3.73 a a 2.36 
15 3'-Deoxythymidine a 3.49 a a 2.37 
16 2'-Deoxyinosine 9.42 7.73 a 3.55 2.82 
 β-Adrenergic Agonists     
17 Adrenaline a 7.47 8.37 5.74 5.03 
18 Noradrenaline a 7.71 a a 4.86 
19 3'-Methoxytyramine 9.75 6.44 6.11 4.67 5.47 
20 Isoproterenol 11.58 6.29 7.66 4.89 4.54 
21 Fenotrole a 7.57 6.29 3.55 3.74 
22 Terbutaline 10.47 6.52 6.07 3.47 4.16 
23 Salbutamol 9.99 6.33 6.45 4.25 4.75 
24 Ritudrine a 6.98 a a 4.05 
25 Metaproterenol 10.75 6.22 6.85 4.11 4.15 
26 Synephrine 11.85 6.33 7.27 5.20 5.12 
27 Dopamine 13.62 7.73 9.30 5.37 5.11 
28 N-methylephrine a a a a 5.77 
29 Norphenylephrine 14.05 7.79 8.74 5.55 5.03 
30 Phenylephrine 11.09 6.25 6.82 5.11 5.12 
31 Tyramine 10.19 6.757 6.41 4.84 5.26 
32 Normetanephrine a 7.74 a 6.57 5.12 
33 Octopamine 14.23 7.62 6.69 5.83 5.11 
34 Methoxamine a 5.95 a 4.18 5.44 
35 Isoxuprine a a a a 4.48 
 Xanthines and Uric Acids     
36 Pentoxyfylline 2.13 2.29 a a 2.64 
37 Guanine a a a a 3.83 
38 Xanthine a 5.40 5.83 3.35 2.81 
39 Caffeine 2.32 2.91 5.81 1.47 2.66 
40 Theophylline a 3.09 2.75 1.57 2.70 
41 Theobromine 2.79 2.85 2.63 1.42 2.67 
42 Diphylline 3.37 5.11 a 1.77 2.67 
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43 7-
Hydroxyethyltheophylline 
a 3.06 2.78 1.66 2.69 
44 1-Methyluric acid 4.81 5.25 8.71 2.28 2.66 
45 1-Methylguanine 5.84 a 5.57 2.29 3.45 
46 9-Methylguanine 6.60 5.87 7.27 2.09 3.68 
47 Uric acid a a a a 2.65 
48 3,7-Dimethyluric acid 4.71 5.27 5.46 2.04 2.56 
49 7-Methylxanthine 4.00 5.40 5.86 2.03 2.72 
50 Hypoxanthine 5.33 a a 2.31 3.40 
51 Proxyphylline a a a a 2.64 
52 1,7-Dimethyluric acid 5.06 4.71 5.26 2.38 2.66 
53 1,3-Dimethyluric acid 5.09 5.25 a 2.18 2.52 
54 1,3,7-Trimethyluric acid 3.11 2.43 a 1.68 2.67 
 Benzoic acids      
55 Salicylic acid 3.05 3.42 4.93 1.30 2.25 
56 5-Methylsalicylic acid 3.18 3.82 3.83 a 2.31 
57 4-Hydroxybenzoic acid 2.67 2.77 2.83 1.28 2.26 
58 3-Hydroxybenzoic acid 3.74 2.74 4.18 1.40 2.26 
59 2,3-Dihydroxybenzoic 
acid 
4.01 a a 1.49 2.26 
60 2,4-Dihydroxybenzoic 
acid 
4.13 a a 1.59 2.23 
61 2,5-Dihydroxybenzoic 
acid 
4.43 a a 1.56 2.23 
62 3,4-Dihydroxybenzoic 
acid 
3.89 3.83 4.32 1.51 2.17 
63 3,5-Dihydroxybenzoic 
acid 
4.60 3.26 5.17 1.52 2.23 
64 Benzoic acid 2.51 a a a 2.27 
65 3-Amino-4-
hydroxybenzoic acid 
2.55 2.85 3.23 1.44 2.25 
66 4-Aminobenzoic acid 2.57 2.65 a 1.36 2.27 
67 4-Aminosalicylic acid 4.05 3.91 4.76 1.28 2.23 
68 3-Aminobenzoic acid 2.45 2.47 3.70 1.34 2.28 
69 Vanillic acid 2.96 3.01 3.10 1.37 2.25 
70 Syringic acid 2.81 2.57 3.53 1.71 2.23 
71 2-Methoxybenzoic acid 2.66 a 3.38 a 2.31 
72 P-Toluic acid 2.42 2.77 a 1.32 2.27 
a outliers corresponded to high k-ratio values (k-ratio more than 1.5)  
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systems, which indicates that the predicted retention values are in relatively 
good agreement with the experimental data. The predicted retention time of 
the test analytes found by applying dual-filtering based QSRR modelling is 
presented in Table 5.13. 
An external validation was performed to evaluate the prediction accuracy 
of the QSRR models for the retention of the unknown compounds. A 
comparison between the predicted retention times and those observed 
experimentally for each test compound using the dual-filtering based GA-
PLS model with the corresponding average RMSEP values (RMSEP values 
obtained for each stationary phase are presented in Table 5.12), is depicted 
in Figure 5.6, and is compared to the diverse, global and TS-based QSRR 
models in the same figure. As seen in Figure 5.6, the dual-filtering based 
GA-PLS models generated for all five columns were very well correlated 
with the experimental data, presenting an average RMSEP value of 11.01%, 
whereas the global and TS-based GA-PLS yielded models with average 
RMSEP values of 46.55% and 27.10%, respectively, while an even higher 
average RMSEP value of 69.28% was found for the diverse QSRR models 
around over all HILIC systems (Figure 5.6A). The same trend is seen in 
Figure 5.7 with a comparison of the predictive ability of global, TS-based 
and dual-filtering-based GA-PLS models on each HILIC stationary phase. 
The obtained results imply that when predicting the retention time of a 
new compound, it is best to assign the most appropriate subset of 
compounds as the training set and to create the QSRR model specific to that 
subset, providing an acceptable level of accuracy of retention time 
prediction. 
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Figure 5.6. Predictive ability of (A) diverse, (B) global, (C) TS-based, and (D) 
dual-filtering based GA-PLS models for an external test set over five different 
HILIC systems. RMSEPavr. is the average value of RMSEP of test analytes over 
five HILIC stationary phases.  
 
 
 
Figure 5.7. Comparison of the predictive ability of diverse, global, TS-based and 
dual-filtering-based GA-PLS models for an external test set over five different 
HILIC systems.
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5.3.4 Relationship between molecular descriptors and the HILIC 
mechanism 
The partitioning of the analytes between an immobilized water-enriched 
layer on a hydrophilic stationary phase and the relatively hydrophobic 
eluent of the bulk mobile phase has been recognised as a significant factor 
in the HILIC mechanism [37]. Besides partitioning, electrostatic interactions 
and hydrogen bonding have also been reported to contribute significantly to 
retention behaviour in HILIC systems [13, 38, 39]. However, the retention 
mechanism occurring in HILIC is acknowledged to be complex and a 
complete theoretical description has not yet been discovered [40, 41]. In this 
study, by analysis of the descriptors appearing in the proposed dual-filtering 
strategy for each stationary phase (Tables 5.10 and 5.11), some insight can 
be gained into the factors that influence the retention mechanism in these 
systems. Although the relevance of some descriptors is still not completely 
clear in terms of their significance to the chromatographic process, other 
descriptors are clearly linked with chemical properties that are relevant to 
the HILIC experimental system. 
The importance of analyte partitioning in the HILIC mechanism is 
underlined by the structural descriptors which were most strongly correlated 
to tR for each of the studied columns (see Table 5.10). The descriptor 
MLOGP (Moriguchi octanol-water partition coefficient (logP)) is selected 
in the dual-filtering process for the bare silica, amine and zwitterionic 
systems, while Hy (hydrophilic factor) is selected in the amide and diol 
systems. HOMT [42] and HATS2p [43, 44] belong to geometrical 
descriptors that capture information on molecular size and shape combined 
with the information on electronic properties. 2D autocorrelation descriptors 
[45] weighted by I-state (ATSC1s and ATSC4s) and van der Waals volume 
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(MATS1v) represent the role of atomic size and electronic properties in the 
retention behaviour of studied analytes in HILIC systems.  
5.3.5 Conclusions 
In this study, a novel compound-filtering-based QSRR modelling 
strategy that comprises a combination of Tanimoto similarity (TS) ranking 
and tR similarity searching prior to GA-PLS modelling was demonstrated 
using HILIC data examples. The GA-PLS model based on a dual-filtering 
strategy permits a robust and accurate prediction of the retention times of 
test pharmaceuticals compared to global, diverse and TS-based QSRR 
models over a wide range of HILIC stationary phases. These results suggest 
that a QSRR model can reliably predict a test analyte’s retention if the test 
analyte is sufficiently similar in structure and retention time to the group of 
compounds used to generate that QSRR model. The proposed method also 
contains sufficient information to enhance the understanding of the HILIC 
retention mechanism. Application of the proposed methodology in HILIC 
method development to identifying initial target columns and 
chromatographic conditions for unknown sample tests is the goal of future 
research.  
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6 General conclusions  
The development of computer-assisted approaches capable of accurate 
prediction of the retention behaviour of analytes, leading to optimisation of 
chromatographic performance, is a major goal for method development in 
chromatography [1]. Statistically derived quantitative structure-retention 
relationships (QSRRs) represent a quite popular approach to retention 
prediction [2]. A QSRR shows the relationships between chromatographic 
parameters, such as the retention as the dependent variable, and parameters 
describing analytes and columns for a given set of test molecules and 
columns. 
Hydrophilic interaction chromatography (HILIC) [3] using a polar 
sorbent in combination with a hydro-organic mobile phase, provides an 
approach for the effective separation and quantitative determination of small 
polar compounds. Recently, HILIC has been successfully applied for the 
analyses of a wide range of small polar compounds, including drugs, toxins, 
plant extracts, and other compounds important to food and pharmaceutical 
industries [4, 5]. The detailed retention mechanism applicable in HILIC is 
still under some discussion and for this reason, method development in 
HILIC is difficult. 
This thesis describes the development of retention prediction models for 
a variety of differently structured pharmaceutical compounds and 
commercially available stationary phases used in the HILIC mode.  
QSRR models were developed to predict the retention times of analytes 
on five HILIC stationary phases (bare silica, amine, amide, diol and 
zwitterionic), with a view to selecting the most suitable stationary phase(s) 
for the separation of these analytes. The study was conducted using β-
adrenergic agonists as target analytes. Molecular descriptors were calculated 
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based only on chemical structures optimised using density functional theory. 
A genetic algorithm (GA) was then used to select the most relevant 
molecular descriptors and these were used to build a retention model for 
each stationary phase using partial least squares (PLS) regression. This 
model was then used to predict the retention of the test set of target analytes. 
This process created an optimised descriptor set which enhanced the 
reliability of the developed QSRR models. Finally, the QSRR models 
developed in the work were utilised to provide some insight into the 
separation mechanisms operating in the HILIC mode. Three performance 
criteria – mean absolute error (MAE), root mean square error of prediction 
scaled to retention time (RMSEP), and the number of selected descriptors, 
were used to evaluate the developed models when applied to an external test 
set of β-adrenergic agonists and showed highly predictive abilities. RMSEP 
values of 4.88-11.12% were recorded. Validation was performed through Y-
randomization and chemical domain applicability, from which it was 
evident that the developed optimised GA-PLS models were robust. The high 
levels of accuracy, reliability and applicability of the models were to a large 
extent due to the optimisation of the GA descriptor set and the presence of 
relevant structural and geometric molecular descriptors, together with 
descriptors based on important physicochemical properties, which establish 
a strong connection between retention time and meaningful chemical 
properties.  
The present strategy holds great promise for broader screening of HILIC 
stationary phases for a desired separation, as well as for acquisition of 
information about molecular mechanisms of separation under 
chromatographic conditions. 
Next, a design-of-experiment (DoE) model was developed, able to 
describe the retention times of a mixture of pharmaceutical compounds in 
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HILIC under all possible combinations of acetonitrile content, salt 
concentration, and mobile-phase pH with R2 >0.95. Further, a QSRR model 
was developed to predict retention times for new analytes, based only on 
their chemical structures, with a RMSEP as low as 0.81%. A compound 
classification based on the concept of similarity was applied prior to QSRR 
modelling. Finally, a combined QSRR-DoE approach was utilised to 
propose an optimal design space in a quality-by-design (QbD) workflow to 
facilitate the HILIC method development. The mathematical QSRR-DoE 
model was shown to be highly predictive when applied to an independent 
test set of unseen compounds under unseen mobile phase conditions with a 
RMSEP value of 5.83%. The QSRR-DoE computed retention time of 
pharmaceutical test analytes and subsequently calculated separation 
selectivity was used to optimise the chromatographic conditions for efficient 
separation of targets. A Monte Carlo simulation was performed to evaluate 
the risk of uncertainty in the model’s prediction, and to define the design 
space where the desired quality criterion was met. Experimental realization 
of peak selectivity between targets under the selected optimal working 
conditions confirmed the theoretical predictions. These results demonstrate 
how discovery of optimal conditions for the separation of new analytes can 
be accelerated by the combination of high-throughput theoretical and 
experimental methods. 
The development of QSRRs with a sufficient accuracy to support high 
performance liquid chromatography (HPLC) method development is still a 
major issue [1, 6]. To tackle this challenge, this thesis has presented a novel 
QSRR methodology based on a dual filtering strategy which combined 
Tanimoto similarity (TS) searching as the primary filter and retention time 
(tR) similarity clustering as the secondary filter, using a database of 
pharmaceutical compound retention times collected over a wide range of 
HILIC systems. To employ tR similarity filtering, correlation to a molecular 
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descriptor was used as a measure of retention time. For the retention time of 
a compound to be modelled, a relationship between experimental 
chromatographic data and various molecular descriptors was calculated 
using a GA-PLS regression. The proposed dual-filtering-based QSRR model 
significantly improved the retention time predictability compared to the 
diverse, global and TS-based QSRR models, with an average RMSEP of 
11.01% over five different HILIC stationary phases. Interpretation of the 
molecular descriptor correlation strategy revealed that particular trends for 
the HILIC mechanism could be captured using the proposed dual filtering 
technique.  
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